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Abstract
Using both novel and established molecular evolutionary modelling techniques, we
have investigated the evolution of primate lentiviruses and interactions with their
hosts. Firstly, we studied SAMHD1, a restriction factor of HIV-1 which is neu-
tralised by lentiviral proteins. SAMHD1 has previously been shown to be under
positive selection in primates, ostensibly due to pressure to escape recognition by
lentiviral antagonists. We show positive selection is not unique to primates but
has occurred throughout chordate evolution. In mammals, we unexpectedly find
SAMHD1 sites under positive selection are clustered in the domain controlling en-
zymatic activation. We hypothesise that positive selection is driven by undiscovered
animal viruses and/or precise regulation of SAMHD1 activity. Secondly, we anal-
ysed the capsid proteins of pandemic HIV-1 and its chimpanzee progenitor, SIVcpz.
We looked for sites evolving under different selective constraints with the aim of
discovering host specific adaptation. We identify sites in the domain bound by host
cofactors, which govern crucial events in virus replication and prevent immune sens-
ing, suggesting host specific responses to cofactor interaction. Thirdly, we apply this
same approach to pandemic HIV-1 and SIVcpz accessory proteins, which mitigate
host immunity. Surprisingly, we identify sites in regions of nef and vpr involved
in putatively conserved interactions with host proteins, suggesting unexpected host
specific adaptation. In vpu, we identify sites involved in antagonism of the restric-
tion factor tetherin — a function acquired by pandemic HIV-1 on adaptation to
humans — together with sites which we hypothesise are similarly involved. Finally,
lentiviruses and other organisms possess overlapping coding sequences, for which
existing codon selection models are unsuitable. We propose a novel approach which
models nucleotide substitution. In synthetic data tests, one of four candidate models
was accurate and we developed a mixture model for identifying positive selection at
codon sites, which we also tested with synthetic data.
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Chapter 1
Introduction
1.1 Molecular Evolution
Molecular evolution is the study of organisms changing across generations, by statis-
tical inference from molecular sequence data. By analysing how protein and genetic
sequences differ between related organisms we can come to understand the process
of evolution at the molecular level, or reconstruct the history of past evolutionary
events. The capabilities of biological evolutionary research have expanded dramat-
ically with the ongoing increase in genetic sequences available from diverse organ-
isms, together with continuously expanding computational resources for storing and
analysing them. Aside from an interest in evolution itself, studying the molecular
adaptation which gave rise to the organisms we see today can guide the research of
our primary interest as biologists, namely how viruses, butterflies or oak trees are
able to function.
1.1.1 Modelling Molecular Evolution
A typical analysis begins with molecular sequences from different organisms being
aligned to one another, compensating for sequence insertions or deletions, such that
related (homologous) sites in each sequence are correctly compared. Simple prob-
abilistic models are devised to represent how nucleotides, codons or amino acids
states undergo substitution by the process of mutation and then fixation by natural
selection. A probabilistic approach is superior to reconstructing past events by iden-
tifying most parsimonious explanations because it accounts for unobserved multiple
substitutions and reversions. These models must balance our understanding of bi-
14
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ology with mathematical tractability. Transitions between states are conventionally
modelled as a continuous-time Markov process, expressed as a matrix Q of instanta-
neous substitution rates between states, populated by parameters representing our
assumptions about the substitution process. For example, the HKY85 nucleotide
model (Hasegawa et al., 1985):
Q =

∗ κpiC piA piG
κpiT ∗ piA piG
piT piC ∗ κpiG
piT piC κpiA ∗
 (1.1)
where pii is the equilibrium probability of nucleotide i, a mathematical contrivance
corresponding to the proportion of time that i would occupy the site over an infinite
duration. κ represents the bias for substitutions of nucleotides of the same chemical
structure (transitions, i.e. purine to purine or pyrimidine to pyrimidine) over those
changing the chemical structure (transversions, e.g. purine to pyrimidine). This
parameter therefore represents a known biological phenomenon. Different models
can be created by adding or removing parameters from Q. The rows of the matrix
must sum to 0, and so the diagonal elements are defined
qii = −
∑
{j|j 6=i}
qij. (1.2)
The models are reversible, meaning the flux of probability density from state i
to j must be identical in the reverse; formally, piiqij = pijqji. Ultimately we wish
to compute the probability of substitution from i to j in a given interval of species
divergence t, equivalent to a branch length on a phylogenetic tree topology. For
convenience Q is multiplied by a scalar ν such that one unit of t represents one
substitution per site. Ordinarily a single Q applies to all sites, in which case
ν =
1
−∑i piiqii . (1.3)
These Markov models assume that evolution at each site has the statistical prop-
erty of being ‘independent and identically distributed’ (i.i.d.), for the purposes of
reducing the number of parameters involved (Yang, 2006). However, we may wish
to have multiple matrices, each applicable to a subset of sites; e.g. one could have a
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separate matrix for each of the three codon positions. In which case,
ν =
∑
kNk
−∑kNk∑i piiqii,k (1.4)
where Nk is the number of sites in subset k, to which Qk is applicable. (Note that∑
kNk is the total number of sites in the alignment.) In this case sites within each
set k are i.i.d., but not between sets.
From the scaled rate matrix, we compute the matrix of substitution probabilities
for the interval t:
P (t) = eQt =
∞∑
n=0
Qn
tn
n!
. (1.5)
1.1.2 Model Likelihood and Hypothesis Testing
The fit of a model and its parameter values can be assessed by the principle of likeli-
hood. The likelihood of the model in light of the data is the probability of observing
the data assuming the model were true. Given a model Q comprising parameter
values {θ}, a tree topology with branch lengths {t} and a sequence alignment, P (t)
is computed for each branch and the likelihood can be computed with Felsenstein’s
pruning algorithm (Felsenstein, 1981). This is a dynamic programming approach
which efficiently sums over substitution probabilities for all possible evolutionary
histories. Finding values for θ which maximise the likelihood gives the parameter
maximum likelihood estimates (MLEs; θˆ). For all but the simplest models the max-
imisation requires numerical optimisation algorithms. Tree topologies themselves
are also estimated by maximum likelihood (ML), using software such as RAxML
(Stamatakis, 2006).
In an ML framework, biological hypotheses can be tested by constructing two
models which differ by one or more parameters, corresponding to null and alternative
hypotheses. For example, one may test whether there is a bias for transitions over
transversions by constructing the HKY85 model (eq. 1.1) as an alternative model
and also a null model which has κ fixed to 1. The models are said to be ‘nested’,
as the null is a special case of the alternative. Both models are fitted to the data
and the null can be rejected if the alternative has a significantly higher likelihood.
A p value is computed from the test statistic D = 2(lnL1 − lnL0), where L1 and
L0 are the likelihood under the alternative and null models, respectively. The null
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distribution of D is approximated by a χ2 with degrees of freedom equal to the
difference in free parameters (1 in the HKY85 example above). This is called the
likelihood ratio test (LRT).
1.2 Modelling Selection
1.2.1 Types of Selection
Often we study molecular sequences in order to identify the action of natural se-
lection. In population genetics theory, natural selection is divided into three types:
negative (purifying) selection, in which genotypic change negatively affects the or-
ganism’s fitness; neutral selection, where there is little or no effect on fitness; or
positive selection, where change is favoured by natural selection. Positive selection
can be further divided into diversifying selection and directional selection. Diver-
sifying selection describes change from the present state being favoured, with little
preference for the target state. For example, in the presence of antibodies, an amino
acid change on a virus’ exterior which prevents antibody binding may be favoured,
regardless of what the new amino acid is. (The result is increased diversity, because
each descendent lineage will likely make different changes to differentiate itself from
the ancestral type.) Conversely, directional selection describes specific changes be-
ing favoured, perhaps because the organism’s environment begins imposing new
selective constraints, for example if a virus begins infecting a new host species.
1.2.2 Codon Models and the dN/dS Ratio
To identify selection in molecular data, one must distinguish substitutions which
have occurred by chance, rather than as adaptive change. A powerful family of
models do so by exploiting the degeneracy of the genetic code. Codon substitutions
which do not change the amino acid (called ‘synonymous’) are assumed to be neutral
(have no effect on fitness), while those that do (‘nonsynonymous’) are assumed to be
subject to selection. Comparing the number of substitutions of each type estimated
to have occurred between sequences gives a measure of selection. The ratio of these
‘genetic distances’ dN and dS being < 1 indicates negative selection, while ≈ 1
indicates neutrality and > 1 indicates positive selection.
By defining a parameter ω = dN/dS, Goldman and Yang (1994) devised a codon
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substitution model which can account for selection, where the rate of substitution
from codon I to codon J is
qIJ =

0, if I and J differ by 2 or 3 nucleotides,
piJ , if I and J differ by synonymous transversion,
κpiJ , if I and J differ by synonymous transition,
ωpiJ , if I and J differ by nonsynonymous transversion,
ωκpiJ , if I and J differ by nonsynonymous transition
(1.6)
where piI is the equilibrium probability of codon I and κ is as defined above. Given
a codon alignment, the likelihood of the model is computed as described above.
To assume a single ω is suited to all sites is unrealistic, however, due to varied
structural constraints in most proteins. Indeed, the majority of sites will be under
negative selection in any coding sequence, meaning positive selection is unlikely to
be identified. Nielsen and Yang (1998) therefore extended this approach to a mixture
model allowing for three classes of sites, represented as three rate matrices featuring
parameters which are constrained to represent the types of selection described above:
ω0 < 1, ω1 = 1 (i.e. fixed) and ω2 > 1. Each site class i has a probability pi of being
applicable. The likelihood for the data X observed at site h is then sum over
components of the mixture:
L(Xh) =
∑
i
piP (Xh|ωi) (1.7)
where P (Xh|ωi) is the likelihood of the model given data Xh computed with the
rate matrix populated with ωi. Each site remains i.i.d., but using a mixture model
accounts for the ambiguity associated with the selection pressure at each codon site,
without resorting to a large number of site-specific parameters. A test for positive
selection can be constructed by fitting to the data both a null model which has
only the negative and neutral selection site classes and an alternative model which
features the positive selection site class in addition. These correspond to models M1a
and M2a respectively (Wong et al., 2004). The LRT is used to assess significance,
with two degrees of freedom. More complex mixture models allow flexibility by
having a range of ω values represented as a beta distribution (Yang et al., 2000),
corresponding to models M7 (null) and M8 (alternative); again the LRT provides a
test for positive selection. A further extension allows tests on specific lineages in a
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phylogeny, such that episodic positive selection can be identified (Yang and Nielsen,
2002). Each of these models are implemented in codeml, in the PAML software
package (Yang, 2007).
1.2.3 Site-Wise Mutation Selection Model
The codon substitution models inheriting from Goldman and Yang (1994) are well
suited to identifying diversifying positive selection, since the ω parameter makes
no distinction between nonsynonymous changes. Arguably these models may be
therefore suited to only a few biological situations (Hughes, 2007).
Tamuri et al. (2009) developed a modeling framework explicitly for studying
directional positive selection. Their interest lay in identifying adaptation of a virus to
new selective constraints following transmission from an animal reservoir to humans
(a zoonosis). They developed an amino acid substitution model, in which amino
acid equilibrium frequencies were specific to each protein site (i.e. site-wise). In their
null model, a single set of equilibrium frequencies is applied to all lineages in the
phylogeny, representing the hypothesis that the evolutionary process is consistent.
Their alternative model permits a separate set of frequencies for a clade of viruses
infecting a different host, representing the hypothesis that the selective constraints
imposed by the host cause the evolutionary process to change. Statistical support is
assessed with the LRT. This approach was applied to influenza virus, which persists
as an avian reservoir but routinely establishes epidemics in humans.
Subsequently these authors (Tamuri et al., 2012) developed a site-wise codon
substitution model (swMutSel) which incorporates both processes of mutation at
the genetic level and selection acting on the protein, with reference to population
genetics theory (Halpern and Bruno, 1998; Yang and Nielsen, 2008; Kimura, 1962).
The substitution rate between codons I and J at site K is
qIJ,K = q
HKY
ij ×
SIJ,K
1− e−SIJ,K (1.8)
where qHKYij is as given in equation 1.1 and represents the rate of mutation be-
tween the nucleotides i and j which differ between the codons (multiple nucleotide
changes in a codon have a rate of 0); this is shared across sites. SIJ,K is the selec-
tion coefficient (difference in codon Malthusian fitnesses f) scaled by the effective
population size N : SIJ,K = 2N(fJ,K − fI,K) = FJ,K − FI,K . Codon fitnesses are
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assumed to be defined solely by the amino acids they encode and are expressed
relative to a single arbitrarily chosen residue, meaning there are 19 scaled fitness
parameters. Mutation parameters and branch lengths are estimated separately by
a related mutation-selection model which is less computationally demanding (Yang
and Nielsen, 2008).
swMutSel has been extended by Asif Tamuri (European Bioinformatics Institute,
UK) to test for site-wise divergent selective constraints similar to the amino acid
model (Tamuri et al., 2009) in the context of a codon mutation-selection model
(Tamuri et al., 2012). The alternative model permits the sublineage of interest
independent amino acid fitness parameters. Significance is assessed with the LRT,
using N − 1 degrees of freedom, where N is the number of residues present at the
site. The performance of swMutSel in identifying directional selection has been
assessed in a simulation study and found to be accurate and conservative, while
also having greater sensitivity than dN/dS codon models for this type of positive
selection (Thiltgen et al., 2016).
1.3 Primate Lentivirus Biology
We are interested in the evolution of primate lentiviruses and the interactions
with their hosts. Lentiviruses are retroviruses (Baltimore class VI), meaning their
genomes are positive sense single stranded RNA and replicated through a DNA
intermediate which is integrated into the host cell genome. Among these are the
human immunodeficiency viruses (HIV), which are causative agents of acquired im-
munodeficiency syndrome (AIDS).
1.3.1 AIDS and its Impact
AIDS was first identified in the 1980s when previously healthy young men in urban
centres presented with infections usually found in immunocompromised patients
(Gottlieb et al., 1981) and a retrovirus was identified as the infectious agent re-
sponsible (Barre-Sinoussi et al., 1983). HIVs are primarily transmitted sexually and
infection is established in mucosal tissue before progressing to the primary target
cells, CD4+ T cells which form an integral part of the adaptive immune system. As
the infection progresses the population of these cells is destroyed, leaving the patient
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vulnerable to infection by opportunistic pathogens (reviewed by Deeks et al., 2015).
Antiretroviral drugs have been developed which inhibit the viral enzymes (reverse
transcriptase, protease and integrase), suppress viral replication and delay progres-
sion to AIDS. However, the virus is not eliminated and will rebound if treatment
is withdrawn. Drug resistance emerges routinely, meaning drugs must be used in
combination (Clavel and Hance, 2004). No successful therapeutic or prophylactic
vaccine has been developed (Esparza, 2013), for reasons discussed below.
AIDS is a pandemic (worldwide epidemic) and its impact on global health has
been profound. 37 million people are estimated to be infected with HIV (UNAIDS,
2016), equivalent to the population size of Canada. Since the emergence of HIV
35 million people are estimated to have died from AIDS-related disease. Globally,
deaths are now declining, having peaked in 2005, partly due to increased availability
of antiretroviral therapy (ART; UNAIDS, 2013). However, still only 37% of infected
people receive ART, which is particularly scarce in developing countries. AIDS is
damaging to communities and societies because it disables young people who would
be otherwise productive. There is a substantial economic impact in the Western
world (Trapero-Bertran and Oliva-Moreno, 2014), but AIDS has significantly hin-
dered the progress of developing nations, particularly in sub-Saharan Africa (Dixon,
2002). Without exaggeration, confronting the AIDS pandemic can be described as
one of the greatest collective challenges in human history.
1.3.2 Virus Particle, Genome and Life Cycle
The lentivirus virion comprises a viral core surrounded by a lipid bilayer, through
which protrude protein spikes (fig. 1.1A). The core is made from the viral capsid
protein assembled into hexamers and pentamers, which in turn assemble into a
cone structure (fig. 1.1B), housing the two copies of the RNA genome and the viral
enzymes. The ∼ 10 kilobase genome encodes 9 genes which produce 15 protein
products: gag encodes structural proteins as a polyprotein, including capsid; pol
encodes the viral enzymes, also as a polyprotein; env encodes the spike protein;
tat and rev are regulatory proteins involved in viral gene expression; nef, vpu, vpr
and vif are accessory proteins involved in mitigating cellular immunity. The HIV-1
genome contains 7 instances of overlapping coding sequences, where a single locus
contains more than one translated reading frame. At one locus the maximum 3
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Three-prime repair 
exonuclease 1
(TREX1). A cytosolic 
exonuclease that degrades 
HIV-1 DNA accumulated in 
target cells. Despite this 
seemingly antiviral function, 
TREX1-mediated degradation 
of viral DNA products 
correlates with an inhibition of 
innate immune sensors leading 
to type I interferon activation.
Reverse transcription 
complex
(RTC). The term used for viral 
ribonucleoprotein after it has 
entered the target cell and 
begun reverse transcription of 
its RNA genome. As reverse 
transcription is thought to 
initiate rapidly after fusion, we 
use this term to generically 
describe the infectious viral 
complex following fusion.
Simple retroviruses
Basic retroviruses, such as 
murine leukaemia virus, that 
contain only the genes gag 
(which encodes viral structural 
proteins, such as matrix and 
capsid), pro (which encodes the 
viral protease), pol (which 
encodes the reverse 
transcriptase and integrase 
proteins) and env (which 
encodes the viral protein 
envelope).
Nuclear pore complexes
(NPCs). Large (~50 mDa) 
multiprotein assemblies that 
govern transport across the 
nuclear envelope. NPCs are 
made up of approximately 30 
different proteins, termed 
nucleoporins.
would imply that uncoating is incomplete until the viral 
genome has entered the nucleus. However, studies exam-
ining the size constraints of cargos that traffic through 
the nuclear pore complexes (NPCs) have found an upper 
limit of ~39 nm25,26, which is significantly smaller than 
the 50–60 nm width of an intact fullerene cone4. Taken 
together, this suggests that the loss of CA from the RTC 
is unlikely to be a single, discrete event, thereby forc-
ing some reconsideration of the definition of uncoating. 
Based on the putative function of CA and the capsid core 
during infection, the uncoating process can be thought 
of as occurring in at least two stages. The first stage is 
the loss of integrity of the intact core. This event is nec-
essarily cytoplasmic, as the capsid core is too large to 
remain intact as it traffics through the NPC. However, 
the recent observation that some CA remains associated 
with the RTC in the nucleus23,24 suggests that whatever 
core destabilization that occurs before nuclear import 
does not remove all of the CA from the RTC.
Understanding the manner in which disassembly of 
the capsid core is coupled to critical aspects of infec-
tion is more than a problem of nomenclature. An intact 
capsid core, housing the viral genome and viral proteins, 
may represent a fundamentally different therapeutic tar-
get to the small amount of CA that may remain asso-
ciated with the RTC following entry into the nucleus, 
although both may be viable therapeutic targets. Some 
host cell proteins, or antiviral drugs, that interact with 
CA may do so only in the context of assembled CA, or 
they may exhibit increased affinity for the assembled 
form of CA7,8. Therefore, it is important to determine 
to what extent assembled CA hexamers or pentamers 
continue to exist following partial disassembly of the 
original capsid core structure.
Much of our understanding of the stability of the cap-
sid core is derived from studies of CA mutations that 
perturb this stability. In this regard, it is important to 
separate mutations that directly alter core stability from 
those that may indirectly affect core stability through 
altered interactions with certain host factors that facili-
tate uncoating (BOX 1). For example, in vitro studies have 
identified CA mutations that increase or decrease the 
intrinsic stability of the core, and both types of mutations 
reduce or abrogate HIV-1 infectivity12, suggesting that 
the intrinsic stability of the capsid core is delicately bal-
anced to promote infection. However, the identification 
of compensatory mutations that improve infectivity of 
hyperstable or unstable CA mutants without restoring 
the stability of the mutant capsid core to levels similar 
to the wild-type capsid core27 demonstrate the complex 
relationship between core stability and infection.
An improved understanding of the links between 
CA, the stability of the capsid core and HIV-1 infec-
tivity is increasingly necessary, given the growing evi-
dence that assembled CA may provide a strong target 
for therapeutic intervention. Unlike HIV-1 enzymes, CA 
is genetically ‘fragile’ (REF. 28), as it is stretched to the 
limit genetically by the pressure to mature into a core 
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Figure 1.1: Structure of the lentivirus virion. (A) Cartoon of the virion. The
viral core comprises the capsid protein (CA) and houses the viral RNA genome
and stabilising nucleocapsid protein (NC). The matrix protein (MA) is positioned
between the core and the lipid envelop , through which the envelope protein (Env,
made from glycoproteins gp120 and gp40) protrudes. (B) Protein odel of the core,
showing capsid proteins arranged in hexamers (orange) and pentamers (yellow).
From Campbell and Hope (2015).
reading frames are occupi d, by tat, rev and nv.
The life cycle begins with he virion binding via its envelope protein the CD4
receptor on a macrophage or CD4+ T cell (fig. 1.2). Interaction with a coreceptor
(typically CCR5) mediates fusion of the viral lipid envelope with the target cell
plasma membrane. The co e traffics t the nucleus and the r verse transcribed ge-
netic material (cDNA) is imported through the nuclear pore. The details and timing
of core uncoating and reverse transcription remain unclear, thoug it is likely ev rs
transcription occurs within an intact or partially intact core (Campbell and Hope,
2015). The viral cDNA is integrated into the host gen e by the viral i tegrase,
and viral transcription and translation proceed as for cellular genes. Polyproteins
of Gag, Gag-Pol and Env aggregate at the plasma membrane, ogethe with viral
genomic RNAs. The nascent virion ‘buds’ from the cell, taking with it a portion of
the plasma membrane, which forms the viral envelope. The particle then undergoes
a maturation event where the vial protease cleaves the polyproteins, introducing
significant conformational changes which gives rise to an infectious virion.
1.3.3 Lentivirus Diversity and Evolution
HIV type 1 (HIV-1) is divided into four groups, each originating from independent
cross-species transmissions. Group M accounts for the vast majority of infections
worldwide, and is itself divided into 9-11 monophyletic subtypes. Group O infects
a few tens of thousands, largely confined to West Africa, while group N has been
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response, resistance development and 
disease progression. The variations in the 
immunological and virological outcomes 
depend on a complex balance of viral and 
host factors, including human leukocyte 
antigen (HLA) variants, which can modu-
late both innate and adaptive immune 
responses. Several HLA-B alleles (includ-
ing HLA-B*57, HLA-B*27 and HLA-B*13) 
have been consistently associated with viral 
control, including in interaction with KIR 
genotypes40–42.
The treatment revolution. From a clinical 
perspective, the outcome of HIV infec-
tion over the past three decades has been 
revolutionized by considerable progress in 
the therapeutic options available, which has 
transformed HIV infection from a fatal to 
a manageable chronic disease that has little 
effect on life expectancy.
At the time of the first reports of AIDS, 
clinicians could only treat the opportunistic 
infections associated with the disease with 
limited success. Only when HIV was identi-
fied as the virus responsible for the disease, 
and its life cycle was characterized, were the 
medical and scientific communities able to 
start investigating antiretroviral approaches.
The first step in HIV therapy was made 
in 1987, when a clinical trial showed that 
azidothymidine (AZT; also known as zido-
vudine) decreased mortality and opportun-
istic infections in patients with AIDS43. AZT, 
which had been originally synthesized as 
an anticancer treatment, was found to also 
block the reverse transcription step of the 
HIV-1 life cycle44. However, viral resistance 
quickly developed, and so new drugs had to 
be developed on the basis of insights into the 
HIV replication cycle and how to target it.
Indeed, almost a decade later, a major 
breakthrough was made with the introduc-
tion of a therapy that combined several 
drugs to limit the development of resistance. 
Studies showed that the introduction of a 
protease inhibitor alongside two nucleoside 
reverse transcriptase inhibitors (NRTIs) 
in combination antiretroviral therapy 
(ART) markedly reduced morbidity and 
mortality45–47.
Clinical research continues to improve 
the therapeutic options available, with the 
aim of successfully controlling viral replica-
tion with minimal side effects and manage-
able treatment regimens. Several studies 
have shown that starting ART early after 
Figure 2 | Schematic overview of the HIV-1 replication cycle. The figure 
illustrates the main steps in the HIV-1 replication cycle: binding to the CD4 
receptor and co-receptors; fusion with the host cell membrane; uncoating of 
the viral capsid; release of the HIV RNA and proteins into the cytoplasm; 
reverse transcription of HIV RNA to DNA; formation of the pre-integration 
complex (PIC); and translocation into the nucleus. Once in the nucleus the viral 
DNA is integrated into the host DNA and subsequently transcribed and trans-
lated to form new viral RNA and viral proteins that translocate to the cell sur-
face to assemble into new immature virus forms. The new viruses bud off and 
are released. Finally, during maturation, the protease enzyme cleaves the struc-
tural polyprotein to form mature Gag proteins, resulting in the production of 
new infectious virions. The major families of antiretroviral drugs (green), and 
the step of the life cycle that they block, are indicated. Also shown are the key 
HIV restriction factors (tripartite motif-containing 5α (TRIM5α), APOBEC3G, 
SAMHD1 and tetherin; red) and their corresponding viral antagonist (Vif, Vpx 
and Vpu; blue). CCR5, CC-chemokine receptor 5; LTR, long terminal repeat; 
NRTIs, nucleoside reverse transcriptase inhibitors; NNRTIs, non-nucleoside 
reverse transcriptase inhibitors.
Timeline | Key moments in HIV research
1981 1983 1984 1985 1987 1993 1994 1996 2001 2002 2003 2004 2005 2006 2009   2010 2011 2013
rMicrobicide trial 
(Caprisa 004)54
rPre-exposure 
prophylaxis trial 
(iPrex)55
Characterization 
of post-treatment 
HIV controllers65,66
rPrevention by early 
treatment in 
serodiscordant  
couples (HPTN 052)58
rIdentification of 
SAMHD1 (REF. 27)
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Figure 1.2: Cartoon illustrati g the lentivirus life cycle, narrated in the text.
Hypothetical and ac ual drug targets ar indic t d, as well as hos restriction factors
targeting various stag s of the life cycle. While th figure suggests uncoating occurs
prior to reverse transcription, recent evidence suggests this is not the case (reviewed
by Campbell and Hope, 2015). From Bar e´-Sinoussi et al. (2013).
isolated from a handful of individuals in the same region and group P has been found
in only two individuals. Phylogenetic evidence shows M and N each arose from cross-
species transmission around the beginning of the 20th century (Korber et al., 2000)
from chimpanzees of the West African subspecies Pan troglodytes troglodytes, where
the virus reservoir is the simian immunodeficiency virus SIVcpz Ptt (Gao et al.,
1999; Keele et al., 2006). Phylogenetically distinct SIVcpz isolates have also been
found in the SIVcpz Pan troglodytes schweinfurthii. Groups O and P have arisen
from transmission of SIVgor (infecting gorillas) to humans, which itself originates
from SIVcpz Ptt (D’arc et al., 2015; Plantier et al., 2009; Van Heuverswyn et al.,
2006). SIVs have now been found infecting more than 40 non-human primate hosts,
mostly African monkey species, where cross-species transmission appears common
(Sharp and Hahn, 2011). HIV type 2 (HIV-2) has arisen from multiple transmissions
of SIVs infecting sooty mangabeys (Hirsch et al., 1989).
Beyond primates, lentiviruses have been identified infecting some domesticated
species (horses, cows, sheep, goats and cats), several species wild cats and hyenas
(VandeWoude and Apetrei, 2006) and wild ibexes (Erhouma et al., 2008). The
discovery of endogenous lentiviruses in several mammalian genomes (e.g. RELIK;
Katzourakis et al., 2007) suggests an ancient origin and therefore the distribution of
lentiviruses across wild mammal species may be presently underestimated (Gifford,
2012).
Lentiviruses are among the fastest evolving organisms known, with a mutation
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rate of 4 × 10−3 per base per replication (Cuevas et al., 2015). Mutations are
introduced by: (1) base incorporation errors by the viral reverse transcriptase; (2)
errors by the host RNA polymerase III (which produces viral genomic RNAs from
integrated proviruses); and (3) editing by the host restriction factor APOBEC3G
(which causes G→A hypermutation via cytosine deamination; Mangeat et al., 2004).
Further variation is generated by recombination, caused by the reverse transcriptase
switching between genomic RNA templates. Positive diversifying selection has been
observed across the genome, driven at least in part by escape from the cytotoxic
adaptive immune response, where cells present viral antigens (‘epitopes’) on their
surface to signal that they are infected (Phillips et al., 1991; Yang et al., 2003).
The antibody response also drives continual diversifying selection in the exposed
envelope protein (Nielsen and Yang, 1998; Joos et al., 2007) and for this reason
developing a protective vaccine is extremely challenging (Baum, 2010).
1.3.4 HIV Selection Analyses
Molecular evolution techniques have been applied to study selection in HIV-1 pre-
viously, using codon models like those of Nielsen and Yang (1998) which employ
dN/dS ratios. These studies have mostly sought signatures of diversifying selection
as the virus tries to escape the adaptive immune response, such as continual sub-
stitutions at epitopes in viral proteins recognised by cytotoxic lymphocytes (Yang
et al., 2003; Price et al., 1997). The same approaches have been used to identify
antibody binding sites in HIV-1 proteins, which can inform vaccine design and even
show diversifying selection in the viral population infecting a single patient over
time (Nielsen and Yang, 1998; de Oliveira et al., 2004). dN/dS methods have also
been used to identify selection for resistance to antiretrovirals (Chen et al., 2004),
and modeified dN/dS codon substitution models have been developed specifically to
identify the episodic positive selection associated with viral drug resistance (Murrell
et al., 2012).
1.3.5 Interaction with Host Restriction Factors
Recent research has found a suite of innate immunity proteins which restrict the
growth of viruses in cells, forming an intracellular immune response. Often these
are expressed in response to interferon (IFN), an immune signalling factor, which is
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itself expressed in response to the cell ‘sensing’ the presence of a pathogen, through
recognition of pathogen associated molecular patterns (PAMPS; Lee, 2013). Re-
striction factors target different stages of the lentivirus life cycle (fig. 1.2; Kirchhoff,
2010; Malim and Emerman, 2008). In turn, primate lentiviruses have evolved acces-
sory proteins whose primary function appears to be mitigating the cellular immune
response, often by direct binding to a restriction factor and targeting it for degra-
dation by cellular mechanisms (Sheehy et al., 2003; Neil et al., 2008; Van Damme
et al., 2008; Hrecka et al., 2011; Laguette et al., 2011).
Recognition of a restriction factor by an accessory protein will presumably neg-
atively affect the fitness of the host. Studies using molecular evolution techniques
have found that all known restriction factors targeting the lentiviruses show evidence
of having undergone positive diversifying selection. Significantly, sites under posi-
tive selection often correlate with the region of the protein bound by the accessory
protein, and in some cases the positive selection analysis has guided the mutagene-
sis experiments which identified the region of interaction (Sawyer et al., 2004, 2005;
Gupta et al., 2009; McNatt et al., 2009; Laguette et al., 2012; Lim et al., 2012).
Often striking species-specificity of the interaction is observed. Diversifying selec-
tion in these regions is consistent with the restriction factor continually changing to
evade recognition, matched by change in the accessory protein to restore it. This
is called the Red Queen hypothesis (Van Valen, 1973), after the character in Lewis
Carroll’s Through the Looking Glass and What Alice Found There who tells Alice
to run as the world rushes past them so they can stay in the same position. Simi-
larly, the restriction factor continually changes in this regions to maintain the same
fitness (reviewed by Duggal and Emerman, 2012). The difference in evolutionary
timescales means a single virus lineage may not be responsible for the effect on re-
striction factor evolution, but instead successive infections throughout evolutionary
history.
1.3.6 The Present Work
In this work, we wish to apply techniques from the study of molecular evolution to
investigate the evolution of lentiviruses and interactions with their hosts.
Previous studies have identified positive diversifying selection in restriction fac-
tors in primates which can restrict lentivirus replication. It has been implicitly
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assumed that primate lentiviruses and their well characterised accessory proteins
have been responsible (Laguette et al., 2012; Lim et al., 2012). We have investi-
gated that assumption by testing for positive selection in the restriction factor and
metabolic enzyme SAMHD1 from more diverse species, including groups of mam-
mals and other vertebrates. We find this adaptive evolution has occurred in almost
every group analysed, indicating primate lentiviruses are not the only possible cause.
In mammals, we find a clustering of sites under positive selection around the region
of SAMHD1 involved in regulating this enzyme’s activity which leads us, unexpect-
edly, to the hypothesis that nonsynonymous changes have occurred to modulate its
catalytic activity.
The lentivirus capsid plays several important roles in the virus life cycle (Camp-
bell and Hope, 2015) and has been implicated in interactions with cellular immunity
(Rasaiyaah et al., 2013). The HIV-1 M transmitted from SIVcpz within the past
century (Gao et al., 1999; Korber et al., 2000) and has become pandemic. We are
interested in the adaptations in capsid following transmission to humans and have
used swMutSel, a relatively new approach, to identify sites in capsid which are ex-
periencing different selective constraints in the two virus groups. We identify sites
in regions bound by host cofactors and potentially relevant to the dynamic structure
of the protein, suggesting host-specific behaviour.
To date, diversifying selection in host restriction factors has been well charac-
terised, consistent with the Red Queen hypothesis. Few studies concentrate on the
evolution of the viral accessory proteins which antagonise them, however. We have
investigated the accessory proteins of HIV-1 M and SIVcpz for indications of host-
specific selective constraints, again with swMutSel. We have identified sites known
to be in regions binding to host factors, suggesting species-specificity in these inter-
actions and adaptation following transmission to humans.
Finally, to comprehensively study selection in lentivirus genomes we must in-
clude the overlapping coding sequences. No existing approaches are adequate for
this situation, however, as swMutSel and the dN/dS approaches described above
are codon substitution models and incapable of accounting for selection on multi-
ple frames. Studying adaptive evolution in overlapping coding sequences therefore
requires a novel approach. We have developed several models for this purpose and
have assessed their performance in simulation studies.
Chapter 2
Positive Selection in Chordate
SAMHD1
2.1 Summary
SAMHD1 is a deoxynucleoside triphosphorylase, which becomes catalytically active
in a tetrameric form. Phosphorylation of threonine (T) 592 destabilises tetramers
and reduces catalytic activity. It is also considered a restriction factor of HIV-1,
which it prevents infecting some cell types by reducing dNTP levels below those
necessary for reverse transcription. Some primate lentiviruses possess accessory
proteins which relieve SAMHD1 restriction by targeting it for proteosomal degrada-
tion. Positive selection has been observed in primate SAMHD1, and this has been
attributed to selection pressure imposed by primate lentiviruses. We have performed
a comprehensive positive selection analysis of chordate SAMHD1 and find positive
selection across all mammals and every clade tested within mammals. We observe a
significant clustering of sites under positive selection around T592, suggesting adap-
tation in the propensity for tetramerisation. We also observe positive selection in
still more divergent animals, including birds and fish. Our results indicate positive
selection in SAMHD1 is a broader phenomenon than previously realised — extend-
ing to all chordates — and may be explained by ‘fine-tuning’ of tetramerisation
regulation or antagonism by undiscovered animal viruses.
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Figure 2.1: Schematic illustration of the SAMHD1 protein and its functional do-
mains. Numbers indicate amino acid positions of human SAMHD1 protein. The
SAM domain, HD domain, nuclear localisation signal (‘NLS’) and the C-terminal
region essential for tetramerisation (‘Tet.’) are indicated. Four residues required for
catalysis and the phospho-acceptor threonine residue at site 592 are also shown.
2.2 Introduction
2.2.1 Identification of SAMHD1
The SAMHD1 gene was first identified in a cDNA library screen in dendritic cells,
where it was described as an orthologue of a mouse interferon (IFN)-γ induced
gene, MG11 (Li et al., 2000). Attention from the immunology community came
when disruptive mutations in SAMHD1 were linked with Aicardi-Goutie`res syn-
drome (AGS), a Mendelian genetic disease whose symptoms mimic congenital virus
infection, including increased IFN-α production (Rice et al., 2009). Other genes
linked to AGS were known to have roles in nucleic acid degradation, which had
suggested the disease was caused by accumulation of nucleic acids leading to an
autoimmune response (Crow et al., 2006). SAMHD1 was therefore suggested to be
similarly involved in nucleic acid metabolism (Rice et al., 2009). It posses an HD
domain spanning residues 115-562 (see fig. 2.1), making it a member of the HD
domain superfamily of metal-dependent phosphohydrolases. SAM (sterile α motif)
domains are found across eukaryotes and mediate protein-protein interactions in
complex-formation or binding of RNA (Qiao and Bowie, 2005).
2.2.2 Tetrameric SAMHD1 as a deoxynucleoside triphos-
phorylase
The suspected nucleic acid degrading activity was later confirmed on finding that
SAMHD1 hydrolyses deoxynucleoside triphosphates (dNTPs) 1, yielding a deoxynu-
1A note on terminology. A nucleoside refers to a nitrogenous base (e.g. adenine, cytosine,
guanine or thymine) covalently bonded to the 5-carbon sugar ribose. If the alternative sugar de-
oxyribose (possessing one less hydroxyl group) is used, the molecule is a deoxynucleoside. The
(deoxy)nucleoside can bond to one or more covalently linked phosphate groups, yielding a (de-
oxy)nucleoside mono-, di- or triphosphate. The abbreviation (d)NTP refers to (deoxy)nucleoside
triphosphate, containing any base. dNTPs are the substrate for synthesis of the polymer DNA
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Figure 2.2: Tetrameric SAMHD1 (residues 114-599) bound to dGTPs. Monomers
are shown as ribbons and coloured pale cyan, wheat, purple and pink respectively.
dGTPs at the allosetic sites (two for each monomer) are shown as spheres in red, with
their connecting magnesium ions shown as yellow spheres. dGTPs in active sites
are shown as blue spheres, away from the tetramer interfaces, with their associated
zinc ions shown as brown spheres. PDB ID: 4BZC; Ji et al. (2013).
cleoside and inorganic triphosphate (Goldstone et al., 2011).
Catalytically active SAMHD1 is a tetramer, which assembles in the presence
of dNTPs and guanosine-containing molecules (either dGTP or GTP; Yan et al.,
2013; Ji et al., 2014) and is therefore an enzyme regulated by the concentration of
its substrate. Crystal structures of the catalytic core show tetramers comprising
two juxtaposed allosteric sites and one catalytic site for each monomer (fig. 2.2;
Ji et al., 2013). Tetramerisation induces dramatic conformational changes at the
subunit interfaces, allowing tighter packing between monomers, in turn inducing
alterations at the catalytic sites. While monomeric or dimeric forms are capable of
some dNTPase activity, they have much lower enzymatic efficiency (Arnold et al.,
2015). The C terminal end of SAMHD1 folds into a ‘major lobe’ and a ‘minor lobe’,
and the latter is involved in protein-protein interactions between monomers which
stabilise the tetramer (Goldstone et al., 2011).
(dexoyribonucleic acid), while NTPs such as GTP (whose base is guanine) are used to synthesise
RNA (ribonucleic acid) and also act as signalling molecules or energy carriers. Triphosphoryla-
tion involves hydrolysis of a (deoxy)nucleoside triphosphate to produce a (dexoxy)nucleoside and
inorganic triphosphate.
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2.2.3 Non-substrate regulation of SAMHD1 activity
SAMHD1 appears to be almost ubiquitously expressed2, its mRNA having been
identified in 25 diverse human tissues and protein in several of these (Schmidt et al.,
2015). Several studies have investigated SAMHD1 induction by interferons and
found different responses in different cell types: while IFN-induced mRNA upreg-
ulation has been reported in microarray analysis of peripheral blood mononuclear
cells (PBMCs; Crow and Wohlgemuth, 2003), and increased protein expression ob-
served in the HEK 293T, HeLa cell lines and monocytes (Berger et al., 2011), no
change in protein levels are observed in dendritic cells, unactivated CD4+ T cells
or monocyte-derived macrophages (St Gelais et al., 2012; Schmidt et al., 2015).
SAMHD1 phosphorylation is more significant. Threonine-592 has been identi-
fied as a phospho-acceptor site, reported to be phosphorylated by CDK1 or CDK2
(Cribier et al., 2013; Pauls et al., 2014; Yan et al., 2015). CDKs and their associated
cyclins mediate control of cell division and their phosphorylation of SAMHD1 ap-
pears to regulate its activity throughout the cell cycle. Mutating residues such that
SAMHD1 phosphorylation is inhibited was found to reduce dATP levels in cycling
cells and was associated with lower incorporation of labelled bases in newly syn-
thesised nuclear DNA (Yan et al., 2015). This suggests SAMHD1 phosphorylation
downregulates its dNTPase activity, which is timed to prevent dNTPase activity
during S phase, when nuclear DNA is replicated. While Cribier et al. (2013) re-
ported that type 1 IFN reduced T592 phosphorylation in PBMCs and CD4+ T cells
(suggesting SAMHD1 is activated in response to virus infection), phosphorylation
was not observed in response to any of a panel of cytokines, including interferons,
by Schmidt et al. (2015).
Phosphorylated SAMHD1 (or a phosphomimetic T592E/D mutant) retains its
dNTPase activity when in the catalytically active tetrameric form, with similar kcat
and KM values (Tang et al., 2015; Arnold et al., 2015). The stability of the phospho-
rylated tetramer, however, is severely compromised, with the majority of species in
the weakly active monomeric or dimeric forms. The structural environment of T592
is predominately negatively charged and therefore the introduction of the negatively
charged phosphate group is suggested to provoke significant structural rearrange-
ments. Indeed, the whole C terminal region (residue 581 onwards) is disordered in
2A notable exception are activated CD4+ T cells, with great relevance for HIV-1 infection
(Ruffin et al., 2015); discussed in §2.2.4.
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phospho-SAMHD1 or SAMHD1T592E and this appears to disrupt interactions which
stabilise the tetramer, leaving the dNTPs at allosteric sites more exposed to solvent
(Tang et al., 2015) and possibly therefore more likely to disassociate at lower dNTP
concentrations (Arnold et al., 2015).
Residues in the SAMDH1 C terminus determine its propensity for phosphory-
lation and affect the stability of the unphosphorylated tetramer. Yan et al. (2015)
found deleting the C terminal 31 residues (595-626) abolishes both phosphorylation
of T592 in cells and interaction with cyclinA2, which associates with the CDKs to
mediate the modification; mutation of specific residues in the C terminus also abol-
ish or weaken cyclinA2 interaction. Deleting the C terminal 43 residues (583-626)
abolishes tetramer formation and dNTase entirely (Yan et al., 2013; Arnold et al.,
2015).
2.2.4 SAMHD1 and HIV-1 restriction
Recent interest in SAMHD1 biology has been motivated by its identification as a re-
striction factor of human immunodeficiency virus type 1 (HIV-1; Hrecka et al., 2011;
Laguette et al., 2011). While HIV-1 replicates poorly in monocytes, dendritic cells,
nondividing macrophages and quiescent CD4+ T cells, HIV-2 and SIVsm (infecting
sooty mangabes) suffer no such block, and this is dependent on their accessory pro-
tein Vpx (Goujon et al., 2007, 2008; Baldauf et al., 2012). HIV-1 does not possess
a Vpx gene and supplying Vpx during HIV-1 infection allows it and similarly re-
stricted retroviruses to replicate successfully in these cells (Goujon et al., 2006). Vpx
interacts with the complex responsible for targeting proteins for proteosomal degra-
dation with ubiquitin, comprising the DDB1 and DCAF1 subunits of the Cullin-4
based E3 ubiquitin ligase machinery (Srivastava et al., 2008; Bergamaschi et al.,
2009). Vpx is therefore an antagonist, acting as an adaptor which binds at separate
interfaces both DCAF1 and SAMHD1, targeting it for destruction (fig. 2.3; Schwefel
et al., 2014).
Hrecka et al. (2011) and Laguette et al. (2011) had shown SAMHD1 hinders
the accumulation of viral DNA and the latter authors found mutating the putative
catalytic H/D residues abolished restriction, suggesting either nuclease or dNTPase
activity was responsible. Lahouassa et al. (2012) went on to show that SAMHD1-
mediated restriction could be relieved in primary monocyte-derived macrophages by
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Figure 2.3: Crystal structure of C terminal SAMHD1 (residues 606-624, cyan),
SIVsm Vpx (yellow) and human DCAF1 (residues 1073-1392, magenta). PBD ID:
4CC9, Schwefel et al. (2014).
supplying exogenous dNTP precursors, concluding that SAMHD1 reduced the dNTP
concentration to below the level necessary for viral cDNA synthesis. Moreover,
mutations in the HIV-1 reverse transcriptase making it less processive or conferring
lower affinity for dNTPs leave the virus more susceptible to SAMHD1 restriction,
further suggesting SAMHD1’s control of dNTP concentration is directly responsible
(Lahouassa et al., 2012; Arnold et al., 2015).
The dNTPase model of restriction was questioned, however, when phosphoryla-
tion of SAMHD1 appeared to negatively regulate HIV-1 restriction without affecting
dNTPase activity (White et al., 2013). Ryoo et al. (2014) reported RNase activity
by SAMHD1 was responsible for restriction, while its dNTPase function was dis-
pensable, and proposed that SAMHD1 prevents reverse transcription by degrading
the viral RNA template. This model naturally requires the enzyme to possess RNase
activity, but this is disputed (Goldstone et al., 2011; Powell et al., 2011; Goncalves
et al., 2012) and reports of it may be attributable to incomplete SAMHD1 purifi-
cation (Seamon et al., 2015; Arnold et al., 2015). The restriction model of Arnold
et al. (2015) proposes that stable SAMHD1 tetramers inhibit reverse transcription
by keeping dNTP concentration low and that SAMHD1 phosphorylation causes
tetramers to disassemble; though limited dNTPase activity is maintained by phos-
phorylated SAMHD1, perhaps explaining the observations of White et al., it is not
sufficient for restriction.
It is perhaps surprising that HIV-1 does not antagonise SAMHD1 like so many
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of its relatives. This may be explained by a lower sensitivity to SAMHD1 restric-
tion, as the reverse transcriptase of HIV-1 is more efficient than that of HIV-2,
allowing replication in environments with lower dNTP concentration (Lenzi et al.,
2015). SAMHD1 expression in myeloid cells may reduce rather than ablate HIV-1
infection and indeed these cells may still play a significant role in HIV-1 infection,
as they have greater longevity compared with CD4+ T cells and contact other cells
in antigen presentation. They may therefore allow efficient onward dissemination
despite being inefficiently infected themselves (Aggarwal et al., 2013). Restricted
replication in myeloid cells may even be advantageous, by preventing their potent
innate immune sensing mechanisms being activated and thus avoiding an immune
response (Laguette et al., 2011; Ballana and Este´, 2015).
2.2.5 SAMHD1 and restriction of other exogenous or en-
dogenous viruses
Restriction by SAMHD1 need not be specific to HIV, as all retroviruses and DNA
viruses require dNTPs. Reverse transcription by both the alpha retrovirus Rous
sarcoma virus and the beta retrovirus Mason-Pfizer monkey virus is also inhibited
in the presence of human SAMHD1 (Gramberg et al., 2013); interestingly, human
T-lymphotropic virus (HTLV)-1 was reported to be insensitive, perhaps because
it has a means of mitigating SAMHD1-mediated restriction, though there was no
evidence of its being degraded. Choi et al. (2015) found the lentiviruses feline
immunodeficiency virus (FIV) and equine infectious anemia virus (EIAV), as well
as the gamma retrovirus Friend murine leukemia virus (FMLV), were all susceptible
to restriction by human SAMHD1 in a myeloid cell line (U937). Restriction was
reported to be dependent on SAMHD1’s putative RNase activity, though restriction
of RNA viruses (other than retroviruses) was not observed.
The DNA viruses vaccinia virus and herpes-simplex virus (HSV)-1 replicate more
efficiently in the absence of SAMHD1 expression in primary MDMs or DCs, respec-
tively (Hollenbaugh et al., 2013; Kim et al., 2013), though its expression does not
entirely restrict infection. Neither virus degrades SAMHD1 but each encode their
own nucleoside biosynthesis enzymes, perhaps mitigating the effect of SAMHD1-
mediated dNTP depletion.
SAMHD1 has also been shown to restrict proliferation of the LINE-1 retrotrans-
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poson, by a mechanism associated with a block to reverse transcription (Zhao et al.,
2013b). The effect was also seen in the presence of SAMHD1 from other mammals,
suggesting repression of retrotransposition is a conserved function. However, mu-
tation at the SAMHD1 catalytic site (D311A) was reported to have no effect on
LINE-1 restriction and the authors therefore suggest retrotransposition is inhibited
by a different means to HIV-1, i.e. other than by dNTP depletion. Hu et al. (2015),
by contrast, report that dNTPase activity is required for LINE-1 repression, and
therefore more work is needed to clarify the underlying mechanism.
2.2.6 Coevolution of primate lentiviruses and primate SAMHD1
Several nonhuman primate lentiviruses encode Vpx orthologues, including SIVsm
(infecting sooty mangabey), SIVmac (macaque, derived from SIVsm), SIVrcm (red-
capped mangabey) and SIVmnd2 (mandrill). Studies employing a mixture of phylo-
genetic modelling and experimental work have uncovered striking adaptation of viral
antagonists to their host species’ SAMHD1, and positive (diversifying) selection act-
ing on SAMHD1 in turn. Using a site-specific model (site model 8 implemented in
codeml; Yang, 2007), Laguette et al. (2012) identified 17 sites in primate SAMHD1
as being under positive selection, five of which in the C terminus, which the authors
then confirmed is required for degradation by SIVmac Vpx. A more complex picture
emerged, however, as species-specific antagonism was revealed: for example, human
SAMHD1 is successfully degraded by Vpx of HIV-2 and SIVsm/mac, but not by
SIVrcm or SIVmnd2 Vpx.
Using the same model, Lim et al. (2012) identified six sites as under positive se-
lection in Old World monkey SAMHD1, clustering at the N-terminus. They too had
observed species-specificity of degradation, with, for example, SIVmnd2 Vpx unable
to degrade African green monkey (AGM) SAMHD1 and SIVagm.Gri (grivet African
green monkey) unable to degrade mandrill SAMHD1. Residues at sites 46 and 69
— predicted to be under positive selection — correlated with degradation suscep-
tibility: while mandrill SAMHD1 appeared to have ‘ancestral’ residues (compared
with other species), AGM SAMHD1 had changed at these sites. Mutating AGM
SAMHD1 to the ancestral residues conferred susceptibility to SIVmnd2 Vpx, while
mutating mandrill SAMHD1 to the AGM residues made it resistant to SIVmnd2
Vpx, suggesting the changes in AGM SAMHD1 were driven by pressure from Vpx
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Figure 2.4: Crystal structure of the N-terminus of mandrill SAMHD1 (showing
residues 1-22, 34-88 and 93-109) bound to SIVmnd2 Vpx and human DCAF1 (show-
ing residues 1075-1392). Colours as in fig. 2.3. PDB ID: 5AJA (Schwefel et al.,
2015).
proteins.
SAMHD1 antagonism is not exclusive to Vpx-endowed viruses, as several SIV
Vpr proteins are capable of SAMHD1 degradation by the same mechanism (Lim
et al., 2012). Vpx is believed to have arisen by duplication of Vpr (Tristem et al.,
1990), and indeed Lim et al. (2012) demonstrate by rooting of the Vpr/Vpx phy-
logenetic tree that SAMHD1 antagonism is a monophyletic phenotype, indicating
that it arose once, prior to the creation of Vpx.
Striking data from Spragg and Emerman (2013) show that SAMHD1 antagonism
may be specific not only to the host species, but to SAMHD1 variants within pop-
ulations. SAMHD1 was found to be polymorphic within all four species of African
green monkey (which diverged from a common ancestor less than 3 million years
ago) and each species is infected by a distinct SIV. No one Vpr from these viruses
could degrade all SAMHD1 variants, but each could degrade the most abundant
variant in their own host species. That this variation in the host SAMHD1 has ap-
parently arisen and been maintained in these populations over relatively short time
suggests antagonism significantly affects fitness and that the ‘arms race’ between
restriction factor and antagonist is ongoing.
Interestingly, while SAMHD1 antagonism has been conserved in several primate
lentiviruses, the site of interaction has been more flexible. HIV-2 and SIVmac Vpx
require the C-terminus of their target SAMDHD1 for successful binding and degra-
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dation, while SIVmnd2/SIVrcm Vpx and SIVsyk/SIVmus Vpr bind the N-terminus
(Fregoso et al., 2013). Furthermore, the determinants for host-specificity can be
mapped to these domains. Figure 2.4 shows the N-terminus of mandrill SAMHD1
in complex with SIVmnd2 Vpx and DCAF1, in contrast to the C terminal binding
by SIVsm Vpx in figure 2.3. The divergent interaction positions could account for
the mix of sites found to be under positive selection at both the N and C termini.
Fregoso et al. (2013) propose a model whereby Vpr/Vpx proteins have ‘toggled’ be-
tween binding the N and C termini in response to substitutions in SAMHD1 which
confer protection from antagonism. Because these ends are adjacent in tetrameric
SAMHD1, each Vpr/Vpx may have strong binding to one terminus and weak bind-
ing to the other, such that sequence change at the preferred binding site does not
destroy SAMHD1 binding entirely and adaptation of the antagonist restores strong
interaction.
2.2.7 Function of SAMHD1
The body of literature describing SAMHD1 various activities leads to the question,
what is SAMHD1’s primary function? What is it for?
SAMHD1 may be best described simply as a metabolic regulator, rather than
an innate immunity protein. Franzolin et al. (2013) take this view, having observed
that silencing SAMHD1 expression slows cell proliferation and radically skews the
relative proportions of the four dNTPs, which can increase mutation rates in DNA
replication. These observations suggest a role with little connection to virus infection
or autoimmunity. Whether SAMHD1 should be called a restriction factor which
regulates dNTP levels, or a dNTP regulator which restricts viruses, will be decided
by examining its effects in wider ranges of cell types and environments.
2.2.8 The present work
SAMHD1 has been shown to be under positive (diversifying) selection in primate
species (Laguette et al., 2012; Lim et al., 2012) and previously this has been specif-
ically attributed to an evolutionary ‘arms race’ with primate lentivirus antagonists.
We are interested to know whether this signature of positive selection is unique
to primate SAMHD1 or common to other animal groups, and therefore part of a
broader phenomenon.
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We have performed a comprehensive selection analysis of SAMHD1 from mam-
mals, clades within mammals, birds, reptiles, amphibians and marine animals (fish)
and find positive selection in the majority of the groups studied. In our analyses of
mammals, the majority of sites identified as under positive selection cluster at the
C-terminus, in close proximity to the phosphorylation site T592. We speculate that
(1) unidentified viral antagonists have driven diversifying selection, and/or (2) the
signature has resulted from continual calibration of SAMHD1’s dNTPase activity.
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2.3 Results
2.3.1 Positive selection across mammals
To investigate the selective pressures acting on SAMHD1 throughout its evolution in
mammals, we compiled a dataset of publicly available SAMHD1 coding sequences
using NCBI BLAST 3 (Ostell and McEntyre, 2007), listed in appendix A. These
searches also yielded HD domain sequences from highly divergent organisms (in-
cluding plants), indicating that all available animal SAMHD1 sequences were within
the scope of the search. These were aligned as codon sequences and a phylogenetic
tree was estimated by maximum likelihood. Our initial analyses focussed on mam-
malian SAMHD1 and other sequences were not included (fig. 2.5; see methods).
The mammal SAMHD1 tree was broadly concordant with the previously reported
mammalian phylogeny (Meredith et al., 2011) and the majority of nodes had non-
parametric bootstrap support values above 70%.
Positive selection identified
We employed the site-specific selection models implemented in codeml of the PAML
package (Nielsen and Yang, 1998; Yang, 2007). The M1a (null) model permits classes
of sites under negative (purifying) and neutral selection, while the M2a (alternative)
model also allows a class of sites evolving under positive selection for which ω > 1
(i.e. dN/dS > 1). M2a can be used to compute the posterior probability of each
site belonging to the positive selection class, according to the Bayes empirical Bayes
calculation (Yang et al., 2005). To guard against identification of local optima by
the optimisation routine, analyses were performed multiple times with different ini-
tial parameter values (see methods). We also attempted analyses of mammalian
SAMHD1 with the more complex M7 (null) and M8 (alternative) models which per-
mit distributions of ω values, but M8 optimisations consistently failed to converge;
we therefore discuss results from models M1a and M2a only.
Using the likelihood ratio test, the alternative M2a model had a significantly
superior fit to the data, supporting the alternative hypothesis of positive selection
in mammalian SAMHD1 (p << 0.01; appendix B). 36 of 626 sites had posterior
probability > 0.95 of belonging to the positive selection class (table 2.1). These
3Sequence collection was done by Christopher Ruis. Alignment was done by Christopher Monit
and Christopher Ruis together.
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Figure 2.5: Maximum likelihood phylogeny for mammalian SAMHD1, estimated with
RAxML. Red squares mark nodes supported by ≥ 70% non-parametric bootstrapping.
Clades of five groups used in some analyses are highlighted and remaining mammal species
are shown in black. Branch lengths expressed as expected nucleotide substitutions per
codon, estimated by codeml model M0 (Yang, 2007) with this topology. When studying
specific mammals groups, irrelevant taxa were either pruned to yield subtrees comprising
only the taxa of interest (site-specific analyses) or the branches of interest were set as
foreground (branch-site-specific analyses).
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Figure 2.6: Codon sites under positive selection in mammalian SAMHD1. Pan-
els represent the linear sequence and vertical lines mark sites where the probability
(Bayes empirical Bayes calculation) is greater than 0.95 that the site is under pos-
itive selection; in parentheses are the total numbers of sites thus identified. Site
numbering is based on the human sequence. The height of the lines is of no sig-
nificance. (A) Results from analysis of all mammals with codeml’s model M2a.
(B) Similar analysis of mammals with primates excluded. (C, D) Published re-
sults of Lim et al. (2012) and Laguette et al. (2012), both from analyses of primate
SAMHD1.
were distributed amongst four clusters across the SAMHD1 sequence (fig. 2.6a): at
the N-terminus (between sites 32 and 112), in the HD domain (between 256 and
284), central domain (between 408 and 488) and at the C-terminus (between sites
566 and 626).
Sites in these regions had previously been identified as being under positive
selection in primate SAMHD1 (Lim et al., 2012; Laguette et al., 2012; table 2.1).
Therefore to test whether the positive selection signal identified in our mammalian
dataset could be attributed to primates, we repeated the site-specific analysis with
primate clade excluded (pruned from the same topology) as a control. Again, model
M8 failed to converge and we discuss the results from the M1a/M2a analysis only.
The alternative model was statistically justified (p << 0.01) and 32 sites were
identified as under positive selection in non-primate mammals (fig. 2.6b; table 2.1).
Of these, 30 had been identified in the analysis of the whole mammals dataset. These
data indicate that non-primate mammalian SAMHD1 is under positive selection.
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Site Res. Ma. No Pr. Cn. Cp. Gl. Pr. Wu. Re. Ma. Lag. Lim
3 R +
15 C +
32 W + + + +
36 L + +
46 G +
52 S + +
55 R + + +
56 R + + + +
57 G + + +
60 E + + + +
62 P +
63 V + + +
67 N +
68 I +
69 R +
79 P +
106 R +
107 L +
112 V + +
114 T +
115 M +
256 Q + + + +
266 C +
280 V + + +
282 D +
283 S + + +
284 L + + + +
346 E +
395 D +
405 K +
408 R + + + +
442 R + +
463 T + + + + +
464 G +
465 Q + +
466 I + + + +
469 K + +
472 D + + +
473 Y +
475 S + + + + +
482 S +
486 K + +
488 L + + + + + +
563 Y +
566 R + + +
574 A + + + +
575 D + + +
585 D +
586 V +
588 A +
594 Q + + +
596 K + + + + +
600 D + + +
601 S + + + +
602 T +
604 V +
605 Q +
609 R +
610 L + + +
611 R + +
614 S + + + + + +
616 S + + + + +
618 V + + + + +
619 Q + + +
622 K + + + +
623 D + +
624 D + + +
625 P + + +
626 M + + + + + + +
Table 2.1: Sites identified in mammalian SAMHD1, using codeml site models M2a or M8. ‘+’ indicates Bayes
empirical Bayes probability > 0.95. Res., human SAMHD1 residue; Ma., all mammals (M2a); No Pr., all mammals
without primates (M2a); Cn., Carnivora (M8); Cp., Chiroptera (M8); Gl., Glires (M8); Wu., Cetiartiodactyla (M8);
Re. Ma., remaining mammals (M8); Lag., sites from Laguette et al. (2012); Lim, sites from Lim et al. (2012).
42 CHAPTER 2. POSITIVE SELECTION IN CHORDATE SAMHD1
A 
B C 
566 
488 
486 
594 
596 
592 
524 
Figure 2.7: Sites identified as under positive selection in mammalian SAMHD1
shown on a published crystal structure (PDB 4TNP, Ji et al. (2014); comprising
sites 114-276 and 282-599), shown in orange and threonine 592 in red, with both
shown as spheres. Monomers in this structure include 15 or 16 of 36 sites identified
in the analysis. (A) SAMHD1 tetramer, with dNTPs (bound at allosteric and
catalytic sites) shown as red sticks (B) SAMHD1 monomer. (C) Enlarged view of
contacting SAMHD1 molecules in tetramer; residues 480-598 (cyan) and residues
521-530 (magenta) are shown as spheres, with sites identified as under positive
selection and T592 coloured orange and red, respectively; residues of special interest
are labelled. Note that the labelled residue 525 is present in the neighbouring
monomer (magenta).
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Sites mapped onto tetramer crystal structure
To assess the biological significance of the sites identified with the mammalian
SAMHD1 dataset, we mapped them onto published crystal structures. Structure
4TNP (Ji et al., 2014) comprises sites 113-276 and 282-598 of human tetrameric
SAMHD1, including 16 sites identified in this analysis (fig. 2.7). The clusters of
residues between sites 408-488 and 566-626, while apparently separate in the linear
sequence, are brought into close proximity in the structure. Considering tetrameric
SAMHD1 (fig. 2.7a), none of the identified sites were located at the interface be-
tween monomers, nor at the dNTP-binding catalytic or allosteric sites. Instead these
sites are positioned on the exterior of the tetramer and many are concentrated in
the C-terminal minor lobe (fig. 2.7c).
Significant clustering around T592
Noticing the preponderance of sites under positive selection around the phospho-
acceptor site T592 (red in fig. 2.7), we asked whether this clustering could be ex-
pected by chance. Taking the residue coordinates for the first peptide chain in
structure 4TNP (i.e. a SAMHD1 monomer, containing 15 of the identified sites),
we calculated the Euclidean distance of each identified residue from T592 and then
computed the harmonic mean distance (whereby a small change at close distance
influences the mean more than a large change further away). Statistical signifi-
cance was assessed by bootstrapping: 15 sites were randomly drawn from the set
of residues present in the chain, and their harmonic mean distance calculated, 105
times. This yields a distribution of unbiased harmonic mean distances. The p value
for clustering around T592 is then given by the proportion of the bootstrap sam-
ples whose harmonic mean distance from T592 is lower than that of the positively
selected sites. The computed value was p ≈ 4 × 10−4, indicating that sites under
positive selection are disproportionately clustered around T592 4.
Sites identified are predicted to be structurally important
Collating our positive selection data, phylogeny and the published tetramer struc-
ture, we found four sites under positive selection to be of particular biological interest
based on positions in the minor lobe (fig. 2.7c) and the different chemical properties
4This calculation was performed using (unpublished) software written by Richard A. Goldstein.
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of the residues observed. Tree topologies annotated with residues observed at these
sites are presented in appendix C.
At site 566 (arginine in humans), which is mostly buried in the minor lobe, many
nonconservative residue substitutions have occurred (fig. C.1) and we see residues
of greatly varied size, including glycine, leucine and histidine. Site 574 (alanine
in humans) is almost entirely buried in the minor lobe, with only 2 A˚2 exposed
to solvent in structure 4TNP (Ji et al., 2014); yet residues with much larger side
chains including leucine, isoleucine and even the aromatic phenylalanine (present in
aadvark SAMHD1) are observed (fig. C.2). The hydrophilic serine also appears to
have arisen multiple times independently.
Sites 594 and 596 (glutamate and lysine in humans, respectively) are both close
to T592 (fig. 2.7c); again, chemically diverse residues are observed at these positions
(fig. C.3 and C.4). Interestingly, residues at site 596 mark the divergence of New
World monkeys (aspartate) from Old World monkeys and apes (lysine) by a charge
difference.
Sites mapped onto Vpx-DCAF1-SAMHD1 crystal structures
Structure 4CC9 (Schwefel et al., 2014), comprises SIVsm Vpx and human DCAF1 in
complex with C-terminal human SAMHD1 (residues 606-624), including nine sites
identified as under positive selection (fig. 2.8a). Of these, five have side chains in
close contact with Vpx residues (609, 610, 611, 618 and 622). All but one of these
(609) were also identified when primate sequences were excluded from the analysis.
Structure 5AJA (Schwefel et al., 2015) includes human DCAF1, SIVmnd2 Vpx and
N-terminal (residues 1-22, 34-88 and 93-109) mandrill SAMHD1. This includes four
sites identified as under positive selection across mammals (55, 57, 60 and 63), of
which 55 is in particularly close proximity to Vpx (fig.2.8b). All but one of these
(63) were also identified with primate sequences excluded. Seven sites found to be
under positive selection are not present in any of the three structures presented (32,
112, 280, 600, 601, 625 and 626), only one of which (626) is not also identified when
primate sequences are excluded.
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Figure 2.8: Sites identified as under positive selection in mammalian SAMHD1
(orange spheres), shown on published crystal structures of SAMHD1 (cyan) in com-
plex with Vpx (yellow) and DCAF1 (magenta). (A) Human SAMHD1 (residues
606-624), Vpx from SIVsm and human DCAF1 (PDB 4CC9, Schwefel et al., 2014);
includes 9 of 36 sites identified. (B) Mandrill SAMHD1 (residues 1-22, 34-88 and
93-109), SIVmnd-2 Vpx and human DCAF1 (PDB 5AJA, Schwefel et al., 2015);
includes 4 of 36 sites identified.
Repeating with alternative tree topologies
Maximum likelihood (ML) selection analyses condition on the tree topology be-
ing exactly correct, but since topologies are themselves estimated by phylogenetic
methods their accuracy cannot be guaranteed. We therefore repeated the M1a/M2a
analyses with three alternative topologies, derived from non-parametric bootstrap-
ping in the initial tree estimation (see methods), to assess the dependence of the
results on the topology used. (The need to repeat each analysis with varying start
values, to lower the risk of identifying local optima, precluded the use of more topolo-
gies.) The M2a model had a statistically significant better fit to the data for each of
the three topologies (appendix B). Comparing the sites identified as under positive
selection (having BEB estimated probability > 0.95), there was almost complete
agreement when using the alternative topologies and the ML topology (table 2.2).
2.3.2 Positive selection within specific mammal groups
We next wanted to determine whether the positive selection signal could be at-
tributed to a specific group within mammals. The mammalian SAMHD1 dataset
46 CHAPTER 2. POSITIVE SELECTION IN CHORDATE SAMHD1
Topology Ti total ML only
(ML \ Ti)
Intersection
(ML ∩ Ti)
Ti only
(Ti \ML)
T1 38 0 sites 36 sites 2 sites (56, 464 )
T2 36 3 (112, 594, 609 ) 33 sites 3 sites (36, 56, 602 )
T3 37 0 sites 36 sites 1 site (36 )
Table 2.2: Comparison of sites found to be under positive selection between max-
imum likelihood (ML) tree topology and three alternative topologies, derived from
non-parametric bootstrap sampling of the same mammalian SAMHD1 sequence
alignment (see methods). Columns show sites found in ML tree analysis only (not
found with alternative topology), found with both (intersection) or with alternative
topology only (not found with ML topology), respectively. The three groups also
represented with set notation. Where there are discrepancies, the relevant sites are
given in parentheses (human sequence numbering).
was divided into 5 clades: Primates (55 taxa), Carnivora (dogs, bears etc.; 8 taxa),
Cetartiodactyla (whales and even-toed ungulates; 18 taxa), Glires (rodents, rabbits
and hares; 16 taxa) and Chiroptera (bats; 6 taxa). A sixth group comprised the
remaining species not belonging to a well represented monophyletic set (17 taxa),
hereafter called ‘remaining mammals’. These subgroups were then subjected to the
same positive selection analyses as was done for the whole dataset, using the same
sequence alignments and subtree topologies. Unlike the whole dataset, model M8
successfully converged when fitted to each subgroup dataset.
Positive selection identified
The alternative models (M2a and M8) had a significantly better fit to the data than
their respective null models (M1a and M7) for each of the six subgroups (appendix
B) and sites with > 0.95 probability of belonging to the positive selection class were
identified (fig. 2.9). For the Carnivora and Primates subgroups, sites identified
with M2a were the same as with M8 and for Chiroptera, Glires and Cetartiodactyla,
the M2a sites were a subset of the M8 sites identified; for the remaining mammals,
only one site (625) was found with M2a but not M8. The M8 results are therefore
prioritised in the following discussion.
The identified sites for each subgroup (table 2.1) fell into the same four clusters
as sites from the whole dataset analysis, though not every cluster was represented
in each subgroup’s results (fig. 2.9). The Chiroptera (bats) had the greatest pre-
ponderance of sites, with 26 identified by M8 and a distribution across the sequence
resembling that of the whole dataset. The Carnivora had the fewest sites (4), all of
2.3. RESULTS 47
Mammal subgroup p value
Carnivora 0.15807
Chiroptera 0.05771
Glires 0.20767
Primates 0.87726
Cetartiodactyla 0.00129
Remaining mammals 0.03504
Table 2.3: Probabilities of the sites identified as being under positive selection
clustering around threonine 592 if their distribution throughout the monomeric
SAMHD1 crystal structure 4TNP (Ji et al., 2014) were random. p values were
computed for the sets of sites identified in each analysis of a mammalian subgroup’s
SAMHD1 which also are present in 4TNP. Taxonomic groups: Carnivora (carni-
vores), Chiroptera (bats), Glires (rodents, rabbits and hares), Primates and Cetar-
tiodactyla (whales and even-toed ungulates).
which fell at the C-terminus. The 15 sites identified in the Cetartiodactyla (whales
and ungulates) were similarly clustered at the C-terminus, while the eight sites found
in the Glires (rodents and rabbits) were clustered at the N and C termini, with one
additional site in each of the central cluster positions. Nine sites were identified in
the remaining mammals, falling in each of the four clusters except at the N-terminus.
Surprisingly, only five sites were identified in the Primates, with none identified at
the N-terminus.
Sites mapped onto crystal structures and tests for clustering around T592
We mapped the sites identified in each subgroup onto the three SAMHD1 crystal
structures referred to in the previous section (fig. 2.10). In almost all subgroups,
sites identified in the N- and C-terminal structures 5AJA and 4CC9 are in direct
contact with Vpx proteins, with the exception of the remaining mammals, where
the two identified sites are oriented away from Vpx. Considering structure 4TNP —
as with the whole mammals dataset — several of the subgroup results appeared to
show clustering of identified sites in the C-terminal minor lobe, in close proximity
to T592. We therefore computed the probability of observing this distribution by
chance, as described above. Only the Cetartiodactyla and remaining mammals had
p < 0.05, though the value for the Chiroptera was close to this threshold (table 2.3).
Branch-site tests of positive selection within mammal groups
We were interested to compare the results found in the subgroups using models
M2a/M8 with those from branch-site tests of positive selection, by using the whole
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Figure 2.9: SAMHD1 sites identified as under positive selection in subgroups of
mammals, presented as in figure 2.6.
Subgroup Branch-site total M8 only
(M8 \ BS)
Intersection
(M8 ∩ BS)
Branch-site only
(BS \M8)
Carnivora 3 2 2 1 (41 )
Chiroptera 8 19 7 1 (546 )
Glires 2 6 2 0
Primates 4 3 2 2 (107, 539 )
Cetartiodactyla 8 10 5 3 (443, 585, 588 )
Remaining mammals 6 6 3 3 (235, 590, 597 )
Table 2.4: Numbers of sites identified as being under positive selection using the
branch-site model, with the given group’s clade/branches as foreground, compared
with the M8 model. Sites identified with the branch-site model only are listed in
parentheses (human sequence numbering).
mammal phylogeny with clades/branches of interest permitted dN/dS > 1 (set as
‘foreground’; Yang and Nielsen, 2002; Zhang et al., 2005). For all subgroups, the
alternative model permitting positive selection only along foreground branches was
found to significantly better fit the data than the null model where ω = 1 on these
branches (appendix B). For each of the subgroups, fewer sites were identified as
having BEB probability > 0.95 by the branch-site method than with M8 (table
2.4). Indeed most sites thus identified were also identified by M8, with only 1-3 sites
being found by the branch-site model alone (listed in table 2.4).
2.3. RESULTS 49
Primates 
Glires 
(rodents, rabbits 
and hares) 
Cetartiodactyla 
(whales and even-
toed ungulates) 
Carnivora 
(carnivores) 
Chiroptera 
(bats) 
Remaining 
mammals 
4TNP 
(114-276 and 282-599) 
4CC9 
(606-624) 
5AJA 
(1-22, 34-88 and 93-109) 
* 
* 
* 
* 
* 
Figure 2.10: Sites identified as under positive selection in mammalian SAMHD1
(orange spheres), shown on published crystal structures of SAMHD1, as in figures
2.7 and 2.8. Threonine 592 is again shown in red. The PDB identifier and the ranges
of sites included in the structures are given at the top of each column of figures.
Asterisks mark analyses which did not identify sites present in the given structure.
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2.3.3 SAMHD1 under positive selection in diverse chordate
groups
Having found positive selection in SAMHD1 extends beyond primates to other mam-
mals, we next asked whether positive selection could be observed among still wider
chordate groups. We had obtained SAMHD1 coding sequences for 51 bird, 7 reptile,
2 amphibian and 19 marine animal species (appendix A). Amphibians were the least
well represented, both sequences coming from the same genus (Xenopus). The ma-
rine animal group (which, though not a formal taxonomic rank, we will call ‘fish’)
comprised 16 ray-finned fishes (class Actinopteri) and one species from each of the
divergent classes Chondrichthyes, Sarcopterygii and Leptocardii. The last of these —
the lancelet, or amphioxus (Branchiostoma floridae) — is considered the most basal
chordate group (Delsuc et al., 2006). Our dataset therefore contains a wide diver-
sity of chordate SAMHD1, representing more than 550 million years of evolutionary
divergence. A ‘master’ tree topology comprising the mammal species (discussed
above) and these non-mammals species was estimated by maximum likelihood (fig.
2.11, see methods).
Positive selection identified across chordates
We began with site-specific analyses of the master SAMHD1 dataset. Model M2a
had a statistically significant better fit to the data than model M1a (appendix B),
while, as with the mammals dataset, model M8 failed to converge. 11 sites were
estimated to have probability > 0.95 of belonging to the positive selection site class
(fig. 2.12, top panel). All of these had previously been identified in the M2a analysis
of mammals alone (i.e. these 11 are a subset of the 36 described above).
To test for positive selection signal outside of the mammal clade, we repeated the
site-specific analysis with mammals excluded. The M2a model of positive selection
was again statistically supported (and again M8 did not converge), but no sites
had > 0.95 probability of being under positive selection (the highest probability
was 0.924, for site 601). The 11 sites identified with all sequences included could
therefore be attributed to signal in mammals alone. However, that the model of
positive selection was supported when mammals are excluded indicated positive
selection was present outside of mammals, and suggested that the failure to identify
specific sites may be because the exact sites responsible for the signal differ between
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Figure 2.11: Maximum likelihood phylogeny for chordate SAMHD1; see legend
fig. 2.5. The mammal clade is collapsed for clarity (this subtree is identical to fig.
2.5). The tree is rooted on the lancelet Branchiostoma floridae branch.
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Subgroup M2a supported M8 supported
Birds + −
Reptiles + +
Amphibians − −
Fish + No convergence
Table 2.5: Summary of statistical support for site-specific models of positive selec-
tion, assessed by the likelihood ratio test with two degrees of freedom for each (i.e.
the difference in the number of parameters between null and alternative models). +
indicates p < 0.05 and − otherwise, from likelihood ratio test. See appendix B for
log-likelihood and p values.
groups.
Evidence of positive selection within chordate groups from site models
Using site-specific models on sublineages, we investigated positive selection within
the chordate groups birds, reptiles, amphibians, fish and (using branch-specific mod-
els only, having used sites-specific already) mammals. Results from the site-specific
models are summarised in table 2.5; support for positive selection was observed in
birds, reptiles and fish. Only one site in one chordate group had probability of
> 0.95 for being under positive selection with either site model (site 266 in birds,
with model M2a). Together, these data suggested positive selection has occurred in
these three groups but the models used were not sufficiently powerful to detect the
sites responsible. It is unsurprising that no signal was observed in amphibians since
only two, highly related, species are represented.
More sites identified with branch-site models
We then used branch-site specific models to analyse the ‘master’ dataset, with groups
of interest set to foreground. There was statistical support for positive selection in
all groups tested (the mammal, bird, reptile, amphibian and fish lineages, appendix
B). Multiple sites were identified as having probability > 0.95 of being under pos-
itive selection, though no sites were identified in amphibians (fig. 2.12 and table
2.6). Unsurprisingly, there was agreement with the previous analysis of mammal
sequences: all 36 sites identified previously in the site-specific analysis of mam-
mals alone were included in the 39 sites identified in this branch-site analysis with
mammals as foreground (i.e. the former is a subset of the latter). The sets of sites
found with mammals, birds, reptiles and fish as foreground were completely non-
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overlapping, accounting for the failure to identify sites using site-specific models and
the whole ‘master’ dataset. In fish the sites identified were evenly spread across the
sequence and in birds the sites were evenly spread through the HD domain (fig.
2.12). Sites identified in reptiles were clustered at the N-terminus. These distri-
butions were in contrast with the densely clustered arrangement of sites found in
analyses of mammals.
Mapping onto crystal structures
We then mapped the sites identified onto the same crystal structures discussed
above. There was no clear clustering in Vpx-interacting regions of sites identified
with non-mammal groups as foreground (fig. 2.13, centre and right). As with the
analysis of mammalian SAMHD1 previously, sites identified within the HD domain
(fig. 2.13, left) were positioned away from tetramer interfaces and mostly exposed
to solvent. Some sites found in birds and fish were positioned somewhat near to
T592 and for completeness we computed p values for clustering around this residue
as before, but a significant value was found only for mammals (table 2.7).
Repeating with alternative tree topologies
The ‘master’ tree topology used did not have high bootstrap support for all nodes
and was particularly poor in the fish lineages (fig. 2.11). We therefore wanted to
determine whether the positive results obtained were robust to variation in topology.
We repeated the site-specific analysis of the whole master dataset and the branch-site
specific tests with each subgroup as foreground using three alternative (bootstrap)
topologies. All tests with alternative topologies were consistent with results from
the maximum likelihood topology (see appendix B). Mostly there was concordance
between the sites identified with the maximum likelihood and alternative topologies
(table 2.8), with the exception of just one topology in the analysis with mammals as
foreground where several more sites were found with the maximum likelihood than
the alternative topology. Together these data indicate that the identification of sites
under positive selection in these analyses is not dependent on the topology used.
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Site Residue Mammals Avian Reptiles ‘Fish’
11 K +
12 R +
32 W +
41 D +
55 R +
57 G +
60 E +
63 V +
92 S +
93 S +
95 G +
103 Y +
112 V +
225 A +
226 R +
247 S +
256 Q +
262 E +
280 V +
283 S +
284 L +
338 A +
357 G +
368 S +
379 G +
397 I +
408 R +
425 N +
436 P +
463 T +
465 Q +
466 I +
471 E +
472 D +
475 S +
486 K +
488 L +
501 D +
504 N +
522 C +
561 S +
566 R +
568 Y +
574 A +
575 D +
594 Q +
596 K +
600 D +
601 S +
609 R +
610 L +
611 R +
614 S +
616 S +
618 V +
619 Q +
622 K +
624 D +
625 P +
626 M +
Table 2.6: Sites identified as under positive selection in chordate SAMHD1 using
branch-site models with the specified groups as foreground branches (Yang and
Nielsen, 2002; Zhang et al., 2005). Alternative model of positive selection supported
for all groups. ‘+’ indicates Bayes empirical Bayes probability > 0.95.
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Foreground chordate subgroup p value
Mammals 0.0005
Birds 0.48279
Reptiles 0.95519
Fish 0.45508
Table 2.7: Probabilities of the sites identified as being under positive selection
clustering around threonine 592 if their distribution throughout the monomeric
SAMHD1 crystal structure 4TNP (Ji et al., 2014) were random. See table 2.3.
Analysis Topology Ti Total ML only Intersection Ti only
Site model (M2)
T1 7 4 7 0
T2 11 1 10 1
T3 10 1 10 0
Mammals f.g.
T1 17 22 17 0
T2 40 1 38 2
T3 38 1 38 0
Birds f.g.
T1 6 0 5 1
T2 7 0 5 2
T3 7 0 5 2
Reptiles f.g.
T1 3 1 3 0
T2 3 1 3 0
T3 3 1 3 0
Fish f.g.
T1 11 2 10 1
T2 12 2 10 2
T3 9 3 9 0
Table 2.8: Comparison of SAMHD1 sites identified as under positive selection
with the maximum likelihood (ML) tree topology and each of three alternative
tree topologies, from site specific and branch-site specific analyses. For branch-site
specific analyses, the group designated foreground (f.g.) is indicated. Presented as
in table 2.2.
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Figure 2.12: Codon sites under positive selection in chordate SAMHD1, displayed
as in figures 2.6 and 2.9. All analyses used the whole chordate dataset; panels la-
belled as ‘foreground’ refer to results from branch-site specific tests with the given
lineages set as foreground branches. No sites were found in the analysis of amphib-
ians, though the alternative model was statistically supported.
2.4 Discussion
Positive selection in SAMHD1 a broader phenomenon than previously
appreciated
Previous studies had found SAMHD1 to be under positive selection in primate
species and this was attributed to escape from antagonistic proteins carried by pri-
mate lentiviruses (Laguette et al., 2012; Lim et al., 2012). We have found, firstly,
that this signature extends throughout the mammalian lineage and we identify 36
sites under positive selection (fig. 2.6). With primates excluded, we still identify 31
sites under positive selection, compared with 17 sites observed by Laguette et al.
in primates alone; this is not explained by differences in the models used, since
codeml’s M2a (used here to study the mammals and mammals excluding primates
datasets) is less powerful, or more conservative than M8, used by Laguette et al.
(Wong et al., 2004). These results show positive selection in SAMHD1 is not unique
to primates.
We also identified positive selection within every subgroup of mammals present
in our dataset, showing that no one group is responsible for the overall signal (fig.
2.9). Surprisingly few sites were identified in our analysis of primate SAMHD1: only
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4TNP 
(114-276 and 282-599) 
4CC9 
(606-624) 
5AJA 
(1-22, 34-88 and 93-109) 
Mammals 
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Site model M2 
Reptiles 
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* 
Figure 2.13: SAMHD1 sites identified as under positive selection in branch-site
tests with animal groups set as foreground, presented as in figure 2.10.
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5 with both M2a and M8, in contrast to 6 found by Lim et al. and the 17 by Laguette
et al. The discrepancy may be explained by differences in sequence alignment, our
approach having been very conservative (see methods). An abundance of sites was
found in bats, despite their being the least well represented mammal subgroup (6
taxa) and it is tempting to speculate that this is connected with bats’ unusually
high burden of endemic virus infection (Luis et al., 2013), to which they may have
adapted to control through innate immunity (Baker et al., 2013).
Apart from mammals, we have found positive selection in SAMHD1 from still
more divergent groups of species, representing all chordates for which reliable se-
quences are presently available (fig. 2.12). Though some of our datasets include
considerable sequence divergence, simulation studies show branch-site methods are
robust to saturation of synonymous codon substitutions, which is associated with
lack of power rather than increased false positive rate (Yang and Dos Reis, 2011;
Gharib and Robinson-Rechavi, 2013; Thiltgen, G., dos Reis, M. and Goldstein, R.
A., in press). Moreover, we consistently observe positive selection with the site
models when analysing the much less divergent subgroups of mammals or other
chordates in isolation.
Together, these data show that positive selection in SAMHD1 has been a feature
of its evolution in all advanced animals. This is in stark contrast to the implicit
assumption that positive selection has occurred in response to primate lentiviruses
specifically (Laguette et al., 2012; Lim et al., 2012; Spragg and Emerman, 2013;
Fregoso et al., 2013). A much larger pattern could similarly apply to other restriction
factors currently assumed to be under positive selection due to primate lentiviruses,
such as tetherin (Gupta et al., 2009; McNatt et al., 2009) or APOBEC proteins
(Compton et al., 2012).
Sites of structural interest
We identified four sites under positive selection in mammals as a whole which were
of special interest because of their position in the minor lobe and the chemical
properties of the residues seen in different species. With site 566 being mostly
buried, the range of residue sizes observed is surprising, and could have dramatic
effects on the shape and stability of the minor lobe. The site is also in close contact
with residue T525 in the neighbouring monomer and therefore repeated substitution
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at 566 could further influence monomer-monomer interactions.
Site 574 is still more deeply buried in the minor lobe and substitution at the
position might be expected to be conservative, since, like 566, the introduction of
bulkier side chains might disrupt the packing of residues; yet we observe almost
the widest possible range of side chain sizes, from alanine to phenylalanine. The
hydrophilic serine also appears to have arisen multiple times independently, despite
this site being hidden from solvent in the human structure.
Sites 594 and 596, near the phospho-acceptor T592, are occupied by residues
with diverse chemical properties in different species, which may lead to significantly
different reactions when the negatively charged phosphate group is introduced. The
charge difference observed at 596 in Old World monkeys and apes (lysine, positive)
and New World monkeys (aspartate, negative) may mark a substantial phenotypic
difference within the primate lineage.
Mutagenesis Experiments
We hypothesise that mutations at the four sites discussed above would be partic-
ularly likely to influence the activities of SAMHD1. With reference to residues
observed elsewhere in the mammalian phylogeny at these sites, we have designed
a set of candidate mutants which we would expect to exhibit altered, but not de-
stroyed, SAMHD1 activity. We have collaborated with the Jonathan Stoye and Ian
Taylor laboratories (Crick Institute, UK), who have constructed the mutant proteins
in a human SAMHD1 background sequence.
Preliminary results indicate the mutant proteins remain enzymatically active and
exhibit variable levels of HIV-1 restriction. Strikingly, for most mutants tested the
fraction of SAMHD1 molecules engaged in tetramers increases, suggesting residues
at these sites indeed influence tetramer stability. This work is ongoing.
Drivers of positive selection
The question then arises: what has driven this preference for change over conser-
vation? We propose two, mutually compatible models for evolution in chordate
SAMHD1: (1) evasion of antagonistic proteins from diverse animal viruses and (2)
continual ‘fine-tuning’ of enzymatic activity to maintain balanced dNTP concentra-
tion.
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Available data from experimental and sequence analysis work strongly suggest
positive selection in primate SAMHD1 is driven — at least partly — by the need
to escape antagonism by SIV Vpr/Vpx proteins (Laguette et al., 2012; Lim et al.,
2012; Fregoso et al., 2013; Spragg and Emerman, 2013). Similar signatures in non-
primate animal lineages may therefore be due to equivalent ‘arms races’ with viruses
infecting those species. Several sites identified within subgroups of mammals are
positioned in regions known to be targeted by SIV Vpr/Vpx proteins, at both N-
and C-termini (fig. 2.10), and these same domains could be targeted by other viral
proteins. However, there is significant variation in the regions targeted by Vpr/Vpx
(Fregoso et al., 2013) and therefore hypothetical antagonists carried by other viruses
could plausibly bind different regions of the protein. This would be consistent with
the different distributions of sites identified in each mammal subgroup studied (fig.
2.6 and 2.12).
The nature of the animal viruses potentially responsible for the selective pressure
is uncertain, since animal pathogens are less well studied, but SAMHD1 antagonism
by Vpr/Vpx-like factors may be shared by other lentiviruses. Indeed, all known
lentiviruses infecting humans (HIVs), other primates (SIVs), horses (equine infec-
tious anemia virus), sheep (ovine maedi-visna virus), goats (caprine arthritis and
encephalitis virus) and cats (feline immunodeficiency virus) all encode accessory
proteins, some of which bear similarities to Vpr (Villet et al., 2003). Still more
lentiviruses infecting other animals may remain undiscovered. Moreover they need
not be the only candidates, since entirely different viruses could have adapted to
antagonise the same restriction factor; just as several lentiviruses (HIV-1 M and O,
HIV-2), filoviruses (Ebola virus and Marburg virus) and a herpes virus (human her-
pes virus 8) have all independently evolved mechanisms for antagonising the restric-
tion factor tetherin (Neil et al., 2008; Kluge et al., 2014; Hauser et al., 2010; Bartee
et al., 2006; Kaletsky et al., 2009). Several diverse non-lentiviruses are reported to
be sensitive to SAMHD1 restriction, suggesting the evolution of antagonists could
offer fitness advantages to other viruses, and the insensitive deltaretrovirus HTLV-1
has already been suggested to encode its own SAMHD1 antagonising factor (Gram-
berg et al., 2013). Since it has been shown to repress LINE-1 (Zhao et al., 2013b),
SAMHD1 may also play a role in limiting spread of endogenous retroelements in
general and escape antagonism from them.
However, the primary function of SAMHD1 may be as a metabolic regulator
2.5. METHODS 61
(Franzolin et al., 2013), and we cannot exclude refinement of the enzyme’s dNT-
Pase activity being responsible for the positive selection signature. In mammals,
we have observed a statistically significant clustering of sites under positive selec-
tion around the (absolutely conserved) phosphoacceptor T592, in the minor lobe of
the C terminus (fig. 2.7), which is involved in regulating the tetramerisation, and
therefore dNTPase activity, of SAMHD1. Residues in the minor lobe (including 618
and 619, which we find to be under positive selection) are known to affect SAMHD1
interaction with cyclinA2, which together with associated CDKs mediates T592
phosphorylation (Yan et al., 2015). Upon phosphorylation, the minor lobe becomes
disordered and prevents formation of stable tetramers (Arnold et al., 2015). Our
identification of positive selection in this region suggests the control of tetramerisa-
tion and enzymatic activity has adapted throughout mammalian evolution.
The distributions of residues at the example sites 566, 574, 594 and 596 show
that dramatic changes in sequence context have occurred throughout mammalian
SAMHD1 evolution, and some residues observed appear inconsistent with what we
know of the structural context in the human tetramer. It is therefore plausible that
the structure of the minor lobe itself has changed significantly, with profound con-
sequences for both the impact of phosphorylation and tetramer stability in different
species. This could have been driven by a need to alter the sensitivity for activat-
ing dNTPase activity in accordance with the different dNTP cellular concentrations
required by each species.
Finally, we note that these two models need not be exclusive. Positive selection
may be driven by both escaping viral antagonism and calibrating enzymatic activa-
tion simultaneously. Indeed, the substitutions needed to evade pathogen recognition
may have necessitated further change to compensate for disruptive effects on the
SAMHD1 structure.
2.5 Methods
2.5.1 Sequence gathering and alignment
Chordate SAMHD1 DNA sequences were collected using NCBI BLAST (blastn al-
gorithm) with human SAMHD1 coding sequence (accession NM 015474.3) as the
query. Where more than one sequence was available from a single species (usu-
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ally transcript variants), sequences most closely matching the human sequence were
selected. The sequence for Tasmanian devil (Sarcophilus harrisii) was found to be di-
vided into two sequence records (accessions XM 003758997.2 and XM 012553363.1);
these were concatenated to give a full length sequence. The list of species and ac-
cession numbers for sequences used are listed in appendix A. Sequences which were
less than 70% of the length of the human SAMHD1 sequence were excluded. Se-
quences were collected by Christopher Ruis, following a strategy devised jointly by
Christopher Monit and Christopher Ruis.
Dividing sequences by animal group (mammal, avian, reptile, amphibian and
fish), these nucleotide sequences were aligned as translated protein using MUS-
CLE 3.8.31 (Edgar, 2004), as implemented in the alignment editor SEAVIEW 4.4.0
(Gouy et al., 2010). Misalignment greatly increases the chance of identifying false
positives in selection analyses, as the apparent rate of nonsynonymous substitution
increases. The resulting codon alignments were therefore further edited manually,
with a highly conservative approach: sections within sequences which could not
be aligned with high confidence were masked, such that they would be treated as
missing data (equivalent to alignment gaps) by phylogenetics tools. To create a
master alignment comprising all sequences, the separate animal group alignments
were again translated to amino acid sequences and aligned to each other as blocks,
using the ‘merge’ function of the MAFFT 7 online alignment tool (Katoh and Stan-
dley, 2013) and the resulting alignment pattern was mapped onto the original codon
sequences. Alignment columns containing no data (either gaps or masked codons)
in ≥ 20% of sequences were removed. Sequences were aligned by Christopher Monit
and Christopher Ruis together.
2.5.2 Phylogeny estimation
A phylogenetic tree was estimated by maximum likelihood using multithreaded
RAxML HPC-PTHREADS-SSE3, version 7.7.2 (Stamatakis, 2006; Ott et al., 2007)
with the general time reversible (GTR) substitution model (Tavare, 1986) and
gamma-distributed rate heterogeneity. Confidence in the tree topology was assessed
by estimating trees from 1000 non-parametric bootstrap samples, also using RAxML
7.7.2. The platypus (Ornithorhynchus anatinus) sequence was found to incorrectly
cluster well outside of the mammalian clade and was therefore excluded from sub-
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sequent analysis.
RAxML saves each of the non-parametric bootstrap trees it estimates. For re-
peating selection analyses with alternative tree topologies, we used three of these
bootstrap trees (finite computing resources precluded using more). To speed up
bootstrap tree estimation, RAxML only computes a new initial estimate tree (by
maximum parsimony) for every 10th bootstrap dataset, while interim trees use the
previously estimated bootstrap tree as the starting estimate. To ensure the alterna-
tive topologies used were independent and identically distributed, we used bootstrap
trees which had had maximum parsimony trees as initial estimates (the 1st, 100th
and 200th tree produced).
When investigating selection on subgroups from this large (‘master’) phylogeny
using site-specific models, taxa not of interest were pruned from the topology and
the sequences omitted from the analysis. Custom software (written by Christopher
Monit) for formatting phylogenetic trees made use of the Phylo package in the
Biopython library (Talevich et al., 2012). Tree figures were produced using FigTree
1.3.1 (Rambaut, 2006).
2.5.3 Selection analysis
Phylogenetic analyses were performed using the codeml program, of the PAML pack-
age (version 4.7a; Yang, 2007). We used the site-specific tests of positive selection
M1a/M2a (Nielsen and Yang, 1998) and M7/M8 (Yang et al., 2000). In some anal-
yses we also used the branch-site specific test where clades of interest were set as
foreground (meaning positive selection is permitted) in the alternative model (Yang
and Nielsen, 2002; Zhang et al., 2005).
To reduce the risk of the log-likelihood optimisation reaching a local optimum,
all program runs were performed five times with different initial parameters for the
transition/transversion ratio (κ) and dN/dS ratio (ω): 0.1, 1 and 10. The exception
was the null model for branch-site specific analyses: since the omega ratio is fixed to
1.0 along foreground branches the user cannot specify an initial ω value other than
1.0. Tree branch lengths were first optimised with codeml’s model 0 (which allows
a single ω value) with the corresponding initial parameter values, and these branch
lengths were used as starting values in subsequent analyses with more complex
models. Codon stationary frequencies were estimated using the F1x4 model by
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default, but F3x4 was used if optimisation errors were encountered with F1x4 (i.e.
if the null model had a superior fit to the alternative, which should not be possible
if both models are fitted correctly).
Statistical justification of the alternative model was assessed using the likelihood
ratio test, where the null distribution of the test statistic D is assumed to follow
a χ2 distribution, with degrees of freedom equal to the difference in the number of
free parameters in the null and alternative models: this was 2 for both site-specific
tests and 1 for branch-site specific tests.
Sites were identified as being under positive selection if the computed Bayes
empirical Bayes probability for the site belonging to the positive selection class was
> 0.95. These sites were mapped onto crystal structures, visualised using PyMOL
1.3 (Schro¨dinger, 2010).
2.5.4 Clustering around T592 of mammalian SAMHD1 sites
under positive selection
The distance of a given residue from T592 was taken as the distance between their
respective α carbon atoms. Positions of atoms in protein databank (PDB) files are
expressed as co-ordinates (in A˚ngstroms) and the distance d between two residues is
therefore given as the Euclidean distance between α carbons a and b (one of which
is T592) in dimensions x, y and z:
d =
√
(ax − bx)2 + (ay − by)2 + (az − bz)2. (2.1)
Computing this distance for each of n sites identified as under positive selection, we
computed the harmonic mean (reciprocal of the mean of reciprocals) of distances
H:
H =
n∑n
i=1
1
di
(2.2)
We then assessed whether this harmonic mean distance was lower than expected
by chance by randomly sampling n sites from the structure, computing d for each
site and then computing H for the sample. We did this 105 times to generate a
distribution of H values for unbiased collections of sites. The p value was thus the
proportion of samples for which H was less than the H found with the sites identified
as under positive selection. These computations were performed using (unpublished)
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software written by Richard A. Goldstein and co-ordinates from PDB file 4TNP (Ji
et al., 2014).
Chapter 3
Divergent Selective Constraints in
HIV-1 M/SIVcpz Capsid
3.1 Summary
The lentiviral capsid (CA) protein comprises the viral core, which houses the RNA
genome and viral enzymes. Recent research has shown the capsid determines many
aspects of the early replication cycle, including prevention of innate immune sensing
and influence over the genome integration site. Many of these activities are de-
pendent on interaction with host cofactors, such as cyclophilin A (CypA). To both
characterise evolutionary differences and inform experimental studies, we sought to
identify the CA sites evolving under different selective constraints in the pandemic
HIV-1 group M and SIVcpz, from which HIV-1 M arose following transmission from
chimpanzees. Using a site-wise mutation selection model, we have identified 23 such
sites. These are found in the external CypA binding domain, in positions deep
within the CA structure and in regions which stabilise CA-CA interactions in the
core. Our results suggest host-specific behaviours, with significant implications for
understanding the establishment of a pandemic human pathogen. Unexpectedly,
we also find evolutionary differences between SIVcpz isolates and between subtypes
of HIV-1 M, suggesting diverse CA behaviours in viruses infecting the same host
species. In collaboration with the Greg Towers laboratory, these results will form
the basis of comparative experimental investigations into lentiviral CA function.
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3.2 Introduction
Near the end of the human immunodeficiency virus type 1 (HIV-1) life cycle, Gag
polyproteins assemble to form immature viral particles, and then are cleaved by the
viral protease. The resulting 231 residue capsid (CA) proteins, comprising a ∼ 150
residue N terminal domain (NTD) and ∼ 80 residue C terminal domain (CTD),
assemble into mostly hexamers, with 12 pentamers included in specific positions
to form the closed viral core (Ganser et al., 1999). In a subsequent infection, the
core serves to enclose the genomic RNA template and reverse transcriptase enzyme
and probably shields the nascent reverse transcribed DNA from innate immunity
sensors, such as cyclic GMP-AMP synthase (cGAS; Gao et al., 2013). Recent ob-
servations indicate that CA has a considerably more complex role than as an inert
shell, however, as it has been shown to orchestrate both the passage of an incoming
viral core through the cytoplasm and delivery of the reverse transcribed genome into
the nucleus for integration (reviewed by Campbell and Hope, 2015).
CA mediates these effects through interaction with several host cofactors. CPSF6
(cleavage and polyadenylation specificity factor subunit 6) is ordinarily involved in
mRNA processing and shuttles between the cytoplasm and the nucleus (Ruepp et al.,
2009). It binds to CA at a conserved interface on the CA hexamer (Price et al.,
2012) and may be responsible for directing the core to the nuclear pore via its
nuclear localisation signal domain (Lee et al., 2010). TNPO3 (transportin 3) is
usually involved in nuclear import of cellular proteins (Kataoka et al., 1999) but
has been reported to bind CA at the same interface and may also be involved in
nuclear import of the core (Zhou et al., 2011). Cyclophilin A (CypA) is a cytoplasmic
peptidyl isomerase which binds to CA via a loop on the exterior of the core (Gamble
et al., 1996). It catalyses the cis-trans isomerisation of the G89-P90 peptide bond in
CA, which induces conformational changes in the NTD away from the binding loop
(Bosco et al., 2002), with possible implications for uncoating. The same binding loop
is used for interaction with the nuclear pore protein NUP358 (Schaller et al., 2011),
which possesses its own cyclophilin domain and projecting filaments which recruit
proteins for passage into the nucleus. CA also associates with NUP153 (Matreyek
et al., 2013), a nuclear pore protein whose filaments project into the nucleoplasm.
Failing to make interactions between CA and cyclophilins (CypA or NUP358-
Cyp) or CPSF6 has been shown to disturb the core’s nuclear import pathway and
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is able to determine whether the virus integrates in more or less transcriptionally
active regions of the host genome (Schaller et al., 2011). These same cofactors are
also required to prevent innate immune sensing of viral DNA in macrophages, as has
been demonstrated with CA mutants P90A and N74D which are incapable of CypA
or CPSF6 interaction, respectively. This leads to detection of viral DNA by cGAS
and type 1 interferon induction, dramatically impeding virus replication (Rasaiyaah
et al., 2013).
Recent work has shown CA hexamers form pores into the viral core, through
which dNTPs are electrostatically drawn, for use in reverse transcription (Jacques
et al., 2016). Their influx is regulated by a hairpin loop comprising short β-sheets on
the surface of the hexamer which can move to block the pore, also involving altered
arrangements of α-helices within the NTD. These conformational changes are pH
dependent, but in vivo may be induced by cofactor recruitment and are possibly
used to prevent untimely reverse transcription which could trigger DNA sensing.
Together, the recent research into the activities of CA show it is deeply involved in
the early phases of infection, making it an attractive drug target (Domenech and
Neira, 2013).
The pandemic HIV-1 group M entered the human population from a single cross
species transmission from the chimpanzee subspecies Pan troglodytes troglodytes
(Ptt ; Gao et al., 1999), where the virus reservoir is known as simian immunod-
eficiency virus from chimpanzee (SIVcpz). Another chimpanzee subspecies, Pan
troglodytes schweinfurthii (Pts) harbours a phylogenetically distinct virus. Separate
cross species transmissions of SIVs to humans have occurred several times, but all
have spread much less successfully in the human population (reviewed by Sharp and
Hahn, 2011). Understanding the molecular basis for high or low degrees of lentiviral
adaptation to the human host is of pressing interest.
Unpublished observations from the Greg Towers laboratory suggest HIV-1 group
O (which transmitted to humans from chimpanzees via gorillas as an intermediary
host; D’arc et al., 2015) may be incapable of regulating access through the CA hex-
amer pore and preliminary data indicate SIVcpz Pts may be similarly impaired,
together suggesting CA functions differ between virus groups and hosts. SIVcpz
is dependent on the same cofactors as HIV-1 M (Laura Hilditch and Greg Towers,
manuscript in preparation) but the nature of these interactions and their conse-
quences remain obscure.
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We wished to characterise the regions of CA involved in the adaptation of HIV-
1 M to the human host, with the intention of informing comparative studies of
lentivirus life cycles. We report findings from a phylogenetic selection analysis of
HIV-1 M and SIVcpz CA using the site wise mutation selection model (swMutSel),
which is suited to identifying amino acid sites evolving under different evolution-
ary constraints, following a cross species transmission event (Tamuri et al., 2009,
2012). swMutSel allows us to test the hypothesis that the evolutionary process is
different in the virus groups specified, against the null hypothesis that the selective
constraints are the same. We have also analysed HIV-1 M and SIVcpz CA with the
selection models M7/M8 (Yang et al., 2000) which use dN/dS ratios to identify pos-
itive (diversifying) selection, without distinguishing lineages. This approach can be
useful for identifying sites targeted by cytotoxic lymphocytes (part of the adaptive
immune system), which have been observed in all regions of the CA sequence (Llano
et al., 2013) and would expected to promote diversifying selection as in other HIV-1
genes (Price et al., 1997). In addition, we have estimated which CA amino acid sub-
stitutions occurred following the cross species transmission which established HIV-1
M in the human population.
Several of the sites identified with swMutSel are located in regions involved in
CA-CA interactions, the cyclophilin binding loop and around the β-hairpin, suggest-
ing divergent activities of CA in the two virus groups. Unexpectedly, we observe
striking differences in CA residues between SIVcpz Ptt and Pts, as well as HIV-
1 M subtypes at sites of functional importance. Together, results presented here
will inform experimental studies in an ongoing collaboration with the Greg Towers
laboratory.
3.3 Results
3.3.1 Sites Identified as Under Different Selective Constraints
We obtained a dataset comprising 1332 HIV-1 and 21 SIVcpz CA sequences from the
Los Alamos HIV sequence database (see Methods). We aligned these manually as
codons and estimated a phylogeny by maximum likelihood (ML; fig. 3.1), in which
the HIV-1 subtypes mostly formed clear monophyletic groups. As expected, SIVcpz
isolates were divided into 13 originating from the Pan troglodytes troglodytes (Ptt)
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chimpanzee subspecies, from which the HIV-1 lineage descends, and a separate clade
comprising the 8 sequences derived from Pan troglodytes schweinfurthii (Pts ; Sharp
and Hahn, 2011).
Using our codon alignment and ML tree we applied the site-wise mutation selec-
tion model (swMutSel; Tamuri et al., 2012), testing the hypothesis that the substitu-
tion process differs for sites evolving in the human (HIV-1) or chimpanzee (SIVcpz)
hosts. We did not analyse sites which are wholly conserved (where a single residue
is seen in all sequences) as we know a priori the null hypothesis cannot be rejected
in these cases; these were sites 145, 151, 157, 158, 176 and 192. Using the likelihood
ratio test (LRT) we identified 23 sites for which the null hypothesis of homogeneous
selective constraints was rejected with p < 0.05, correcting for multiple hypothesis
testing (see methods; table 3.1 and table D.1). We had no swMutSel data for site
120 as log-likelihood optimisation failed to converge.
The 23 sites were distributed across the CA sequence, but there was greater
concentration in the N terminal domain (NTD) than the C terminal domain (CTD)
and particularly dense clustering in the cyclophilin binding loop (fig. 3.2, red). 11
of the 23 were positioned in linker regions between secondary structure elements.
For comparison, we fitted models M7 and M8 implemented in codeml (Yang,
2007) and found the M8 model of positive selection was statistically justified with
the LRT (p < 0.05). 7 sites had estimated Bayes empirical Bayes probabilities of 1.0
for belonging to a positive selection site class (table 3.1; fig. 3.2, yellow; table D.1)
and no others had BEB probability > 0.5. Four of these had also been identified
with swMutSel. All but one of the sites identified with M8 were positioned in the
NTD, two of which are in or near the cyclophilin binding loop.
3.3.2 Protein Structure Context
We mapped the identified sites onto a published CA crystal structure, which had
been assembled into both hexamer and multiple hexamer units by molecular dy-
namics simulation (Zhao et al., 2013a; fig. 3.3). Sites 5 and 13 are in or near the
β-hairpin and sites 86, 87, 91, 94 and 98 are in or near the cyclophilin binding loop.
Pairs of sites 68/141 and 41/131 are each positioned within helices and have side
chains in close proximity, suggesting chemical interaction.
To examine whether the identified sites were involved in CA-CA interactions,
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CA Site HXB2 Res. swMutSel M8 (BEB >0.95)
5 N +
13 Q +
14 A + +
15 I +
31 A +
41 S +
47 A +
50 Q +
58 T +
68 M +
83 V + +
86 V +
87 H +
91 I + +
94 G +
98 E +
110 T +
116 G + +
120 N n/a +
131 K +
141 I +
171 T +
177 A +
194 A +
204 A +
225 G +
Table 3.1: Sites identified in HIV-1 M and SIVcpz capsid (CA) with swMutSel
(likelihood ratio test with degrees of freedom N − 1 where N is the number of
residues at the site) and/or codeml model M8 (Bayes empirical Bayes probability
for belonging to positive selection site class > 0.95). Amino acid residues are shown
from the HIV-1 reference sequence HXB2 (group M, subtype B; accession K03455).
There was no data for site 120 from swMutSel as the model failed to converge while
fitting to data.
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Figure 3.1: Maximum likelihood phylogeny for 1332 HIV-1 and 21 SIVcpz capsid
sequences, estimated by RAxML. Clades for HIV-1 subtypes (denoted by letter
name) are collapsed for clarity, and the numbers of taxa contained in each are
indicated. The SIVcpz sequences are divided by the subspecies of their respective
hosts, Pan troglodytes troglodytes (Ptt ; red) and Pan troglodytes schweinfurthii ; blue
(Pts), and the tree is rooted with the latter as the outgroup (Sharp and Hahn,
2011). Nodes with > 70% support (from 1000 non-parametric bootstrap datasets)
are indicated by red squares. Branch lengths are shown as nucleotide substitutions
per site.
H1 β H2 H3 H4 CypA 
BL 
H5 H6 H7 310 H8 H9 H10 H11 
N terminal domain C terminal domain 
Capsid Amino Acid Site 
Figure 3.2: Sites identified in HIV-1 M and SIVcpz capsid (CA) with swMutSel
(red), codeml’s M8 (yellow) or both (orange). The height of the bars is of no signifi-
cance. Secondary structure elements (as defined by Gres et al., 2015) are indicated:
β, β-hairpin loop; H, α-helices; CypA BL, cyclophilin A (and other cyclophilins)
binding loop; 310, short helix defining boundary between domains. The N terminal
domain (sites 1-145) and C terminal domain (150-231) are indicated.
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Figure 3.3: Sites mapped onto capsid monomer structure (PDB ID 3J3Q; Zhao
et al., 2013a). N terminal domain and connecting linker (sites 1-149) are shown in
cyan and the C terminal domain is shown in blue. Sites identified with swMutSel
(red), codeml M8 (yellow) or both (orange) have their side chains shown as spheres.
The cyclophilin A binding loop (CypA BL) and β-hairpin are indicated. Pairs of
sites whose side chains are in close contact are indicated. Panel B is a 180◦ rotation
of A; panel C shows an enlarged and 90◦ clockwise rotation of A; panel D is an
enlarged view of A.
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we mapped them onto the same assembled CA structure multimerised to form hex-
amers. Considering two interacting monomers (fig. 3.4), we saw sites 68, 58 and
15 (identified with swMutSel) are in close contact with 212, 35 and 42 respectively
(not identified with either method) in the neighbouring monomer. Sites 5 and 14
were both identified with swMutSel and similarly are in close proximity between
monomers. In the hexamer as a whole (fig. 3.5) we saw that the greatest density
of sites is on the external side of the hexamer (fig. 3.5A, D) with no side chains of
identified residues protruding into the lumen of the hexamer chamber (fig. 3.5B).
All sites identified with M8 were positioned on the exterior of the hexamer, mostly
on the front as viewed from outside of the viral core, or on periphery of the CTD
(fig. 3.5C, D). Strikingly, identified sites 5 and 13 in and near the β-hairpin project
into the pore at the centre of the hexamer. Mapping the identified sites onto a CA
pentamer model (PDB ID: 3P05; Pornillos et al., 2011; data not shown) showed the
same pattern of interacting side chains as for the CA hexamer.
We went on to consider involvement in hexamer-hexamer interactions (fig. 3.6).
Site 204 in the CTD identified with swMutSel is in close proximity with site 231,
an interaction which stabilises the hexamer lattice by taking part in hydrophobic
interactions between CTDs in neighbouring hexamers (Gres et al., 2015; Zhao et al.,
2013a). The sites identified in the cyclophilin binding loop, such as site 86 at the
apex of the loop, project into the space bounded by interacting hexamers.
3.3.3 Alternative Tree Topologies
We went on to investigate the sensitivity of our results to the tree topology used,
as the ML tree did not have very high branch support at the deeper internal nodes
(fig. 3.1) and low support at shallow nodes within HIV-1 M subtype clades (not
shown). We repeated the swMutSel and codeml M8 analyses with 5 alternative tree
topologies, originating from bootstrap replicate datasets produced while estimating
support for the ML tree. The sets of sites identified with the ML tree compared with
the alternative topologies were mostly concordant; the greatest discrepancy was a
difference of 7 out of 23 sites found using swMutSel with the ML topology but not
found with an alternative (T1; table 3.2).
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Figure 3.4: Identified sites mapped onto a pair of interacting capsid monomer
structures, which form part of a CA hexamer (PDB ID 3J3Q; Zhao et al., 2013a).
(A, right) N terminal domain and connecting linker (sites 1-149) are shown in cyan
and the C terminal domain is shown in blue. Sites identified with swMutSel (red),
codeml M8 (yellow) or both (orange) have their side chains shown as spheres. The
interacting monomer (left) is shown in dark yellow, with identified sites similarly
coloured but with side chains hidden for clarity. Pairs of sites whose side chains are
in close contact between monomers are indicated. Panel B is a 180◦ rotation of A;
panels C-E are enlarged images showing sites interacting between monomers, with
residues of interest shown as spheres in the second monomer (dark yellow).
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Figure 3.5: Identified sites mapped onto capsid hexamer structure (PDB ID 3J3Q;
Zhao et al., 2013a). For each monomer the N terminal domain and connecting linker
(sites 1-149) are shown in cyan and the C terminal domain is shown in blue. Sites
identified with swMutSel (red), codeml M8 (yellow) or both (orange) are coloured
on all monomers and have their side chains shown as spheres on a single monomer
(panels A, B and C) or all monomers (D). (A) shows the front of the hexamer,
viewed from outside the viral core; (B) shows the rear of the hexamer, viewed from
inside the core; (C) shows a view from the side; and (D) shows the same view as
(A).
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Figure 3.6: Identified sites mapped onto a capsid structure in complex with other
monomers forming interacting hexamers (PDB ID 3J3Q, Zhao et al., 2013a; shown
in cyan, green and dark yellow, respectively). Both N and C terminal domains of
the monomer of interest are coloured blue, with side chains of sites identified with
swMutSel (red), codeml M8 (yellow) or both (orange) shown as spheres. (A) Three
interacting hexamers, with site 86 in the cyclophilin binding loop and site 204 in the
C terminal domain indicated. (B) Enlarged view of interacting C terminal domains
in neighbouring hexamers, showing pairs of interacting sites, of which site 204 was
identified with swMutSel.
Model Topology Ti Total ML \ Ti ML ∩ Ti Ti \ML
swMutSel T1 21 7 (13, 14, 47, 86, 116,
171, 194)
16 5 (6, 27, 148, 208,
210)
” T2 23 3 (13, 116, 171) 20 3 (10, 123, 208)
” T3 24 5 (14, 86, 110, 116,
171)
18 6 (10, 123, 148, 154,
208, 210)
” T4 25 3 (14, 83, 116) 20 5 (64, 92, 120, 208,
210)
” T5 26 3 (13, 14, 116) 20 6 (64, 123, 148, 154,
208, 210)
codeml M8 T1 6 1 (50) 6 0
” T2 11 0 7 4 (6, 15, 96, 180)
” T3 6 1 (50) 6 0
” T4 10 0 7 3 (15, 96, 154)
” T5 6 1 (50) 6 0
Table 3.2: Sites identified with alternative tree topologies, T1-5, using swMutSel
(top; multiple hypothesis test adjusted p < 0.05 from LRT with the degrees of
freedom N − 1, where N is the number of residues observed at the site) or codeml’s
M8 (bottom; BEB probability > 0.95). Columns: [Ti Total], total number of sites
found with topology Ti; [ML \ Ti], number of sites found with ML tree but not Ti;
[ML ∩ Ti], number of sites in intersection; [Ti \ ML], number of sites found with
Ti but not ML topology. Where there are discrepancies in the sites found with an
alternative topology compared with the ML topology, the capsid site indices are
given in italics.
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3.3.4 Observed Residue Distributions
We examined the distributions of amino acids observed at the alignment sites we had
identified with swMutSel and the ML topology. At many of the sites the frequencies
of residues differed between the HIV-1 M and SIVcpz groups but with some overlap
in the residues observed; e.g. at site 68 (fig. 3.7), where methionine was observed
in virtually all HIV-1 M sequences (with a small number of paraphyletic isoleucine
residues) while a mixture of valine, isoleucine and methionine are observed in SIVcpz
sequences. At other sites there was a more pronounced difference between SIVcpz
Pts and SIVcpz Pts, such as site 141 (fig. 3.8), where leucine was observed in all
but one SIVcpz Pts, while valine or isoleucine was seen in SIVcpz Pts and isoleucine
was seen in almost every HIV-1 M sequence. At a minority of identified sites the
distributions of amino acids were very similar between HIV-1 M and SIVcpz, such as
site 204 (fig. 3.9), where alanine was observed in nearly every sequence, except for a
minority of paraphyletic glycine residues in HIV-1 M; strikingly, not a single glycine
was observed in HIV-1 M subtype B despite this group being better represented in
the dataset. Site 204 is involved in inter-hexamer interactions (fig. 3.6; Gres et al.,
2015).
3.3.5 Substitutions Involved in Host Shift
To further investigate the evolutionary events in the zoonosis which established HIV-
1 M, we sought to estimate which specific amino acid changes had occurred around
the time of the cross species transmission. Using the WAG amino acid substitution
model (Whelan and Goldman, 2001) and our capsid alignment translated to protein
sequences, we computed the probabilities of each pair of amino acids states existing
at the node representing the most recent common ancestor (MRCA) of both a chim-
panzee virus and the human viruses together and the node representing the MRCA
of only human viruses, conditional on model parameters and previously estimated
branch lengths. To provide more evolutionary context, we used a larger ML tree
comprising the HIV-1 M and SIVcpz sequences described above, and in addition
sequences from HIV-1 groups N, O and P, together with sequences from viruses in-
fecting gorillas (SIVgor), all of which ultimately originate from independent SIVcpz
cross species transmissions (Sharp and Hahn, 2011).
Eight sites had a non-identical amino acid pair with transition probability > 0.5
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Figure 3.7: Residues observed at capsid site 68, on annotated maximum likelihood
phylogeny (top, with HIV-1 M clade collapsed for clarity) and in pie charts (below)
showing residue frequencies in 1332 HIV-1 M sequences and 21 SIVcpz sequences.
Amino acids are specified by single letter code at the end of the taxon names or an-
notating the pie charts. The sets of SIVcpz sequences isolated from each chimpanzee
subspecies (Pan troglodytes troglodytes, Ptt and Pan troglodytes schweinfurthii, Pts)
are indicated. Branch support is indicated in figure 3.1. (NB the amino acid colour
schemes are not consistent between the tree and the pie charts.)
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Figure 3.8: Residues observed at capsid site 141, on annotated maximum likelihood
phylogeny (top, with HIV-1 M clade collapsed for clarity) and in pie charts (below)
showing residue frequencies in 1332 HIV-1 M sequences and 21 SIVcpz sequences.
Amino acids are specified by single letter code at the end of the taxon names or an-
notating the pie charts. The sets of SIVcpz sequences isolated from each chimpanzee
subspecies (Pan troglodytes troglodytes, Ptt and Pan troglodytes schweinfurthii, Pts)
are indicated. Branch support is indicated in figure 3.1. (NB the amino acid colour
schemes are not consistent between the tree and the pie charts.)
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Figure 3.9: Residues observed at capsid site 204, on annotated maximum likelihood
phylogeny (top, with HIV-1 M clade collapsed for clarity) and in pie charts (below)
showing residue frequencies in 1332 HIV-1 M sequences and 21 SIVcpz sequences.
Amino acids are specified by single letter code at the end of the taxon names or an-
notating the pie charts. The sets of SIVcpz sequences isolated from each chimpanzee
subspecies (Pan troglodytes troglodytes, Ptt and Pan troglodytes schweinfurthii, Pts)
are indicated. Branch support is indicated in figure 3.1. (NB the amino acid colour
schemes are not consistent between the tree and the pie charts.)
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CA Site Transition Probability
6 A → L 0.999
41 M → T 0.813
72 V → T 0.999
115 V → I 0.789
120 S → H 0.822
128 D → E 0.855
200 S → T 0.536
203 R → K 0.994
Table 3.3: Conditional probabilities for capsid amino acid transitions along the
HIV-1 M ancestral branch, computed with the WAG substitution model, having
first estimated branch lengths with the same model implemented in aaml (Whelan
and Goldman, 2001; Yang, 2007). Shown are transitions with probability > 0.5
at sites where at least one transition nonidentical transition met this threshold.
Transitions are presented as if from the most recent common ancestor (MRCA) of a
SIVcpz and HIV-1 M to the MRCA of HIV-1 M only; amino acid states are shown
by conventional letter codes.
(table 3.3). Several of these were chemically conservative changes (e.g. negatively
charged aspartate to glutamate transition at site 128), with the exception of sites
41 (hydrophobic methionine to polar threonine), 72 (hydrophobic valine to polar
threonine) and 120 (polar serine to positive histidine). From the set, site 41 was
identified with swMutSel and 120 with M8 (table 3.1).
We mapped these 8 sites onto the capsid hexamer structure (fig. 3.10). Most sites
are positioned on the external side, on or around the β-hairpin loop (such as site 6),
but none on the cyclophilin binding loop. Two sites (200 and 203) project out from
the CTD and are involved in inter-hexamer interactions (Zhao et al., 2013a; see fig.
3.6.)
3.4 Discussion
We have sought to identify positions within the viral CA protein which have evolved
under different selective constraints in SIVcpz compared with HIV-1 M, with the
aim of informing experimental investigation. Using swMutSel, we have identified
23 out of 231 CA sites as having statistical support for undergoing different evolu-
tionary processes in each virus group. Importantly, we sought to distinguish sites
experiencing distinct constraints from sites undergoing diversifying selection: we
also identify 7 sites with codeml’s model M8 (which identifies positive selection us-
ing a distribution of dN/dS ratios without distinguishing lineages). The sites found
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Figure 3.10: Sites with transitional probabilities > 0.5 for non-identical residues
mapped onto capsid hexamer structure (PDB ID 3J3Q; Zhao et al., 2013a), shown as
magenta spheres. For each monomer the N terminal domain and connecting linker
(sites 1-149) are shown in cyan and the C terminal domain is shown in blue. (A)
shows the front of the hexamer, viewed from outside the viral core; (B) shows the
rear of the hexamer, viewed from inside the core; (C) shows a view from the side.
Sites 6, 200 and 203 are indicated.
with M8 are positioned on the exterior of CA hexamers (fig. 3.5), consistent with
diversifying selection being confined to less structured regions. This may be driven
by the need to escape from cellular immunity; indeed epitopes recognised by cyto-
toxic lymphocytes (CTL) have been identified in all regions of the HIV-1 M capsid
(Llano et al., 2013).
Four of the seven sites found with M8 were also identified with swMutSel (table
3.1) and the question arises what type of selection is active at these sites, since
M8 is likely to be suited to identifying diversifying selection, while swMutSel was
developed to identify directional selection. Data from a simulation study indicate
codeml’s site models such as M8 are poor identifiers of directional selection, though
the lineage-specific model has higher sensitivity (Thiltgen et al., 2016). It therefore
seems most likely that these are sites undergoing diversifying selection in one virus
group or the other (e.g. due to different CTL epitope positions), accounting for the
identification by swMutSel as experiencing different selective constraints.
Several of the sites identified with swMutSel are positioned within the loop on
the exterior of the hexamer to which cyclophilins bind, namely cyclophilin A (CypA)
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and NUP358 (fig. 3.3; Thali et al., 1994; Gamble et al., 1996). Catalysis of the cis-
trans isomerization of the Gly89-Pro90 peptide bond of CA by CypA, which induces
conformational rearrangements away from the binding site itself, may influence core
disassembly (Bosco et al., 2002). Like HIV-1 M, SIVcpz is dependent on cyclophilin
cofactors (Laura Hilditch and Greg Towers, manuscript in preparation) and finding
these sites to be under different selective constraints in the two groups suggests they
each mediate different interactions with the host cyclophilins, or that the outcome
of cyclophilin interaction is different. As interaction with CypA is required for HIV-
1 M to avoid innate immune sensing in macrophages (Rasaiyaah et al., 2013) and
interaction with NUP358-Cyp determines the region of the host genome where the
virus integrates (Schaller et al., 2011), the significance of a host-specific CypA or
NUP358-Cyp interaction could be profound. Experimental studies comparing HIV-
1 M and SIVcpz CA behaviour should prioritise investigation of the identified sites,
for example in mutation experiments.
We also identify sites in (i.e. site 5) and at the base of (i.e. site 13) the β-hairpin
loop, the position of which modulates dNTP flux through a pore at the centre of the
CA hexamer in HIV-1 M, probably to enable reverse transcription within the viral
core (Jacques et al., 2016). Unpublished observations by the Greg Towers laboratory
suggest the β-hairpin in HIV-1 group O CA is inflexible by comparison with group
M CA, which suggests it may be unable to regulate the flux of dNTPs into the
viral core. This may make it more vulnerable to innate immunity DNA sensors
in macrophages, accounting for poorer growth kinetics they observe. Moreover,
mutation of site 12 in HIV-1 M has been observed to dramatically impair flexibility
of the β-hairpin, indicating that chemical properties of the residues surrounding the
loop are important for regulating the activity of the hexamer pore. That these sites
are evolving under different constraints in HIV-1 M and SIVcpz suggests that their
β-hairpin loops may have different levels of flexibility. Indeed, it remains uncertain
whether the β-hairpin in SIVcpz CA is flexible at all and, should this be a property
unique to HIV-1 M, substitutions at the identified sites may have been responsible.
None of the identified sites are in the region bound by CPSF6 and TNPO3. This
is unsurprising as this hydrophobic pocket has been noted to be conserved across
diverse primate lentiviruses (Price et al., 2012). Like the cyclophilin-containing
proteins, SIVcpz interacts with these cofactors (Laura Hilditch and Greg Towers,
manuscript in preparation), but we find no evidence suggesting divergent interac-
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tions by SIVcpz and HIV-1 M CA.
The majority of identified sites fall in the linking regions between helices (fig.
3.2), consistent with the helices themselves being conserved to maintain the overall
shape of the CA hexamer, while sites in the linking regions could affect helix ori-
entations in a dynamic structure. This may be because interactions with cofactors
are common to both HIV-1 M and SIVcpz, but different structural implications of
cofactor interaction may mediate host-specific CA activities (Greg Towers, personal
communication). Movement of helices is also involved in the opening and closing of
the hexamer pore (Jacques et al., 2016). Several of the identified sites are buried
within the hexamer, potentially because because allosteric regulation of pore open-
ing, or other putatively co-factor dependent behaviours, require different structural
rearrangements in the two viruses. Some identified sites are within helices, how-
ever, and have side chains in close proximity to helices in neighbouring monomers
(fig. 3.4). We also find sites in the CTD which are involved in hydrophobic interac-
tions between hexamers (fig. 3.6; Gres et al., 2015), suggesting potentially divergent
regulation of viral uncoating.
We also identified sites with high probability of having undergone amino acid
substitution in the interval in which cross species transmission had occurred (table
3.3, fig. 3.10). Interestingly, site 6 is at the top of the β-hairpin and projects into
the lumen of the hexamer pore (fig. 3.10A); the predicted substitution of the small
alanaine to the bulkier leucine could have significantly reduced the rate at which
dNTPs are trafficked into the viral core. Furthermore, substitutions at sites 200 and
203 in the CTD (fig. 3.10C) could influence the stability of inter-hexamer interactions
(Gres et al., 2015), though these predicted substitutions were chemically conservative
(polar S → T and positively charged R → K). Highly probably changes at other
positions, such as sites 41 (M → T) and 72 (V → T) are both buried deep in the
hexameric structure and chemically nonconservative, with potentially significant
effects on hexamer structure. Furthermore, site 41 was identified with swMutSel,
suggesting this site underwent a substitution following zoonotic transmission and
continued experiencing different constraints in the new host. We note, however,
this analysis is arguably less informative than our swMutSel results, as it does
not account for ongoing evolutionary process in either group, and may identify
substitutions which were present in the HIV-1 ancestor by chance (‘founder effects’)
rather than due to novel selective constraints.
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Unexpectedly, we found a difference in the distributions of residues in SIVcpz
from Pan troglodytes troglodytes (Ptt) or Pan troglodytes schweinfurthii (Pts) at
some of the identified sites, such as site 141 (fig. 3.8). In this work we have chosen to
consider SIVcpz as a single group, because few sequences are available and we want
to maximise statistical power, as swMutSel is a parameter-rich model. However, it
may be appropriate to consider them as separate viruses (just as HIV-1 is divided
into groups M, N, O and P), either by investigating divergent constraints in HIV-1
M and the more closely related SIVcpz Ptt only, or even comparing SIVcpz Ptt and
SIVcpz Pts directly. The considerable sequence divergence between SIVcpz isolates
(fig. 3.1) suggests in fact there may be sufficient statistical power from even a small
dataset, and may be investigated in future work.
Again unexpectedly, we found sites where mostly the same residue is seen in
both SIVcpz and HIV-1 M, but we observe a remarkable difference between HIV-
1 M subtypes; e.g. at site 204 (fig. 3.9) alanine is predominant in both groups
with few independently occurring glycine residues in all HIV-1 M subtypes except
subtype B, where exclusively alanine is observed, despite this subtype being the
best represented in our dataset (n = 662). This site is important for hexamer-
hexamer hydrophobic interactions (fig. 3.6; Gres et al., 2015) and its identification
with swMutSel suggests HIV-1 M as a whole is more tolerant of the flexible glycine
at this position than SIVcpz. But in addition it appears there is selective pressure
for greater conservation within subtype B; an observation which suggests future
work should address divergent selective constraints between HIV-1 M subtypes and
may yield indications of different strategies, such as alternative cofactor recruitment
or timing of uncoating, specific to certain subtypes. Biological differences between
subtypes are likely to be under-appreciated at present, since most experimental
studies use laboratory virus strains derived from subtype B only.
In future work, it will be interesting to investigate whether these sites are un-
dergoing interdependent substitution processes; that is, if they are co-varying. Un-
published software by Richard Goldstein is able to assess statistical support for
co-evolution of a subset of protein sites and could be applied to the sites identified
with swMutSel. Co-varying sites are likely to be engaged in the same function, or
indicate sites where compensatory changes must be made.
In addition, it would be informative to examine a large set of CA structures solved
under different conditions (such as pH, which affects pore opening; Jacques et al.,
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2016), to quantify the extent to which the positions and side chain interactions of
the identified sites are altered during secondary structure rearrangement. This may
reveal connections involving the identified sites not apparent in a single structure.
Most significantly, the identification of this set of sites warrants investigation
by mutagenesis experiments comparing the early events in SIVcpz and HIV-1 M
replication. This will form the basis of an ongoing collaboration with the Greg
Towers laboratory.
In conclusion, we have found evidence of sites in CA experiencing divergent
selective constraints in SIVcpz and HIV-1 M, several of which are in positions known
to be of significant biological importance. We have also found unexpected differences
between SIVcpz Ptt and Pts and HIV-1 M subtypes. The identification of these sites
contributes to our understanding of the evolutionary events involved in establishing
a pandemic human pathogen, and will be used to guide experimental investigations
into virus-host interactions.
3.5 Methods
3.5.1 Sequence Data and Phylogeny Estimation
A dataset of full length genome HIV-1 (groups M, N, O and P), SIVcpz and SIV-
gor sequences was obtained from the Los Alamos HIV Sequence Database, the
2012 curated dataset (http://www.hiv.lanl.gov/content/sequence/NEWALIGN/
align.html). Known HIV-1 M inter-subtype recombinants and SIVcpz sequences
known to be derived from the same molecular clone were excluded, leaving 1332
and 21 HIV-1 M and SIVcpz sequences, respectively. Capsid sequences (reference
sequence HXB2 co-ordinates 1186-1879) were excised and aligned manually (using
the alignment editor SEAVIEW version 4.4.0 Gouy et al., 2010) as protein sequences
and mapped back to produce a codon alignment.
From the codon alignment, a phylogeny of all HIV-1 groups, SIVcpz and SIVgor
was estimated by maximum likelihood (ML) using RAxML 7.7.2 HPC-HYBRID-
AVX (Stamatakis, 2006; Ott et al., 2007), with GTR model of nucleotide substitution
and Gamma-distributed rates. Clade support was assessed by 1000 non-parametric
bootstrap replicates. For analyses involving HIV-1 M and SIVcpz only the same
tree topology was used, with irrelevant sequences pruned.
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RAxML saves each of the non-parametric bootstrap trees it estimates. For re-
peating selection analyses with alternative tree topologies, we used five of these
bootstrap trees (limited computing resources precluded using more). RAxML only
computes a new initial estimate tree (by maximum parsimony) for every 10th boot-
strap dataset, while interim trees use the previously estimated bootstrap tree as
the starting estimate. To ensure the alternative topologies used were independent
and identically distributed, we used bootstrap trees which had had independent
maximum parsimony trees as initial estimates.
Custom software written for rooting and pruning phylogenetic trees made use
of the Phylo package in the Biopython library (Talevich et al., 2012). Tree figures
were produced using FigTree 1.3.1 (Rambaut, 2006).
3.5.2 Selection Analysis
The site wise Mutation-Selection model (swMutSel) was written by Asif Tamuri
and is open source (https://github.com/tamuri/swmutsel; Tamuri et al., 2009,
2012). All amino acid fitness parameters were estimated by ML, with mutation pa-
rameters (transition/transversion rate ratio and nucleotide equilibrium frequencies)
and branch lengths estimated separately by FMutSel0 (Yang and Nielsen, 2008),
implemented in codeml of the PAML package (version version 4.7a; Yang, 2007).
The swMutSel alternative model allows a separate rate matrix for each group of
taxa studied; all branches in the HIV-1 M clade were assigned to the HIV-1 M spe-
cific matrix and all remaining branches to the SIVcpz matrix, with the connecting
branch divided in half between the two. For each site analysed the likelihood ratio
test (LRT) was used to assess support for the alternative model, with N −1 degrees
of freedom, where N is the number of amino acids observed at the site. Resulting p
values were corrected for multiple hypothesis testing at each site analysed separately
by adjusting p value threshold such that the false discovery rate is reduced to 5%
(Benjamini and Hochberg, 1995).
Codeml (PAML) models M7 (null) and M8 (alternative) were also applied, with
support for M8 assessed with the LRT using 2 degrees of freedom. Default starting
parameter values were used.
Sites identified were mapped onto a capsid crystal structure (PDB ID 3J3Q;
Zhao et al., 2013a) and images produced with PyMol 1.3 (Schro¨dinger, 2010).
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3.5.3 Computing Ancestral Transition Probabilities
Probabilities for specific amino acid transitions along the HIV-1 M ancestral branch
at each site h in dataset X were computed with a modified implementation of the
pruning algorithm (Felsenstein, 1981), where we compute the conditional probability
of amino acid I being the state existing at node A and amino acid J being the state
existing at node B, given the substitution model parameters θ and the data. We
compute this for each of 202 pairs of states and normalise by the total probability of
the data conditional on the model parameters only (i.e. as conventionally computed
with the pruning algorithm):
P (IA, JB|Xh, θ) = P (IA, JB|θ)P (Xh|IA, JB, θ)
P (Xh|θ) =
P (IA)P (IB|IA, θ)P (Xh|IA, JB, θ)∑
I′A
∑
J ′B
P (I ′A)P (I
′
B|I ′A, θ)P (Xh|I ′A, J ′B, θ)
(3.1)
Note that P (I) = piI is the equilibrium frequency of I and P (IB|IA, θ) = P (IA →
IB|θ) is the transition probability along the branch connecting A and B. We used the
WAG matrix substitution rates and equilibrium frequencies (Whelan and Goldman,
2001) and branch lengths estimated with this same matrix, as implemented in aaml
in the PAML package (Yang, 2007).
Our implementation of this computation was written in Java and made use of
the Phylogenetic Analysis Library for phylogenetics specific data structures (Drum-
mond and Strimmer, 2001) and Apache Commons Math for linear algebra (Apache-
Commons, 2015).
Chapter 4
Divergent Selective Constraints in
HIV-1 M/SIVcpz Accessory
Proteins
4.1 Summary
Primate lentiviruses posses accessory proteins which serve to manipulate the innate
immune response, often by neutralising host innate immunity factors which restrict
virus replication. Interactions with host proteins are often species specific, and
therefore when a virus spreads to a new host adaptation may be required. These
restriction factors show signs of diversifying selection, as amino acid changes occur
to prevent recognition by the accessory protein. Much less studied is the evolution
of the accessory proteins themselves. We aimed to investigate the species specific
adaptation of pandemic HIV-1 group M, compared with its progenitor SIVcpz, which
infects chimpanzees. Using a site-wise mutation selection model, we have analysed
the accessory genes nef, vpu and vpr for evidence of evolving under different selec-
tive constraints in HIV-1 M compared with SIVcpz. Surprisingly, in nef and vpr
we identify sites involved in putatively conserved interactions with host proteins,
suggesting unexpected host specific adaptation. In vpu, we identify sites involved in
the antagonism of the restriction factor tetherin — a function acquired by HIV-1 M
during its adaptation to humans — together with sites which we hypothesise are sim-
ilarly involved. This work demonstrates adaptation of a pandemic pathogen to the
human host and should inform experimental investigation of virus-host interactions.
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Protein Functions Reference
Nef CD4 downregulation Garcia and Miller (1991)
MHC-1 downregulation Schwartz et al. (1996)
Signalling disruption Saksela et al. (1995)
Tetherin antagonism (SIVcpz) Sauter et al. (2009)
SERINC3/5 antagonism (Usami et al., 2015)
Vpu CD4 downregulation Willey et al. (1992)
Tetherin antagonism (HIV-1 M) Neil et al. (2008);
Van Damme et al. (2008)
Vpr Cell cycle arrest Re et al. (1995)
Apoptosis Stewart et al. (1997)
Immune signalling mitigation Laguette et al. (2014)
Table 4.1: Summary of known functions for the HIV-1 M/SIVcpz accessory pro-
teins studied in this work.
4.2 Introduction
All retroviruses possess three essential genes, known as gag, pol and env, whose
products form structural or enzymatic components of viral particles. Lentiviruses
are genetically distinguished from more simple retroviruses by also possessing genes
involved in viral gene expression (tat and rev) and accessory, or auxiliary genes, so
called because they can be dispensable for infection in laboratory cells lines. HIV-
1 possesses four accessory proteins: vif, nef, vpu and vpr (table 4.1). Research
in recent years has shown that these accessory proteins serve to mitigate the host
innate immune response to enable viral replication. A common theme is antagonism
of ‘restriction factors’, host proteins which appear to have evolved specifically to
restrict virus replication, and are often induced by interferon (Malim and Emerman,
2008). The first of these to be recognised was APOBEC3G, a cytosine deaminase
which can introduce hypermutation of the retroviral genome. By targeting it for
destruction through the E3 ubiquitin ligase pathway, the HIV-1 Vif protein degrades
APOBEC3G (Sheehy et al., 2002, 2003; Lecossier et al., 2003; Yu et al., 2003).
Diversifying selection has been identified in many restriction factors, apparently
driven by pressure to escape recognition by antagonistic accessory proteins (Sawyer
et al., 2004, 2005; Gupta et al., 2009; McNatt et al., 2009; Laguette et al., 2012; Lim
et al., 2012). The evolution of the accessory proteins themselves, however, is much
less studied.
The HIV-1 M Nef protein has been shown to influence progression to AIDS in
both animal models and patients (Kestler et al., 1991; Kirchhoff et al., 1995) and
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has been implicated in several functions. Nef downregulates cell surface expression
of CD4, the primary virus receptor in T cells and macrophages (Garcia and Miller,
1991), by interactions with both CD4 and a clathrin adaptor protein complex (AP-
2), which causes CD4 to be absorbed into endosomal compartments (Aiken et al.,
1994; Lindwasser et al., 2008; Chaudhuri et al., 2009). The purpose of the down-
regulation is suggested to be for preventing superinfection, allowing efficient release
of new virions by preventing interaction with the receptor and/or disrupting T cell
activation. This is a conserved behaviour, as SIVcpz can similarly downregulate hu-
man CD4 (Sauter et al., 2009). Nef also downregulates the major histocompatability
complex 1 (MHC-1; Schwartz et al., 1996), again through a clathrin adaptor protein
(AP-1; Greenberg et al., 1998), which prevents antigen presentation and therefore
prevents the cell being destroyed by the cytotoxic immune response (Collins et al.,
1998). This too is apparently conserved, as MHC-1 downregulation by HIV-1 O and
SIVgor has been reported (Kluge et al., 2014), which, like HIV-1 M, both originate
from SIVcpz. In addition, Nef interferes with cell signalling by interactions with
Src family tyrosine kinases, specifically their common SH3 domains (Saksela et al.,
1995), which induces gene expression changes in T cells resembling immune activa-
tion. Recent observations have implicated HIV-1 M Nef with the downregulation
of the putative restriction factor proteins SERINC3 and SERINC5 (Usami et al.,
2015). This permits more efficient virus replication, though the exact mechanism of
restriction by SERINC proteins or their antagonism by Nef remain unclear (Trautz
et al., 2016).
Vpu comprises a single helix transmembrane domain and a cytoplasmic domain
made from two short helices (Maldarelli et al., 1993). Though by a different mech-
anism to Nef, Vpu also induces CD4 downregulation (Willey et al., 1992) and this
appears to be a conserved Vpu behaviour in all HIV-1 groups and SIVs infecting
both apes and some monkeys (Sauter et al., 2009). The most important function
of HIV-1 M Vpu, however, appears to be antagonism of the host restriction factor
tetherin (BST2), which in the absence of Vpu ‘tethers’ budding virions to the pro-
ducer cell surface (Neil et al., 2008; Van Damme et al., 2008). Vpu and tetherin
interact through their transmembrane domains and E3 ubiquitin ligase is recruited
to target tetherin for proteosomal degradation. Surprisingly, human tetherin antag-
onism by Vpu was apparently acquired following the cross species transmission from
chimpanzees which established HIV-1 M, as SIVcpz Vpu antagonises neither human
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nor chimpanzee tetherin. Instead SIVcpz uses its Nef protein (Sauter et al., 2009).
SIVcpz Nef is ineffective against human tetherin due to a small deletion relative to
its chimpanzee and gorilla tetherin orthologues.
Vpr remains the least understood accessory protein, having not been associ-
ated with any specific function with a clear benefit to the virus life cycle. Putative
apoptosis induction has been described (Stewart et al., 1997), together with incor-
poration into virions, suggesting a role in the early stages of infection (Cohen et al.,
1990). The most prominent activity attributed to Vpr is arrest of the cell cycle at
the G2/M checkpoint in cycling cells (Re et al., 1995), the purpose of which is still
unclear. This is a conserved behaviour, having been observed originally in HIV-1
M Vpr and then Vprs from HIV-2 and SIVs infecting sooty mangabeys and African
green monkeys (Planelles et al., 1996; Stivahtis et al., 1997).
Via residues 60-68 in its core helix bundle, Vpr interacts with the E3 ubiquitin
ligase machinery by binding DCAF1 (Zhao et al., 1994), which acts to recognise
substrates to be targeted for proteosomal degradation, and this activity is required
for cell cycle arrest (Belzile et al., 2007; DeHart et al., 2007; Hrecka et al., 2007).
Similarly, the related Vpx protein found in the HIV-2/SIVsm lentivirus lineage in-
teracts with DCAF1, with the purpose of degrading the restriction factor SAMHD1
(Hrecka et al., 2011; Laguette et al., 2011); however, no target for degradation by
Vpr has been reported.
Recent work (Laguette et al., 2014) has uncovered some detail of the mecha-
nism underlying Vpr-mediated cell cycle arrest, identifying Vpr’s interaction with
factors comprising a complex surrounding the SLX4 scaffold protein (collectively,
SLX4com), which ordinarily coordinates DNA repair events during S phase. Vpr
activates the complex prematurely, disrupting its role in DNA repair and therefore
preventing progress through the G2/M checkpoint. Significantly, Vpr interaction
with SLX4com was associated with preventing interferon induction, which suggests
a role for Vpr in avoiding innate immune sensing. The arrest of the cell cycle and
interaction with both DCAF1 and SLX4 have since been replicated with a panel of
Vprs from SIVs infecting several Old World monkeys encompassing wide lentiviral
divergence, suggesting the activities were present in the ancestral primate lentivirus
Vpr (Berger et al., 2015). Moreover, species specificity was observed, with some
SIVs incapable of cell cycle arrest and SLX4 interaction in human cell lines, while
able to do so in African green monkey cells.
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As species specificity is a common feature of accessory proteins’ interactions with
host factors, it suggests adaptation is required following each transmission to a new
host, as has occurred multiple times throughout primate lentivirus evolution (Sauter
et al., 2009; Laguette et al., 2012; Lim et al., 2012; Kluge et al., 2014; Sharp and
Hahn, 2011). Antagonism by these viral proteins involves direct interactions, and
the target restriction factors have shown phylogenetic signatures of diversifying se-
lection at binding interfaces, as non-specific amino acid change is favoured to prevent
recognition by the antagonist (Duggal and Emerman, 2012). Models such as those
implemented in codeml (Yang, 2007) which identify elevated rates of indiscriminate
nonsynonymous codon substitutions have proved highly successful in identifying this
type of selection (Sawyer et al., 2004; McNatt et al., 2009; Laguette et al., 2012;
Lim et al., 2012). Conversely, we would expect adaptation by the accessory protein
to involve specific changes to fulfill the new selective constraints associated with the
change of host, as only a narrower set of amino acids in the binding sites will be
able to mediate an interaction.
We have sought to characterise the host-specific adaptation of the HIV-1 M acces-
sory genes nef and vpu following transmission to humans from chimpanzees, as these
genes have contrasting interactions with the restriction factor tetherin depending on
the host and virus. In addition we have analysed HIV-1 M and SIVcpz vpr as this
is of special interest given recent investigations into Vpr function (Laguette et al.,
2014). Using a site-wise mutation selection model (swMutSel; Tamuri et al., 2012),
we have tested the hypothesis that the selective constraints in these proteins differ
in HIV-1 M compared with SIVcpz. From this we have identified sites undergoing
divergent constraints in each accessory gene. Surprisingly, in nef and vpr, many of
these sites are in regions of the proteins involved in conserved functions, suggesting
previously unrecognised species specificity of the interaction. In vpu, we identify
sites known to be involved the interaction between HIV-1 M Vpu and human teth-
erin, suggesting these sites underwent directional selection as Vpu acquired a new
function. We hypothesise other identified sites in Vpu may be similarly involved,
which will be of interest to experimentalists investigating Vpu-tetherin interactions.
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HIV-1 M (n=1330) 
SIVcpz Ptt 
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Figure 4.1: Maximum likelihood phylogeny for 1330 HIV-1 and 21 SIVcpz Nef se-
quences, estimated by RAxML. The HIV-1 clade is collapsed for clarity. The SIVcpz
sequences are divided by the subspecies of their respective hosts, Pan troglodytes
troglodytes (Ptt) and Pan troglodytes schweinfurthii ; (Pts), and the tree is rooted
with the latter as the outgroup (Sharp and Hahn, 2011). Nodes with > 70% support
(from 1000 non-parametric bootstrap datasets) are indicated by red circles. Branch
lengths are shown as nucleotide substitutions per site.
4.3 Results
4.3.1 Nef
34 Sites Identified as Experiencing Divergent Selective Constraints
We obtained a dataset comprising 1330 HIV-1 M and 21 SIVcpz Nef codon sequences
from the Los Alamos HIV sequence database, which we aligned manually. We esti-
mated a phylogeny by maximum likelihood (ML; fig. 4.1), for which non-parametric
bootstrapping indicated high support for deep internal nodes, but lower support
within the HIV-1 clade (not shown). With this codon alignment and ML topology,
we applied the site-wise mutation selection model (swMutSel; Tamuri et al., 2009,
2012), testing the hypothesis that the substitution process differs for sites evolving
in the human or chimpanzee hosts.
Using the likelihood ratio test (LRT) we identified 34 sites for which the null hy-
pothesis of homogeneous selective constraints was rejected with p < 0.05, correcting
for multiple hypothesis testing (table 4.2 and table E.1). Separately, we fitted mod-
els M7 and M8 implemented in codeml (Yang, 2007) for comparison and found the
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Nef Amino Acid Site 
PxxP loop 
N terminal anchor Core domain 
Flexible loop 
Figure 4.2: Sites identified in HIV-1 M and SIVcpz Nef with swMutSel (red),
codeml’s M8 (yellow) or both (orange). The height of the bars is of no significance.
Secondary structure elements (as defined by Geyer et al., 2001) are indicated.
M8 model of positive selection was statistically justified with the LRT (p < 0.05).
23 sites had estimated Bayes empirical Bayes (BEB) probabilities > 0.95 for belong-
ing to a positive selection site class (table 4.2) and no others had BEB probability
> 0.5. 11 of these had also been identified with swMutSel. The sites found with
either method were distributed across the Nef primary sequence (fig. 4.2).
Interaction with Host Factors
We mapped the identified sites onto Nef protein structures. The amphipathic na-
ture of the protein has prevented a full-length structure being determined, but a
composite structure produced by modelling interactions of Nef domains has been
described (Geyer and Peterlin, 2001). The identified sites are distributed across the
structure, without obvious clustering (fig. 4.3). The CD4 interaction surface of Nef
comprises a hydrophobic patch on the core domain (fig. 4.3, cyan), which is highly
conserved in HIV-1 M (Geyer and Peterlin, 2001). Consistent with this activity
being conserved in both viruses, none of these sites are identified in our analyses,
though sites 54, 100 and 113 identified with swMutSel only are in close proximity
(fig. 4.3).
Since CD4 downregulation is dependent on interaction with subunits of AP-2,
we considered the same sites in the context of AP-2 binding. The interaction is
mediated by sites 160-165, with contributions from sites 174-175, which are mostly
conserved within HIV-1 M (Lindwasser et al., 2008; fig. 4.4, cyan). Surprisingly, site
163 was identified by swMutSel as undergoing divergent selective constraints. This
interacts with σ2 residues N97 and V98 which form part of a loop connecting two
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Nef site HXB2 Res. swMutsel (p < 0.05) M8 BEB > 0.95
14 P + +
15 T +
16 V +
21 R +
24 E + +
39 K +
45 S +
47 N +
48 T +
49 A +
50 A +
53 A +
54 A +
76 L +
83 A +
85 V + +
87 L +
100 L +
102 H +
113 W +
116 H +
120 Y +
125 Q +
126 N +
133 V + +
135 Y +
137 L +
138 T +
142 C +
143 Y +
151 D + +
158 K +
163 S +
168 V +
169 S +
173 M + +
176 P +
178 R +
180 V +
182 E + +
184 R +
188 R + +
194 V + +
196 R +
198 L + +
202 Y + +
Table 4.2: Sites identified in HIV-1 M and SIVcpz Nef with swMutSel (likelihood
ratio test with degrees of freedom N − 1, where N is the number of residues at
the site; corrected for multiple hypothesis testing) and/or codeml model M8 (Bayes
empirical Bayes probability for belonging to positive selection site class > 0.95).
Nef amino acid residues are shown the HIV-1 reference sequence HXB2 (accession
K03455).
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Figure 4.3: Sites identified with swMutSel and M8 mapped onto HIV-1 M Nef
composite structure, described by Geyer and Peterlin (2001) and kindly provided
by Matthias Geyer (personal communication). All atoms are shown as spheres.
Cyan, sites implicated in CD4 binding (reviewed by Foster et al., 2011); red, sites
identified with swMutSel; yellow, sites identified with M8; orange, sites identified
with both. Sites 54, 100, 113 and 116 identified with swMutSel and close to the CD4
interacting region are indicated. Sites 62 and 165 are indicated for reference between
panels. (A) The N terminal domain is indicated, shown in an ‘open’ conformation,
away from the core domain in the centre of the structure. (B) Rotated view of (A),
approximately 45◦ to the right, with part of the N terminal domain obscured.
helices (fig. 4.4B). In addition, Nef site 169, also identified with swMutSel interacts
with σ2 residue A63 (fig. 4.4C) and Nef site 173, identified with both swMutSel and
M8, interacts with residue Q301 of subunit α2 (fig. 4.4D).
We next considered interactions relevant to MHC-1 downregulation, which we
would expect to be conserved in SIVcpz as well as HIV-1 M, as this has been observed
in HIV-1 O and SIVgor (Kluge et al., 2014). We mapped the identified sites onto
a crystal structure comprising Nef, the cytoplasmic domain of MHC-1 and subunit
μ1 of AP-1 (Ren et al., 2014; fig. 4.5). Unexpectedly, the identified sites 76, 138
and 139 were found to be positioned along the MHC-1 binding interface (fig. 4.5A),
interacting with MHC-1 sites A323/A324, A329 and Q330, respectively. Moreover,
Nef sites 126 and 137 found with swMutSel, together with site 202 found with both
swMutSel and M8, form a binding pocket in which resides a loop within subunit μ1
(fig. 4.5B).
Nef Alternative Tree Topologies
To test the sensitivity of our results to the tree topology used, we repeated the
analyses with swMutSel and M8 using 5 additional tree topologies, originating from
estimates from non-parametric bootstrap datasets. Using swMutSel, most sites
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160 
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163 
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160 
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169 
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173 
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Figure 4.4: Sites identified with swMutSel and M8 mapped onto HIV-1 M Nef
(approximately residues 56-203, blue spheres) in complex with subunits σ2 (pink
cartoon) and α2 (pale yellow cartoon) of adaptor protein 2 (AP-2). Nef residues
160-165 and 174-175 required for AP-2 interaction are shown in cyan. Nef sites
identified by swMutSel are coloured in red, M8 in yellow and sites identified by both
are in orange. (A) A view of the whole complex; (B) Enlarged in view of (A); (C)
Approximately 90◦ clockwise rotation of (B); (D) Approximately 90◦ anticlockwise
rotation of (B). Crystal structure PDB ID 4NEE; Ren et al. (2014).
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Figure 4.5: Sites identified with swMutSel (red), M8 (yellow) or both (orange) in
Nef (spheres) bound to the cytoplasmic tail of MHC-1 (cyan cartoon, residues 314
to 332) and subunit μ1 of adaptor protein 1 (AP-1, pale yellow cartoon, residues 160
to 423). Nef sites identified with either method in interaction with either partner are
indicated. (B) is a 180◦ rotation of (A); site 204 is indicated for reference between
panels. PDB ID 4EN2; Ren et al. (2014).
found with an alternative topology had also been identified with the ML topology
(table 4.3, top). Only 2 sites were found with the ML topology and not at least one
alternative.
The alternative model M8 was found to be statistically supported over the null
M7 model for each alternative topology (p < 0.05). There was greater range in the
numbers of sites identified across topologies (table 4.3, bottom) and several sites
were found with the ML topology but not found with one or more alternative; none
of these were implicated in host factor binding.
4.3.2 Vpu
13 Sites Identified as Experiencing Divergent Selective Constraints
Following a similar protocol as for Nef, we analysed HIV-1 M and SIVcpz Vpu.
This dataset comprised 1333 HIV-1 M and 21 SIVcpz vpu codon sequences from
the Los Alamos HIV sequence database. Due to alignment uncertainty at the gene’s
5’ end and coding sequence overlap with the env gene at the 3’ end, we confined
our analysis to codon sites 5-53. From our original estimations of phylogeny by
ML, groups expected to be monophyletic were found to be mixed throughout the
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Model Topology Ti Total ML \ Ti ML ∩ Ti Ti \ML
swMutSel T1 40 4 (48, 76, 138,
151)
30 10 (33, 49, 50,
51, 104, 105, 120,
135, 157, 177)
” T2 37 5 (48, 76, 138,
194, 198)
29 8 (32, 49, 89, 105,
120, 168, 176,
177)
” T3 42 3 (48, 138, 198) 31 11 (3, 15, 32, 39,
49, 55, 104, 108,
120, 135, 177)
” T4 38 5 (48, 76, 138,
151, 198)
29 9 (18, 33, 49, 51,
89, 102, 157, 170,
177)
” T5 45 2 (48, 138) 32 13 (3, 18, 33, 49,
98, 105, 107, 108,
120, 157, 168,
170, 177)
codeml M8 T1 11 12 (24, 39, 120,
133, 135, 151,
158, 168, 173,
176, 188, 202)
11 0
” T2 24 0 23 1 (3)
” T3 14 9 (39, 120, 133,
135, 168, 173,
178, 188, 202)
14 0
” T4 15 8 (39, 135, 151,
173, 176, 178,
188, 202)
15 0
” T5 24 1 (173) 22 2 (3, 170)
Table 4.3: Nef sites identified with alternative tree topologies, T1-5, using swMutSel
(multiple hypothesis adjusted p < 0.05, LRT with the degrees of freedom N − 1,
where N is the number of residues observed at the site; top) or codeml’s M8 (BEB
probability > 0.95; bottom). Columns: [Ti Total], total number of sites found with
topology Ti; [ML \ Ti], number of sites found with ML tree but not Ti; [ML ∩ Ti],
intersection; [Ti \ML], number of sites found with Ti but not ML topology. Where
there are discrepancies in the sites found with an alternative topology compared
with the ML topology, the Nef site indices are given in italics.
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Transmembrane domain 
Region Analysed 
Cytoplasmic H1 Cytoplasmic H2 
Vpu Amino Acid Site 
6 14|15 10 23|25|27|29 34 37 42|43 46 
Figure 4.6: Sites identified in HIV-1 M and SIVcpz Vpu with swMutSel. The
height of the bars is of no significance, and site indices are indicated (delimited by
‘|’ if close together, for clarity). Secondary structure elements are indicated. Some
sites were excluded from the analysis due to alignment uncertainty or overlapping
coding sequences; the region analysed (sites 5-53) is indicated.
ML topology and with poor non-parametric bootstrap support (data not shown),
probably due to so few sites being present in the alignment. As the topology itself
is not of primary interest, we estimated the phylogeny by ML while imposing a
constraint topology which required HIV-1 M subtypes and SIVcpz Pts each to be
monophyletic.
Using swMutSel to compare evolutionary processes in HIV-1 M with SIVcpz
Vpu, we identified 13 sites as having support for divergent selective constraints
(p < 0.05 with LRT; table E.2). 7 of these were positioned in the transmembrane
domain, which is involved in tetherin interaction by HIV-1 M Vpu. A further 3 in
the first helix of the cytoplasmic domain were identified (fig. 4.6), which has similarly
been implicated in tetherin antagonism. Interestingly, sites 14, 25 and 27, identified
as experiencing different selective constraints, have previously been implicated in
tetherin binding by HIV-1 M Vpu (Vigan and Neil, 2010; McNatt et al., 2013).
No data were available from codeml models M7 and M8 as M8 failed to converge
after > 2 weeks’ running time. Models M1a and M2a were also used but convergence
with M1a was not achieved after the same duration.
Protein Structure Context
We mapped these positions onto available Vpu nuclear magnetic resonance (NMR)
structures. Sets of sites 10/14/15 and 23/25 each comprise a small cluster in the
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25 
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15 
10 
14 
Figure 4.7: NMR structure of the Vpu transmembrane domain (including residues
7-25). Five sites identified with swMutSel have side chains shown as red spheres.
PDB ID 2GOF; Park et al. (2003).
transmembrane domain (fig. 4.7). Side chains of residues at sites 42 and 46 in
the first helix of the cytoplasmic domain, identified with swMutSel, interact with
residues at sites 61, 65 and 68 in the second helix, which were not analysed due to
gene overlap (fig. 4.8).
Vpu Alternative Tree Topologies
To investigate the effect of the topology used, we repeated the analyses with 5
alternative tree topologies, again applying the constraint that HIV-1 M subtypes
and SIVcpz Pts each be monophyletic. The sites found with the ML topology were
consistently identified when using most alternative topologies, the exceptions being
sites 6 and 46 (in the transmembrane and cytoplasmic domains, respectively) which
were not found with more than one alternative (table 4.4). As with the ML topology,
model M8 failed to converge when using each alternative topology.
4.3.3 Vpr
The same procedure was followed for analysing HIV-1 M and SIVcpz Vpr as Vpu,
involving 1333 and 21 HIV-1 M and SIVcpz sequences, respectively, from the Los
Alamos HIV sequence database. Again it was necessary to use introduce a constraint
tree to force subtypes and SIVcpz Pts each to be monophyletic. We excluded the
5’ and 3’ ends of the gene as they overlap with vif and the first exon of tat in
the genome respectively (tat was also found to begin 6 nucleotides earlier in most
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Figure 4.8: NMR structure of the Vpu cytoplasmic domain (including residues
36-81). Four sites in this region identified with swMutSel (red) and interacting
partners in the second helix have side chains shown as sticks. Regions which could
not be analysed due to overlapping coding sequences are coloured grey. (B) is a
180◦ rotation of (A); (C) an enlarged view of (A), with side chains in cytoplasmic
domain helix 2 (not analysed) interacting with identified sites shown as sticks. PDB
ID 2K7Y; (Wittlich et al., 2009).
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Topology Ti Total ML \ Ti ML ∩ Ti Ti \ML
T1 26 0 13 13 (7, 9, 11, 12, 16, 17, 22, 24,
26, 28, 31, 36, 41)
T2 17 5 (6, 25,
42, 43, 46)
8 9 (7, 11, 12, 17, 24, 26, 31, 33,
40)
T3 24 0 13 11 (7, 9, 12, 17, 20, 24, 26, 28,
31, 36, 40)
T4 24 1 (46) 12 12 (7, 9, 11, 12, 16, 22, 26, 28,
36, 40, 41, 49)
T5 22 2 (6, 46) 11 11 (7, 9, 16, 22, 24, 28, 30, 31,
36, 40, 41)
Table 4.4: Numbers of Vpu sites identified with alternative tree topologies, T1-5,
using swMutSel (multiple hypothesis test adjusted p < 0.05 from LRT with the
degrees of freedom N − 1, where N is the number of residues observed at the site).
Columns: [Ti Total], total number of sites found with topology Ti; [ML\Ti], number
of sites found with ML tree but not Ti; [ML ∩ Ti], number of sites in intersection;
[Ti \ ML], number of sites found with Ti but not ML topology. Where there are
discrepancies in the sites found with an alternative topology compared with the ML
topology, the Vpu site indices are given in italics.
SIVcpz Pts isolates, and these sites were excluded in these sequence). We therefore
analysed codon sites 22-84, of the total 96.
Using swMutSel, two sites were found to have statistical support for divergent
constraints (p < 0.05 with LRT; table E.3). Surprisingly, these were sites 61 and
63 and positioned on helix 3 (fig. 4.9), which forms part of the interaction interface
with DCAF1, which would be expected to be a conserved interaction (Berger et al.,
2015). Site 61 is isoleucine in most HIV-1 M sequences, and engages in hydrophobic
interactions with sites 23 and 26, which are each leucine, stabilising the three-helix
bundle comprising the Vpr core (fig. 4.9B). As with Vpu, codeml models M1a and
M8 failed to converge and therefore no comparison was available.
We repeated the analyses with 5 alternative topologies. More sites were identified
with each alternative than the ML topology, and sites 61 and 63 were identified
consistently (table 4.5). Again M8 failed to converge with each alternative topology.
4.4 Discussion
In this study, we have investigated evolutionary constraints acting on the lentiviral
accessory genes nef, vpu and vpr. Numerous studies of primate lentiviruses have
demonstrated species specific interactions involving viral accessory proteins and host
restriction factors (e.g. Sauter et al., 2009; Lim et al., 2012; Laguette et al., 2012).
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Figure 4.9: NMR structure of the Vpr, showing the two sites identified with
swMutSel as red sticks. Regions which could not be analysed due to overlapping
coding sequences are coloured grey. (A) Whole structure with helix designations
(‘H’) indicated; (B) is an enlarged view of (A), with additional residue side chains
shown as sticks. PDB ID 1M8L; (Morellet et al., 2003).
Topology Ti Total ML \ Ti ML ∩ Ti Ti \ML
T1 7 0 2 5 (37, 41, 45, 60, 66)
T2 6 0 2 4 (37, 58, 60, 66)
T3 5 0 2 3 (37, 60, 84)
T4 4 0 2 2 (37, 60)
T5 6 0 2 4 (58, 60, 66, 77)
Table 4.5: Vpr sites identified with alternative tree topologies, T1-5, using swMutSel
(multiple hypothesis test adjusted p < 0.05 from LRT with the degrees of freedom
N−1, where N is the number of residues observed at the site). Columns: [Ti Total],
total number of sites found with topology Ti; [ML \ Ti], number of sites found with
ML tree but not Ti; [ML ∩ Ti], number of sites in intersection; [Ti \ML], number of
sites found with Ti but not ML topology. Where there are discrepancies in the sites
found with an alternative topology compared with the ML topology, the Vpr site
indices are given in italics.
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Restriction factors are often found to be experiencing diversifying selection to evade
recognition by accessory proteins. To investigate evolution of the accessory proteins
themselves, we have asked whether we can identify divergent evolutionary processes
in these genes in the pandemic virus HIV-1 M and its animal reservoir SIVcpz, to
characterise the sites involved in the host-specific adaptation.
The novelty of this approach is to use swMutSel, a selection analysis tool specif-
ically designed for studying divergent selective constraints. Positive selection in
lentiviral accessory proteins has been investigated previously, by Soares et al. (2008)
using models employing dN/dS parameters (including codeml models), though none
of the sites identified in their study were identified in our analyses with swMutSel
or M8 for any gene. These authors used much smaller sequence datasets (maximum
of 43 sequences) with different proportions of HIV-1 M subtypes, perhaps explain-
ing the discrepancies with our M8 results. We would not necessarily expect their
data to concur with our observations with swMutSel since the respective modelling
frameworks are significantly different.
Nef
In nef, we identified 34 sites with statistical support for divergent selective con-
straints (table 4.2; fig. 4.2). As expected, sites likely to be directly involved in CD4
binding are not identified, consistent with this function being conserved in the two
viruses (fig. 4.3; Sauter et al., 2009). Unexpectedly, however, we identify nef sites
163, 169 and 173 which are involved in the AP-2 complex interaction which mediates
CD4 downregulation (fig. 4.4). The mechanism by which SIVcpz Nef downregulates
CD4 has not been investigated experimentally and it could be expected to closely
match that of HIV-1 M Nef. However, these data suggest the putative interaction
between SIVcpz Nef and chimpanzee AP-2 subunits is not dependent on the same
side chain interactions as for HIV-1 M Nef. In this case, the sites we have identi-
fied may have undergone species specific directional selection following transmission
to the human host, in order to maintain CD4 downregulation via interaction with
AP-2.
Whether SIVcpz Nef downregulates MHC-1 surface expression has not been de-
termined, though this activity has been demonstrated for HIV-1 groups M, O and
SIVgor (infecting gorillas; Schwartz et al., 1996; Kluge et al., 2014), suggesting their
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common precursor SIVcpz possesses the same phenotype. It is therefore surprising
that with swMutSel we identify sites 76 and 138 which form part of the interface
with MHC-1 itself (fig. 4.5A). As with CD4 downregulation, other identified sites
interact with the recruited complex which mediates MHC-1 downregulation, namely
subunit μ1 of AP-1 (fig. 4.5B). Together these data suggest the exact interaction
between MHC-1 and AP-1 is not conserved in HIV-1 M and SIVcpz Nef proteins,
and adaptation at the identified sites may have accompanied the spread to humans.
However, we note in both MHC-1 and μ1, the interaction interfaces involve many
more Nef sites than we identify, and it is not certain to what extent the identified
sites contribute to the binding affinity.
While HIV-1 M Vpu is responsible for antagonising human tetherin, SIVcpz uses
its Nef protein to counter the chimpanzee orthologue (Sauter et al., 2009). HIV-1 M
Nef has no such activity and therefore the sites evolving under different constraints
may be involved in tetherin antagonism by SIVcpz. The molecular details of the
interaction have not been investigated and therefore the sites identified here may
serve to inform experimental inquiry into this function.
We also identified 23 sites with M8, suggesting pervasive diversifying selection in
nef. HIV-1 M Nef is known to be highly immunogenic, containing several epitopes
used in antigen presentation for cellular immunity (Llano et al., 2013). Diversifying
selection has previously been identified in HIV-1 M and also SIVmac (infecting
rhesus macaques; Price et al., 1997; Evans et al., 1999; Cavalieri et al., 2009).
Vpu
Our analysis of vpu was motivated by experimental observations showing that while
SIVcpz Vpu does not antagonise chimpanzee tetherin, HIV-1 M Vpu has appar-
ently acquired this function on adapting to the human host (Sauter et al., 2009). In
the Vpu transmembrane domain (TMD), which mediates interactions with human
tetherin (Iwabu et al., 2009), we identified 7 sites undergoing divergent selective con-
straints with swMutSel (fig. 4.6; fig. 4.7). In mutagenesis experiments, Vigan and
Neil (2010) identified TMD sites 14, 18 and 22 as required for tetherin engagement.
They noted that both sites 14 and 18 are conserved in HIV-1 M Vpu, which antago-
nises tetherin, but not in SIVcpz or HIV-1 O Vpu, which do not, suggesting a change
of selective constraints at these sites which allowed for tetherin antagonism following
4.4. DISCUSSION 109
establishment of HIV-1 M in humans. Consistent with this, we have identified site
14 with swMutSel. McNatt et al. (2013) went on to implicate experimentally TMD
sites 4, 7, 20, 21, 25, 26 and 27 in the tetherin interaction. Of these, we have found
sites 25 and 27 with swMutSel, again consistent with a gain of function inducing a
change in selective constraints. Moreover, the greatest density of identified sites is
in same region, between sites 20-29 (fig. 4.6).
We also identified 5 sites in and around the first helix of the Vpu cytoplasmic
domain (fig. 4.8) which like the TMD has been implicated in tetherin antagonism by
HIV-1 M Vpu (McNatt et al., 2013), though the exact sites have not been mapped.
Together, our analysis of HIV-1 M and SIVcpz Vpu has identified several sites
already known to be involved in tetherin antagonism. We hypothesise that the
remaining identified sites are similarly under different selective constraints due to
the gain of anti-tetherin function by HIV-1 M Vpu. This list will be of interest
to experimentalists using mutagenesis techniques to probe the mechanism of Vpu-
tetherin interaction.
However, while we have emphasised the acquisition of tetherin antagonism as a
putative driver for the divergent selective constraints in Vpu, we note that HIV-1 M
and SIVcpz Vpu also downregulates CD4 (Willey et al., 1992; Sauter et al., 2009)
and has other activities which are poorly defined (Strebel, 2014). We therefore
cannot rule out that the identified sites are involved in divergent Vpu activities in
the two viruses which are as yet unrecognised.
Vpr
Two sites are identified with swMutSel in Vpr. Strikingly, these are within the re-
gion in helix 3 (sites 60-68) to which HIV-1 M Vpr is known to interact with DCAF1
and recruit the E3 ubiquitin ligase complex (Zhao et al., 1994). While SIVcpz Vprs
have not been tested, DCAF1 interaction has been observed in divergent virus lin-
eages and suggests this is an ancestral trait common to most primate lentiviruses
(Berger et al., 2015). Furthermore, human and chimpanzee DCAF1 are highly con-
served (data not shown) and therefore it is surprising sites in this interaction domain
would be identified. It may be that the nature of the DCAF1 interaction differs be-
tween the viruses, just as Vpx proteins from different SIVs bind the restriction factor
SAMHD1 at different interfaces (Fregoso et al., 2013). However, they may be expe-
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riencing divergent selective constraints due to host-specific interactions connected
with another, possibly undiscovered, Vpr function.
It would be interesting to perform similar comparative analyses with lentivirus
groups known to possess divergent Vpr functions. Berger et al. (2015) have found
species specific interaction between Vpr proteins and the SLX4 complex (SLX4com),
with the result that some SIVs are incapable of arresting the cell cycle in human
cell lines, while maintaining this function in African green monkey cells. Testing
for different selective constraints between those that do and do not bind SLX4com
in human cells could therefore identify the regions of Vpr responsible for SLX4com
engagement. However, we note that highly divergent Vprs have high numbers of
insertions and deletions, making confident alignment very challenging; and only
small numbers of sequences from SIVs infecting monkeys are publicly available,
potentially limiting statistical power.
General Discussion
HIV-1 M is substantially better represented in our datasets than SIVcpz, with over
1000 sequences compared with 21. (SIVcpz isolates are rare because chimpanzees
are endangered and samples must be collected in field expeditions to remote parts of
Africa; e.g. Keele et al., 2006.) If one virus group is insufficiently defined due to lack
of data, we would expect the alternative model (representing the hypothesis of non-
homogeneous selective constraints) to fit the data little better than the null model
(representing homogeneous constraints), in which case the null hypothesis cannot
be rejected. Therefore our identification of sites is not an artifact of sampling bias,
provided the available SIVcpz sequences are representative. The small number of
SIVcpz sequences provides sufficient statistical power due to the high amount of
sequence divergence (fig. 4.1).
In our analyses of both vpu and vpr, we found our initial phylogeny estimations
by ML did not produce topologies where HIV-1 M subtypes were monophyletic,
which suggested there was insufficient phylogenetic signal in these short alignments
(147 and 189 nucleotides long, respectively). We therefore resorted to constraining
the topologies so subtypes were monophyletic. The impact of inaccurate topologies
on swMutSel results has not been determined, but we sought to mitigate the danger
of inaccurate topologies introducing false positives by repeating the analysis with
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several alternative topologies and found all (Vpr, table 4.5) or all but one (Vpu,
table 4.4) of the sites were identified consistently, suggesting the results were not
dependent on the topology used. As the sequences used were originally excised
from whole virus genome sequences, in future work topologies could be estimated
by expanding the alignment used to include nucleotide sites flanking the genes of
interest. Selection analyses would still be confined to non-overlapping parts of the
genes themselves, but the resulting topology itself may be more reliable.
We were also unable to compare our vpu and vpr swMutSel results with data from
codeml models M7 and M8, as M8 consistently failed to converge with each topology
used. In future work this could be addressed by repeating the model fittings with a
range of starting parameter values, to allow the numerical optimisation routine to
better explore the parameter space.
In conclusion, we have identified sites in nef, vpu and vpr experiencing diver-
gent selective constraints in HIV-1 M and SIVcpz. In vpu, we identify several sites
known to contribute to HIV-1 Vpu anti-tetherin function and several more which
we hypothesise to be similarly involved. Surprisingly, in nef and vpu we identify
sites in regions which bind host factors, in interactions expected to be conserved in
these viruses. This suggests the mechanisms of action differ in host dependent ways
and therefore human specific adaptation may have occurred at the identified sites
during the establishment of pandemic HIV-1 M.
4.5 Methods
A dataset of 1333 HIV-1 and 21 SIVcpz full length sequences was obtained from the
Los Alamos HIV Sequence Database, the 2012 curated dataset (http://www.hiv.
lanl.gov/content/sequence/NEWALIGN/align.html). Known HIV-1 M inter-subtype
recombinants and SIVcpz sequences known to be derived from the same molecular
clone had been excluded. nef, vpu and vpr nucleotide sequences were excised and
aligned manually (using the alignment editor SEAVIEW version 4.4.0; Gouy et al.,
2010) as protein sequences and mapped back to produce codon alignments. As nef
is positioned at the 3’ end of the primate lentivirus genome, genome sequencing had
had apparently terminated before the end of the coding sequence in many cases: 117
sequences had only 120 codon sites at the 5’ end, and of these 84 had fewer than 36
codon sites at the 5’ end. Several nef sites were omitted due to alignment uncer-
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tainty (corresponding to sites 8-11, 22-25, 61-65, 124 and 204-206, inclusive) and we
did not analyse sites 56 and 134 as they were universally conserved throughout the
dataset; 188 sites were analysed in total. Sites involved in coding sequence overlap
in vpu and vpr were also excluded.
Phylogenies were estimated by maximum likelihood, using RAxML 7.7.2 HPC-
HYBRID-AVX (Stamatakis, 2006; Ott et al., 2007), with GTR model of nucleotide
substitution and Gamma-distributed rates. Three HIV-1 M nef sequences were
positioned in clades other than their classified subtype; since these may represent
recombinant sequences they were excluded by pruning from the tree (sequence acces-
sions: JF683759, JQ403079 and JF683760). RAxML permits a ‘constraint tree’ to
be specified, which allows the search space to be confined to topologies conforming
to the groupings in the constraint tree. For the vpu and vpr trees we constrained
each HIV-1 M subtype and SIVcpz Pts to be monophyletic. No constraint was
used for nef. Alternative tree topologies were obtained and tree figures produced as
described in §3.5.1.
Selection analyses were performed as described in §3.5.2.
Chapter 5
Detecting Positive Selection in
Single-Strand Overlapping Coding
Sequences
5.1 Summary
In a wide range of organisms, multiple protein-coding sequences can be found over-
lapping at a single genetic locus, occupying different reading frames. Conventional
selection analysis tools will produce false positives if applied in this situation, be-
cause they cannot account for selection acting on multiple frames. Indeed, several
published studies have wrongly inferred positive selection in overlapping coding se-
quences for this reason. Previous attempts to produce adequate models for the
purpose have been either heuristic or too computationally expensive for routine
use. We have developed a new likelihood approach which infers selection pressure
on overlapping coding sequences on a singe DNA strand using novel ‘codon aware’
nucleotide substitution models. We present four such models and have tested their
ability to estimate parameters accurately with synthetic data. Only one of these was
accurate under all conditions tested and had low false positive and false negative
rates for identifying positive selection. From this we developed a mixture model to
identify positive selection at a minority of codon sites. The mixture model was found
to have a high false positive rate, and we suggest modifications to the underlying
substitution model which may improve the specificity.
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5.2 Introduction
In protein-coding nucleic acid sequences, amino acid sequences are represented by
sets of contiguous codons, which, if they contain no stop codons, forms an open
reading frame and can be translated into a polypeptide. If translation is initiated one
or two nucleotides further along, the reading frame, or phase, changes, and a different
set of codons can be obtained from the same nucleotide sequence. For example, the
codons ATG, GGA and CCG if read directly translate to the amino acids methionine,
glycine and proline. Starting translation from the second nucleotide, however, yields
the complete codons TGG and GAC, which translate to cysteine and aspartate
residues. As codons comprise triplets of nucleotides, there are three reading frames
present in a single sequence, and a further 3 frames when considering the opposite
strand in double stranded nucleic acids. Some organisms exploit these additional
frames and allow multiple, overlapping, coding sequences to be present in the same
nucleotide sequence.
Overlapping coding sequences were originally identified in the first DNA genome
to be sequenced, the bacteriophage ΦX174 (Barrell et al., 1976), but have since been
found in all domains of life. In bacteria, overlapping coding sequences are found
across many diverse species and reportedly as many as a third of bacterial genes are
engaged in overlap (Johnson and Chisholm, 2004). Most of these are short (85% are
< 30 bp) and on the same strand, perhaps because close union of genes allows their
transcription to be tightly coupled and produces consistent stoichiometries of gene
products. Greater proportions of overlapping coding sequences are observed among
bacterial species with very small genomes, suggesting genome compression may be
a cause in some cases (Sakharkar et al., 2005).
Because eukaryotic genomes are large and apparently nonfunctional regions are
abundant, it had been implicitly assumed overlapping coding sequences do not oc-
cur in these organisms (Mouilleron et al., 2016). But more recent surveys of diverse
vertebrate genomes have identified instances of overlapping coding sequences from
humans to zebra fish (Makalowska et al., 2005). A study of 34,604 human genes iden-
tified 57 overlapping coding sequences and a similar proportion was found among
mouse genes (Veeramachaneni et al., 2004), while other work has found many over-
laps are homologous in the two species, suggesting they persist through long periods
of time (Sanna et al., 2008). (Still higher numbers of overlapping genes have been
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observed, where exons of one gene are interspersed with those of another at the
same locus, without overlap of coding exons themselves; these are not the interest
of the present work.) The well studied examples of overlapping coding sequences
in humans (e.g. Klemke et al., 2001; Nekrutenko et al., 2005; Bergeron et al., 2013)
have found the encoded proteins interact with each other, suggesting the overlap
confers the benefit of consistent co-expression for fulfilling the same function.
Coding overlap is still more common in viruses, with 75% of around 2000 discov-
ered virus species found to exhibit at least some overlap (Chirico et al., 2010), includ-
ing opposite strand overlap (e.g. Epstein-Barr virus) and even cases where all three
reading frames on one strand are protein coding at a single locus (e.g. lentiviruses
such as HIV-1). Explanations for the preponderance of overlap in viruses include:
the need for compactness in relatively short genomes (both for genome packaging
and rapid replication); controlled co-expression as proposed for bacteria; and even
as a means to produce genetic innovation, as new genes are unlikely to be created
by large genomic rearrangements (Brandes and Linial, 2006).
Techniques for identifying selection in canonical coding sequences (e.g. Nei and
Gojobori, 1986; Goldman and Yang, 1994) have been widely applied in studies of
protein coding sequences. The presence of more than one coding sequence in a sin-
gle nucleotide sequence, however, gives rise to unusual evolutionary pressures which
make these methods unsuitable. Synonymous codon substitutions are usually as-
sumed to have a neutral effect on fitness, but a synonymous change in one reading
frame is likely to be nonsynonymous in another. Because most approaches assume
codon sites evolve independently, the interdependence of multiple coding frames
cannot be accounted for. Following an example we presented in Monit et al. (2015),
consider two overlapping coding sequences A and B as in figure 5.1 and a selection
analysis of gene A. The first nucleotide position in each gene B codon corresponds
to the third nucleotide position in gene A codons. We see from the universal genetic
code that substitutions in the first nucleotide position of a codon are likely to be
nonsynonymous in that frame, meaning purifying selection acting on gene B would
reduce substitution rates at these sites. This corresponds to a decreased substi-
tution rate at the third nucleotide position in gene A codons, which are likely to
be synonymous in that frame, therefore inflating the dN/dS ratio for gene A and
resulting in the mistaken impression of positive selection. Failing to account for
selective constraints acting on alternative frames therefore renders conventional se-
116 CHAPTER 5. SELECTION IN OVERLAPPING CODING SEQUENCES
1 2 3 
2 3 1 1 2 
3 1 Gene A codon positions 
Gene B codon 
positions 
Nucleotide position 
(arbitrary numbering) 1 2 3 4 5 
Figure 5.1: Overlapping codons of two hypothetical genes, A and B. Boxes repre-
sent nucleotide positions and solid black lines show the boundaries between codons.
Numbers within boxes represent nucleotide positions within each codon triplet. It
can be seen that the nucleotide occupying the first position in gene B codons is the
same as the nucleotide at the third codon position in gene A. Adapted from Monit
et al. (2015), with permission.
lection analysis tools invalid. Many published studies (e.g. Obenauer et al., 2006;
Snoeck et al., 2011; Roy et al., 2015) have reported finding positive selection selec-
tion when studying overlapping coding sequences, and it is highly likely that these
are false positives resulting from this model misspecification.
Several strategies for modelling selection in overlapping reading frames have been
attempted previously. The first (Hein and Stovlbaek, 1995) generalised to overlap-
ping coding sequences the method of Li et al. (1985), a heuristic counting method
for estimating selection pressure. This relies on assigning nucleotide sites within
codons to degeneracy classes based on whether substitutions introduce nonsynony-
mous codon changes. A single sequence in the dataset is used to determine the
classes and it is assumed they do not change through time. While the method of-
fers the advantages of speed and simplicity, it is approximate only. Similarly, Wei
and Zhang (2015) extended the method developed by Nei and Gojobori (1986) to
accommodate overlapping coding sequences, but as this is also a heuristic counting
method.
Pedersen and Jensen (2001) tackled directly the fundamental problem of being
unable to assume independence between sites by developing a probabilistic model
in which substitutions between whole sequences are considered. The substitution
process is treated as a reversible, homogeneous Markov process with parameters
common to codon substitution models such as the transition/transversion rate ratio
(κ) and a dN/dS ratio for each gene. However, the size of the state-space forces them
to use a Monte Carlo simulation to compute transition probabilities. The procedure
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is computationally expensive and is therefore impractical for analysing more than
two sequences.
Sabath et al. (2008) noted the disadvantages of the approximate and whole-
sequence approaches and proposed a model in which the unit of evolution was a
sextet, comprising two adjacent codons in one frame and an overlapping codon in
another frame. They construct a sextet substitution matrix for each gene, including
dN/dS parameters for both genes, from which they derive codon transition prob-
ability matrices by amalgamating substitution rates for sextets sharing the same
central codon. Both the probability matrices are used to compute the probability
of observing the sequence data, and these values are then multiplied to give the
total likelihood of the model. The approach therefore treats evolution of the two
overlapping genes as independent events, despite their being in the same sequence.
Motivated to identify selection on coding overlaps for genome-wide screens rather
than selection analysis, Chung et al. (2007) developed a codon model dealing with
uncertainty about flanking states affecting an overlapping gene by marginalising;
but like Sabath et al. (2008) substitutions in the two genes are ultimately treated
as independent processes.
The presence of overlapping coding sequences in diverse cellular organisms and
their prevalence in clinically relevant viruses makes understanding their evolution a
matter of importance. The following qualities would be desirable from an approach
to studying selection in overlapping coding sequences: (1) adequate separation of
effects on the different genes, so the selective constraints acting on each can be
identified; (2) ability to test hypotheses about the nature of the selective constraints;
(3) computationally tractable, so datasets of more than a handful of sequences can
be analysed; and (4) preferably modelling substitutions as a Markov process, to
take advantage of the well developed mathematical framework used in phylogenetics
(Felsenstein, 1981). None of the selection analysis methods developed to date satisfy
all of these and so, as yet, there is no appropriate tool suitable for studying these
genes routinely.
In this work we present a new approach to modelling selection in single-strand
overlapping coding sequences. We have developed four nucleotide substitution mod-
els which account for protein-level selection. In tests with synthetic data, only one
of these (the pentamer model) estimated parameter values accurately; summarised
in table 5.1. To identify varied selection pressure across overlapping genes, the pen-
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Sub. Model Theory Results Outcome
Genetic code
weighting model
§5.3.2.1;
p120
§5.4.1.1;
p132
Overestimated w in some cases and,
when used to detect positive selection,
had high false positive rate
Codon weighting
model
§5.3.2.2;
p122
§5.4.1.3;
p135
Overestimated w in some cases; sug-
gests high false positive rate
Frame Indepen-
dence Model
§5.3.2.3;
p123
§5.4.1.4;
p138
Overestimated w in some cases; sug-
gests high false positive rate
Pentamer model §5.3.2.4;
p125
§5.4.1.5;
p138
Accurately estimated w and had low
false positive rate. Used this to develop
mixture model
Table 5.1: Summary of the four substitution (‘sub.’) models developed and the
outcome of tests with synthetic data generated with uniform ω = dN/dS. Sections
(§) and page numbers (p) describing them are indicated.
tamer model was used to implement a mixture model inspired by a commonly used
codon mixture model (Nielsen and Yang, 1998). We found the mixture model had
an unacceptably high false positive rate, using both the likelihood ratio test and
parametric bootstrapping. We suggest modifications to the underlying model which
may improve the specificity.
5.3 Theory
5.3.1 Premise
5.3.1.1 Aims
We seek to develop substitution models applicable to overlapping coding sequences
which account for protein-level selection using the conventional dN/dS = ω ratio
(Goldman and Yang, 1994). Computing transition probability matrices, the likeli-
hood of a model can then be computed with the traditional approach (Felsenstein,
1981). That framework in place, we can test the hypothesis of positive selection
being active in one of the overlapping genes using the likelihood ratio test (LRT).
As discussed above, codon-based Markov models are not applicable to overlap-
ping coding sequences because sites are assumed to evolve independently, while
codons in alternative reading frames span boundaries between codons in the frame
considered. We aim to salvage the assumption of site independence by modelling
codon-level selection at the nucleotide level and including parameters representing
selection on amino acid changes. To bridge the gap between nucleotide and codon
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Figure 5.2: Overlapping reading frames and site types.
substitutions, we weight these selection parameters in accordance with our uncer-
tainty about whether the given nucleotide change causes a nonsynonymous codon
substitution, which is dependent on the site’s (unknown) sequence context.
We assume that overlapping coding sequences are evolving independently of
each other and that the substitution process is the same in overlapping and non-
overlapping parts of a gene.
5.3.1.2 Genetic Layout
A nucleic acid strand contains three overlapping reading frames (fig. 5.2), which
we name A, B and C. Nucleotide substitutions at the three positions within a
codon do not have equal chances of resulting in nonsynonymous change in codon:
in the universal genetic code, we see most (95.5%) changes at the first position, all
changes at the second position and few (28.4%) at the third position will result in
nonsynonymous codon change. Any nucleotide site is simultaneously a first, second
and third codon position depending on the frame. This gives rise to three types of
site (hereafter site types), which we name α, β and γ. α sites are defined as codon
position 1 in frame A, β sites are codon position 1 in frame B and γ sites are codon
position 1 in frame C (fig. 5.2).
Furthermore, if we consider a stretch of the genome containing several genes, we
will have zones (or alignment partitions; sets of contiguous sites) in which the gene
in each frame is consistent. Moving from one end of the sequence to another, a new
zone begins with each beginning or end of a gene in any frame. The HIV-1 genome,
for example, can be divided into 18 zones (fig. 5.3).
We model nucleotide substitutions at each site type in each partition as distinct
Markov processes with their own rate (Q) matrices (in total 3Nz matrices, if Nz is
the number of zones), and parameter values are estimated by maximum likelihood
(ML). We call these models codon-aware nucleotide (CAN) substitution models.
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gag vif tat nef 
pol env vpr 
vpu rev 
Figure 5.3: Coding zones (partitions) in the HIV-1 genome. Protein-coding open
reading frames A, B and C shown top, middle and bottom, respectively (coloured
as in fig. 5.2). Genes tat and rev are both made up of two exons. Gene lengths are
not to scale.
5.3.2 Substitution Models
5.3.2.1 Genetic Code Weighting Model
Our simplest model extends the HKY85 nucleotide substitution model (Hasegawa
et al., 1985) to include protein-level selection in each frame.
Let pn be the probability of a nucleotide substitution within a codon causing
a nonsynonymous codon substitution, while the probability of being synonymous
ps = 1− pn. In the first instance, pn can be derived from the fraction of nucleotide
substitutions at the given codon position (first, second or third) which cause non-
synonymous codon changes, with reference to the genetic code. That is, over all
combinations of codons we count the number of codon pairs which are nonsynony-
mous at the codon position (Cn) and the number which are synonymous (Cs). For
the first, second and third codon positions,
C1n =
4∑
x
4∑
y
4∑
z
3∑
x′ 6=x
g(xyz, x′yz) (5.1)
C2n =
4∑
x
4∑
y
4∑
z
3∑
y′ 6=y
g(xyz, xy′z)) (5.2)
C3n =
4∑
x
4∑
y
4∑
z
3∑
z′ 6=z
g(xyz, xyz′) (5.3)
where x, y and z denote nucleotide states making up codons, and g(xyz, x′y′z′)
returns 1 if the codons are both nonsynonymous and neither are stop codons, and
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0 otherwise. Cs is defined similarly, but counting synonymous differences. Then,
pn =
Cn
Cn + Cs
. (5.4)
From the universal genetic code, pn is 0.954, 1.0 and 0.284 for the three codon
positions, respectively. (Alternative values could be computed for other genetic
codes, such as mitochondrial.)
Which value of pn applies to a nucleotide substitution then depends on the site
type and the frame of interest. For example, the probability of a nonsynonymous
nucleotide substitution in frame A at an α site is 0.954, as α sites are defined as
codon position 1 in frame A; if considering frame C at a β site, pn is 0.284, as this
is the third codon position (fig. 5.2).
We then define a weighting function f , specific to frame F and site type s:
fF,s(ωG) = pnωG + ps (5.5)
where ωG is the dN/dS ratio for gene G which resides in frame F , and the value of pn
is determined by F and s. Since ω = 1 is appropriate for a synonymous substitution,
the function returns ωG value weighted by the probability of the substitution type,
summed over the probabilities that the change is nonsynonymous or synonymous.
The HKY85 substitution matrix is defined
qHKYij = νpijK(i, j) (5.6)
and
qHKYii = −
∑
i 6=j
νpijK(i, j) (5.7)
where K(i, j) returns the transition/transversion rate ratio κ if i and j are both
purines or pyrimidines, but 1 otherwise. ν is a scaling factor which ensures the
mean substitution rate across sites is equal to 1:
ν =
1
−∑i piiqHKYii . (5.8)
We apply the weighting function accounting for selection as a scalar multiplication:
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qij,s = νpijK(i, j)f
s
F (ωG)c (5.9)
and
qii,s = −
∑
i 6=j
νpijK(i, j)f
s
F (ωG)c. (5.10)
As the selection term will alter the overall substitution rate, we include a free pa-
rameter c shared among all sites which allows the matrices to be scaled such that
the overall substitution rate matches the branch length units.
Extending the model to 3-fold gene overlap, we define an ω for each gene (named
1, 2 and 3 below, occupying frames A, B and C respectively) present at this site
(which is of site type s) and introduce a weighting function for each frame.
qij,s = νpijK(i, j)fA,s(ω1)fB,s(ω2)fC,s(ω3)c. (5.11)
This yields a substitution matrixQ for every site type s within each zone. If a frame
in a given zone is noncoding, ω for that frame is fixed to 1. Corresponding tran-
sition probability matrices and site log-likelihoods are computed as with standard
phylogenetic models (Felsenstein, 1981), and log-likelihoods are summed across sites
to give the total log-likelihood. We use branch lengths estimated separately with
the HKY85 substitution model (Methods §5.6.1). In all, the model has NG + 5 free
parameters: κ, piT , piC , piA (with piG = 1 − piT − piC − piA), c and one ω for each of
NG genes.
5.3.2.2 Codon Weighting Model
The codon table weighting model assumes all sense codons are equally probable.
It is well known, however, that codon probabilities are uneven in most organisms,
for example in response to unequal concentrations of synonymous tRNA (reviewed
in Plotkin and Kudla, 2011). We therefore modify the above to allow for codon
biases. If we have a normalised codon probability distribution, where a codon xyz
has probability (frequency) Pxyz, then we can extend equation 5.1 above:
C1n =
4∑
x
4∑
y
4∑
z
3∑
x′ 6=x
g(xyz, x′yz)Pxyz (5.12)
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Figure 5.4: Pentamer containing three overlapping codons. As we model substi-
tutions at the central nucleotide site only (occupied by state i and then j following
a substitution), we are ignorant of nucleotide states g, h, k and l. Note that the
central site occupies a different codon position (first, second or third) depending on
the codon’s frame: for example, if this were an α site, codon ikl is in frame A, ghi
in frame B and hik in frame C (see fig. 5.2).
with C2n, C
3
n (equation 5.2 and 5.3) and the synonymous counts similarly modified.
That is, we weight each putative codon transition by the probability of the starting
codon. pn is then computed as in equation 5.4. We assume codon probabilities in
non-coding frames are all 1/64.
Codon probabilities for many organisms have been estimated and made avail-
able in the Codon Usage Database (http://www.kazusa.or.jp/codon/; Nakamura
et al., 2000), which estimates frequencies from sequence data from the 2007 NCBI-
GenBank release. We use human and HIV-1 codon probability estimates from this
database, as well as a uniform distribution (each sense codon having probability
1/61).
5.3.2.3 Frame Independence Model
A more complex model deals with the uncertainty about sequence context explic-
itly. We imagine the nucleotide site of interest resides at the centre of a pentamer
ghikl, which contains one complete codon in each reading frame (fig. 5.4). i → j
substitution at the central site will cause each codon in the pentamer to change.
The instantaneous substitution rate at the central nucleotide site is assumed to
be dependent on the codon probabilities of the original and target codons in each
frame, as well as selection acting on each gene present. As we are considering sub-
stitutions at nucleotide sites independently, we remain ignorant of the nucleotide
states at the neighbouring two sites on either side. We therefore marginalise over
nucleotide triplets (i.e. codon probabilities), with a term for each codon comprising
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the pentamer. For an α site,
qij,α = νK(i, j)×
∑4
k
∑4
l ΩA(ikl, jkl)PiklPjkl∑4
k′
∑4
l′ Pik′l′
×∑4
g
∑4
h ΩB(ghi, ghj)PghiPghj∑4
g′
∑4
h′ Pg′h′i
×∑4
h
∑4
k ΩC(hik, hjk)PhikPhjk∑4
h′
∑4
k′ Ph′ik′
(5.13)
where
ΩF (xyz, x
′y′z′) =
ωF , if codons xyz and x
′y′z′ are nonsynonymous
1, otherwise
(5.14)
and F being the frame in question and ωF the dN/dS ratio for the gene present in
frame F at this site. Indices g-l represent nucleotide states. Substitution to or from a
stop codon is not counted in the summations since we assume the codon probability
P for each stop is 0. β and γ sites are similarly defined, the only difference being a
rearrangement of codon arguments in the Ω functions.
Each term is divided by a sum over the starting state codon so that qij represents
an instantaneous rate of transition from i to j, rather than flux. Ensuring the model
is reversible (satisfying detailed balance: piiqij = pijqji) we define the equilibrium
frequency of nucleotide i:
pii =
(
4∑
k
4∑
l
Pikl
)(
4∑
h
4∑
k
Phik
)(
4∑
g
4∑
h
Pghi
)
. (5.15)
This model has NG + 1 free parameters: κ and one ω for each of NG genes.
Rather than normalising the matrix first by estimating a compensating scaling
factor as above, for this model we undertook to normalise each rate matrix by
computing the scalar ν exactly:
ν =
∑Nz
z
∑3
s nzs
−∑Nzz ∑3s nzs∑4i piiqii,zs (5.16)
where nzs is the number of sites in zone z and site type s ∈ {α, β, γ}, Nz is the
number of zones, i is nucleotide state and qii,zs is an element of Q[zs], which is
specific for sites of type s in zone z. The numerator is equal to the total number of
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nucleotide sites in the alignment.
5.3.2.4 Pentamer Model
The frame independence model treats a substitution as an independent process in
each frame. In fact, nucleotide substitutions in overlapping codons are not inde-
pendent, since a substitution affects all three frames simultaneously. We assume,
however, that the probabilities of overlapping codons are independent of each other.
We can therefore define the probability of a nucleotide pentamer ghikl, comprising
three complete codons, as
Pghikl =
PghiPhikPikl∑4
g′
∑4
h′
∑4
i′
∑4
k′
∑4
l′ Pg′h′i′Ph′i′k′Pi′k′l′
(5.17)
where codon probabilities Pxyz are taken from counts in sequence databases, as de-
scribed above. A derivation explaining the relationship between codon and pentamer
probabilities is presented in appendix F. For an α site,
qij,α =
νK(i, j)
∑4
g
∑4
h
∑4
k
∑4
l PghiklΩA(ikl, jkl)ΩB(ghi, ghj)ΩC(hik, hjk)Pghjkl∑4
g′
∑4
h′
∑4
k′
∑4
l′ Pg′h′ik′l′
(5.18)
where Ω functions are defined as in equation 5.14 and the matrix scaling factor ν is
computed as in equation 5.16. Nucleotide equilibrium frequencies are defined
pii =
4∑
g
4∑
h
4∑
k
4∑
l
Pghikl (5.19)
and it can be seen that detailed balance is satisfied. This model has the same free
parameters as the frame independence model.
5.3.3 Test for Positive Selection
5.3.3.1 Uniform Selective Constraints
Using the models above one can test for positive selection (i.e. test if ω > 1) in a
chosen gene using the LRT. A null model is fitted where the gene 1’s ω is fixed to 1,
while ω values of other genes are freely optimised. An alternative model is separately
fitted without constraint. The LRT with 1 degree of freedom then provides statistical
significance for non-neutral evolution, and a maximum likelihood estimate (MLE)
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ω > 1 indicates positive selection.
5.3.3.2 Mixture Models For Identifying Varying Selective Constraints
The models above will estimate a single ω value for each gene present in the dataset.
It is unlikely, however, that selective constraints will be uniform across a coding
sequence. Nielsen and Yang (1998) defined mixture models of codon evolution for a
single gene, permitting negative, neutral and positive selection selection by defining
ω0 < 0, ω1 = 1 (fixed) and ω2 > 1 which populate three separate codon substitution
matrices. A site class probability distribution comprising p0, p1 and p2 = 1−p0−p1
is estimated and a site’s probability is given by a sum over site classes, in which the
probability of the site class is multiplied by the probability of the site, conditional
on that site class’ ω. Two mixture models are defined: the null model has two site
classes (ω0 < 0, ω1 = 1) and the alternative has the positive selection class (ω > 1)
in addition. The LRT is used to assess significance of a superior fit of the positive
selection model.
Similarly, we define two or three site classes with the same constrained ω param-
eters and site class probability distributions, but for each individual gene. For the
positive selection (alternative) model we define a rate matrix Q[zsmAmBmC ] which is
specific to the two or three site classes m for the genes in frames A, B and C in a
site of type s in zone z. Again we normalise with scalar ν so the average substitution
rate across all matrices is 1:
ν =
∑Nz
z
∑3
s nzs
−∑Nzz ∑3s nzs∑NmmA∑NmmB∑NmmC pAmApBmBpCmC∑4i piiq[zsmAmBmC ]ii (5.20)
where mA, mB and mC are site classes (of which there are up to Nm; i.e. 2 for the
null model and 3 for alternative) and pAmA is the probability that the gene in frame
A of zone z is in site class mA at this site, etc.
Having computed transition probability matrices, the likelihood for nucleotide
alignment column Xk is then given by
L(Xk) =
Nm∑
mA
Nm∑
mB
Nm∑
mC
pAmAp
B
mB
pCmCP (Xk|ωAmA , ωBmB , ωCmC ), (5.21)
where P defines the probability of column Xk given the combination of ω parameters
for each frame (together defining Q[zsmAmBmC ]), computed by the pruning algorithm
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(Felsenstein, 1981). The total likelihood for an alignment is then a product over
individual sites, or, in practice, a sum of log-likelihoods.
For the alternative model, the free parameters are: κ and for each gene ω0, ω2
(ω1 = 1), and also for each gene p0 and p1 (p2 = 1− p0− p1). The null model differs
in having no ω2 and only p0 is free (p1 = 1− p0) for the gene of interest. In practice
we fix κ to the MLE from HKY when estimating branch lengths.
Positive selection is inferred to occur at some sites in the gene of interest if the
alternative model has significantly better likelihood than the null, assessed with the
LRT and two degrees of freedom. This mixture model scheme could be applied to
any of the models outline above, though we have done so with the pentamer model
only.
5.3.3.3 Empirical Bayes Procedure
Continuing in the vein of Nielsen and Yang (1998), we can then identify sites with
statistical support for undergoing positive selection. Maximum likelihood estimates
(MLEs) for parameter values are used in an empirical Bayes procedure to compute
the posterior probability that an alignment column belongs to a particular site class,
conditional on the data observed at that site.
The probability of nucleotide alignment column Xk belonging to site class x in
the gene residing in frame A at this site is
P
(
ωA(k) = ωAmA|Xk
)
=
pAmA
∑
mB
∑
mC
pBmBp
C
mC
P (Xk|ωAmA , ωBmB , ωCmC )∑
m′A
∑
m′B
∑
m′C
pAm′A
pBm′B
pCm′C
P (Xk|ωAm′A , ω
B
m′B
, ωCm′C
)
, (5.22)
where each ωFm is the MLE ω of site class m belonging to the gene in frame F and
pFm is the MLE probability of site class m for the gene in frame F .
However, the site class of an individual nucleotide site is not biologically mean-
ingful, as we assume selection acts at the level of codons rather than nucleotides.
Indeed, neighbouring nucleotide sites comprising a single codon in a particular frame
could be ascribed different site classes, implying paradoxically that a codon can expe-
rience apposing selective constraints simultaneously. We therefore want to calculate
the probability that a codon in any frame belongs to a particular site class.
A single codon V made up of nucleotide sites V1, V2 and V3 partially overlaps
with four other codons W , X, Y and Z (fig. 5.5). W and X are neighbouring
codons in the same frame and may belong to the same gene (and the same for Y
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V1 V2 V3 
W1 W2 W3 
X2 X3 
Z1 Z2 
Y1 Y2 Y3 
Figure 5.5: A single codon partially overlaps with four other codons in the two
remaining reading frames. Columns in the grid represent nucleotide sites comprising
a pentamer, at the centre of which lies codon V . Positions within each codon are
shown as subscripts and the boundaries of codon V are shown with bold lines. Each
lower row contains a codon partially overlapping with V . Codons X (of which only
positions 2 and 3 are shown) and W are neighbours in the same frame (yellow);
likewise codons Y and Z (of which positions 1 and 2 are shown) are in the same
frame (blue). If V spans a zone boundary, W/Y will be in a different gene (or
noncoding region) to X/Z.
and Z), but considering them separately allows for the situation where V spans a
border between zones and the neighbouring codons belong to separate genes, or one
is non-coding. As defined here, frames V , WX and Y Z could represent frames A,
B and C in any combination; e.g. if V1 is an α site then V is in frame A, XW is
in frame B and Y Z is in frame C. (We do not calculate probabilities for codons
which span splice boundaries (as in the HIV-1 genome, fig. 5.3) since concatenating
terminal sites to form the bridging codon in the frame of interest, as would happen
in splicing, gives rise to non-existent codons in the other frames.)
The probability of codon V belonging to site class i given data at nucleotide
sites V1, V2 and V3 is equal to the (prior) probability of site class i for the gene to
which codon V belongs (pVi ) multiplied by the likelihood of nucleotide sites V1, V2
and V3 conditional on the ω for the V gene being of class i (ω
V
i ), normalised by the
unconditional likelihood of the data at nucleotide sites V1, V2 and V3:
P (ωV = ωVi |XV ) =
pVi P (V1, V2, V3|ωVi )
P (V1, V2, V3)
=
pVi
∑
j,k,l,m[p
W
j p
X
k p
Y
l p
Z
m]P (XV 1|ωVi , ωXk , ωYl )P (XV 2|ωVi , ωWj , ωYl )P (XV 3|ωVi , ωWj , ωXk )∑
i′,j′,k′,l′,m′ [p
V
i′ p
W
j′ p
X
k′p
Y
l′ p
Z
m′ ]P (XV 1|ωVi′ , ωXk′ , ωYl′ )P (XV 2|ωVi′ , ωWj′ , ωYl′ )P (XV 3|ωVi′ , ωWj′ , ωXk′ )
(5.23)
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where, i, j, k, l, m and the same variables with primes represent site classes for the genes
residing in codons V , W , X, Y and Z, respectively. As in equation 5.21, the likelihood
functions involve constructing rate matrices from the sets of ω parameters, which will
depend on the site types of V1, V2 and V3.
5.3.4 Synthetic Data for Model Testing
5.3.4.1 Uniform Selective Constraints (LSD Simulation)
We want to test our nucleotide substitution models with synthetic data involving over-
lapping genes, generated by a process where selection has acted at the codon level. We
use a kinetic Monte Carlo simulation which makes nucleotide substitutions at rates de-
pendent on states at both the changing site and its neighbours. We call this the local site
dependence (LSD) simulation.
Each nucleotide site is at the centre of a pentamer (fig. 5.4) and has a rate of substitu-
tion to a specific target nucleotide dependent on the probabilities for the new pentamer’s
three codons and the ω value for each relevant gene, if the substitution causes a nonsyn-
onymous codon change in that frame. For example, if site x is of type α and is in the
centre of pentamer which has nucleotide states ghikl, then the rate of substitution i→ j
is
rx(i, j|g, h, k, l) = νK(i, j)ΩA(ikl, jkl)ΩB(ghi, ghj)ΩC(hik, hjk)PjklPghjPhjk, (5.24)
the components of which are defined as in §5.3.2. The formulation for β and γ sites is
the same, but with alternative combinations of codons and Ω functions, as the codons
belong to different genes. (ν is a scaling factor which scales the rates so branch lengths
can represent 1 substitution per site per unit length, which we define below.)
The overall rate of substitution across the sequence is then
R =
Nsites∑
x
3∑
j 6=i
rx(i, j|g, h, k, l) (5.25)
where Nsites is the number of nucleotide sites and again ghikl are the nucleotide states of
pentamer centred on site x.
Substitutions arise as a Poisson process and therefore, evolving along a branch of
length T , intervals between substitutions δt are drawn from an exponential distribution
parameterised by R, so that
P (δt|R) = Re−Rδt. (5.26)
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A nucleotide site x and target state j are chosen with probability
rx(i, j|g, h, k, l)
R
(5.27)
and an i → j substitution occurs at site x. This is repeated until the sum of δt values
equals or would otherwise exceed T (at which point we have reached the end of the branch).
As we can compute substitution rates only for sites at the centre of a pentamer, we do not
permit substitutions at the first and last two nucleotide sites of the sequence. Evolution
can be simulated in this way along each branch in a tree topology.
The root or starting sequence for the simulation is created by firstly choosing each site’s
state from a uniform distribution, and any stop codon (TAA, TGA or TAG) identified in
any frame has its leading T replaced with a C. This sequence is then ‘evolved’ along a
branch length of 10.0 substitutions per site using the procedure described above and the
specified parameter values, so that the root sequence is in equilibrium at the start of the
simulation.
The scaling factor ν is computed by numerical simulation. The product of a branch
length t and overall substitution rate R gives the number of substitutions to have occurred;
we wish to scale R such that t = 1 corresponds to 1 expected substitution per site.
Evolution of a single sequence (starting from a random sequence corrected for stop codons,
as above) is performed with the above procedure (but where ν = 1 in equation 5.24) until
a specified number of substitutions have occurred (in practice Nsubs = 1000). With each
substitution a δt is drawn from an exponential distribution, as in equation 5.26. If the
sum of these is T , then
ν =
T
Nsubs/Nsites
, (5.28)
where Nsites is the number of sites in the sequence. Scaling each rx(i, j|g, h, k, l) as in
equation 5.24 results in
R =
R0T
Nsubs/Nsites
(5.29)
(where R0 is the unscaled value), causing R ≈ Nsites, because the other terms cancel.
Therefore if t = 1, then tR = Nsubs ≈ Nsites, meaning there is one expected substitution
per site. For each simulation, we estimate 10 ν values independently with different starting
sequences and use the mean of these in the simulation which generates sequences for
analysis.
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Gene 1 
Gene 2 
1 901 77 825 
Figure 5.6: Layout of genes in synthetic data simulations and used for testing
substitution models. Genes 1 and 2 were in frames A and B, respectively, and each
275 codons long. The total length of the sequences was 901 nucleotides, and the
nucleotide site numbers for the zone boundaries are indicated. Not drawn to scale.
5.3.4.2 Variable Selective Constraints (vLSD Simulation)
Equation 5.24 assumes each gene has a single ω value. For testing the effectiveness of
our mixture models at identifying codon sites undergoing different types of selection, we
modify the simulation algorithm so two or three ω values can be specified for each gene,
and call this the variable local site dependence (vLSD) simulation. Prior to the simulation,
each codon in a gene is dedicated to one of three site classes, according to probabilities
p0, p1 and p2, the values of which are specified for each gene. We then specify values for
parameters ω0 < 1, ω1 = 1 and ω2 > 1 for each gene. Then, 5.24 becomes:
rx(i, j|g, h, k, l) = νK(i, j)ΩA(ikl, jkl|x)ΩB(ghi, ghj|x)ΩC(hik, hjk|x)PjklPghjPhjk,
(5.30)
where the Ω functions are defined as before (equation 5.14), but now return the ω associ-
ated with the site class of the codon to which nucleotide site x belongs. All other aspects
of the simulation remain the same.
5.4 Results
5.4.1 Testing Substitution Models
We tested the substitution models described above under varying conditions of ω values,
total branch length and overlap proportion. We generated five datasets for each test
condition, using the local site-dependence simulation (LSD). Every dataset comprised 64
sequences simulated using a bifurcating tree topology and contained two genes (numbered 1
and 2) and, unless varying overlap proportion itself, with most of their lengths overlapping
(fig. 5.6; see Methods §5.6.3). These were analysed with each of the models described to
assess accuracy of ω estimation, particularly for gene 1.
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5.4.1.1 Genetic Code Weighting Model Over-Estimates ω
Overlap proportion and sequence divergence
We tested accuracy of ω estimation by the genetic code weighting model (Theory §5.3.2.1)
over increasing proportions of gene overlap in the local site dependence (LSD) simulation
and found no clear correlation between inaccuracy and overlap proportion (appendix G.1).
However, it was clear that accurate ω estimation is not possible when sequences are en-
tirely overlapping, and so subsequent tests were done with a proportion of 5/6 overlap to
provide challenging but not impossible test cases (fig. 5.6). Similarly, testing ω estimation
with data generated using a range of input branch lengths found no correlation between
inaccuracy and divergence within a biologically relevant range (appendix G.2). In both
these sets of tests, over-estimation of ω was seen when the input ω > 1 for the gene of
interest and when using HIV-1 codon probabilities.
Varied input ω values
We then tested the model’s ability to estimate ω for the gene of interest across varying
input ω values using data generated with the LSD simulation, where the background gene
(gene 2) ω ∈ {0.7, 1.7} (fig. 5.7). Using equal codon probabilities (panels A and B) there
is slight overestimation of ω at high values (> 2) but approximately accurate estimation
of the ω for gene 2. Using human codon probabilities (fig. 5.7 panels C and D) the MLE
value is accurate except when the input ω = 3. Using HIV-1 codon probabilities (panels
E and F), however, shows overestimation of ω for each gene in almost every condition.
False positive rate
We sought to assess the rate at which the model falsely identifies positive selection. We
simulated 100 sequence datasets for each of the three sets of codon probabilities used
above, for both conditions where the gene 2 input ω is 0.7 or 1.7 and where gene 1 input
ω is 0.4, 0.6, 0.8 or 1.0 (i.e. 100 × 3 × 2 × 4 = 2400 datasets in total). We then fitted
the genetic code weighting model as above to each dataset and a null model where the
ω parameter is fixed at 1.0. As the null model is nested within the alternative with a
difference of one free parameter, we can use the likelihood ratio test (LRT) with 1 degree
of freedom to assess the statistical significance of the alternative model’s better fit to the
data. We define a false positive as the LRT wrongly rejecting the null model and ωˆ > 1+,
where ωˆ is the MLE value from the alternative model and  is a tolerance threshold, which
we set to 0.2.
Table 5.2 shows the false positive counts. There were no false positives in any condition
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Figure 5.7: Maximum likelihood estimates of ω values estimated by the genetic
code weighting model as a function of input ω value for gene 1 in simulated data.
While the gene 1 ω value was varied across simulated data sets (red points, with
solid red line showing the true value), gene 2’s ω was fixed at either 0.7 or 1.7
(purple triangles, with solid purple line showing true value). Each point is the mean
estimate from 5 simulated datasets and error bars show 1 standard deviation unit.
NB the scale for the y-axis is different in panels E and F compared with others.
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Codon Prob. Input G. 1 ω Input G. 2 ω False Positives (of 100 tests)
1/61 0.4 0.7 0
1/61 0.6 0.7 0
1/61 0.8 0.7 0
1/61 1.0 0.7 0
1/61 0.4 1.7 0
1/61 0.6 1.7 0
1/61 0.8 1.7 0
1/61 1.0 1.7 0
H. sapiens 0.4 0.7 0
H. sapiens 0.6 0.7 0
H. sapiens 0.8 0.7 0
H. sapiens 1.0 0.7 0
H. sapiens 0.4 1.7 0
H. sapiens 0.6 1.7 0
H. sapiens 0.8 1.7 0
H. sapiens 1.0 1.7 1
HIV-1 0.4 0.7 0
HIV-1 0.6 0.7 0
HIV-1 0.8 0.7 4
HIV-1 1.0 0.7 89
HIV-1 0.4 1.7 0
HIV-1 0.6 1.7 0
HIV-1 0.8 1.7 16
HIV-1 1.0 1.7 98
Table 5.2: Genetic Code Weighting Model False Positives. Codon Prob., codon
probabilities set; G., gene.
where the input ω for gene 1 was 0.4 or 0.6, and there were none when using equal
codon probabilities for any input ω value. There was a single false positive when using
human codon probabilities and the input ω value was 1.0. But when using HIV-1 codon
probabilities, the number of false positives was unacceptably high, rising to 98% when
input ω = 1 and gene 2 ω = 1.7. This is consistent with the other simulation test data
(fig. 5.7) showing overestimation of ω at high input values, particularly when using HIV-1
codon probabilities.
5.4.1.2 High Inequality of Synonymous Codon Probabilities Affects ω
estimation
The very high false positive rate found when using HIV-1 codon probabilities contrasted
markedly with the very low rate found when using equal or human codon probabilities.
Comparing the sets of probabilities directly, we observed that the distribution of codon
probabilities within a set of codons coding for the same residue appears more uneven in
HIV-1 probabilities than in human, as measured by the Gini coefficient, a measure of
inequality (fig. 5.8; Ceriani and Verme, 2012). In the LSD simulation, the substitution
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Figure 5.8: Gini coefficient (G) for each set of synonymous codon probabilities
(denoted by the letter code for the amino acid they represent), comparing those of
Homo sapiens and Human Immunodeficiency Virus type 1, from the Codon Usage
Database.
rate at a nonsynonymous nucleotide site is given by a product of the ω value and the target
codon probability (eq. 5.24). Therefore substitution from a codon of high probability to
a synonymous codon of much lower probability could have a lower rate than substitution
to a nonsynonymous codon, even if ω < 1.
To test whether uneven probabilities within synonymous codon groups are responsible
for the inaccurate ω estimation, we generated new sets of simulated data as before but using
human and HIV-1 codon probabilities averaged across synonymous groups. Fitting the
genetic code weighting model to each of these datasets, we found accuracy of ω estimation
was much improved (fig. 5.9). This suggested the accuracy of the model was sensitive to
codon bias and we therefore considered adjustments to the model to account for it.
5.4.1.3 Codon Weighting Model Over-Estimates ω
We tested the ability of the codon weighting model (Theory §5.3.2.2) to accurately estimate
ω using the same simulated datasets (fig. 5.10). As would be expected, there is little
difference in the accuracy of ω estimation when using codon probabilities of 1/61, since
the effect is only to take account of the three stop codons (eq. 5.12). There was little
difference in accuracy when using human codon probabilities and over-estimation of ω
was actually worse when using HIV-1 probabilities. It is therefore likely the false positive
rate would be unacceptably high.
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Homo sapiens codon frequencies A B
HIV codon frequencies C D
Figure 5.9: Codon weighting model fitted to data simulated using averaged human
and HIV-1 synonymous codon probabilities. While the gene 1 ω value was varied
across simulated data sets (red points, with solid red line showing the true value),
gene 2’s ω was fixed at either 0.7 or 1.7 (purple triangles, with solid purple line
showing true value). Each point is the mean estimate from 5 simulated datasets
and error bars show 1 standard deviation unit. Note that all panels are on the same
scale.
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Figure 5.10: Codon weighting model and varied ω values, presented as in fig.
5.7. While the gene 1 ω value was varied across simulated data sets (red points,
with solid red line showing the true value), gene 2’s ω was fixed at either 0.7 or 1.7
(purple triangles, with solid purple line showing true value). Each point is the mean
estimate from 5 simulated datasets and error bars show 1 standard deviation unit.
NB panels E and F are on a different scale.
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5.4.1.4 Frame Independence Model Over-Estimates ω
We sought to develop a new model which accounted for both codon biases and uncertainty
about sequence context explicitly. The frame independence model (Theory, §5.3.2.3) was
assessed for its ability to accurately determine ω values by fitting to the same simulated
datasets (fig. 5.11). These data show almost entirely accurate estimation of ω when using
equal and human codon probabilities. There is an improvement in accuracy when using
HIV-1 codon probabilities compared with the models presented above, but there is still
a considerable over-estimation. We anticipate, as with the genetic code weighting model,
the over-estimation of ω would produce a high false positive rate.
5.4.1.5 Pentamer Model Accurately Estimates ω Values and Has Low
False Positive Rate
ω Estimation
Reflecting on the previous approach, we noted that the frame independence model consid-
ers codon transitions in each frame as independent events (equation 5.13), when nucleotide
transitions involving codon biases may be better represented by considering a set of over-
lapping codons as a single unit.
We therefore developed the pentamer model (Theory, §5.3.2.4) and tested its ability
to estimate ω values as above, by fitting the model to the same simulated datasets. There
was accurate estimation and lower variance under all conditions compared to other models
(fig. 5.12).
We next tested the effect on ω estimation of increasing the proportion of overlap using
the same simulated data as analysed with the genetic code weighting model (appendix.
G.3). We found ω values were accurately estimated in most conditions, with the exception
of the extreme case of near total overlap (6/6), where there was over-estimation and much
higher variance of the estimate. We then tested the effect of increasing branch lengths on
ω estimation, again using the same data used to test the genetic code weighting model,
and found mostly accurate estimates within a biologically relevant range of divergence
(appendix G.4).
False Positive and Negative Rates
We assessed the false positive rate in the same approach taken in testing the genetic
code weighting model, using the same simulated datasets. There were no false positives
in any condition when using equal or human codon probabilities. Using HIV-1 codon
probabilities, there were 2 false positives when gene 1’s input ω = 1.0 and gene 2 input
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Figure 5.11: Frame Independence Model and Varied ω Values, presented as in fig.
5.7. While the gene 1 ω value was varied across simulated data sets (red points,
with solid red line showing the true value), gene 2’s ω was fixed at either 0.7 or 1.7
(purple triangles, with solid purple line showing true value). Each point is the mean
estimate from 5 simulated datasets and error bars show 1 standard deviation unit.
NB unlike in some previous figures, all panels are on the same scale.
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Figure 5.12: Pentamer model and varied ω values, presented as in fig. 5.7. While
the gene 1 ω value was varied across simulated data sets (red points, with solid
red line showing the true value), gene 2’s ω was fixed at either 0.7 or 1.7 (purple
triangles, with solid purple line showing true value). Each point is the mean estimate
from 5 simulated datasets and error bars show 1 standard deviation unit. NB unlike
in some previous figures, all panels are on the same scale.
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Codon Prob. Input G. 1 ω Input G. 2 ω False Negatives (of 100 tests)
1/61 1.2 0.7 12
1/61 1.4 0.7 0
1/61 1.6 0.7 0
1/61 1.2 1.7 8
1/61 1.4 1.7 0
1/61 1.6 1.7 0
H. sapiens 1.2 0.7 17
H. sapiens 1.4 0.7 1
H. sapiens 1.6 0.7 0
H. sapiens 1.2 1.7 16
H. sapiens 1.4 1.7 0
H. sapiens 1.6 1.7 0
HIV-1 1.2 0.7 0
HIV-1 1.4 0.7 0
HIV-1 1.6 0.7 0
HIV-1 1.2 1.7 0
HIV-1 1.4 1.7 0
HIV-1 1.6 1.7 0
Table 5.3: Pentamer Model False Negatives. Codon prob., codon probabilities set;
G., gene.
ω = 0.7, while there were 3 false positives when the gene of interest’s input ω = 1.0 and
the gene 2’s input ω = 1.7, each out of 100 datasets.
We then assessed the false negative rate, following the same procedure but simulating
data where gene 1 was under mild positive selection, with input ω equal to 1.2, 1.4 or 1.6
(table 5.3). Out of 100 tests, we found the highest number of false negatives was 17, when
the input ω = 1.2, using human codon probabilities and when gene 2’s input ω = 0.7;
most conditions had no false negatives. Together, these data showed the pentamer model
had acceptably low false positive and false negative rates.
5.4.2 Testing Pentamer Mixture Model
Having found the pentamer model to be accurate in simulation studies where genes expe-
rience uniform selective constraints across sites, we constructed a mixture model based on
the pentamer model to account for more varied constraints (Theory, §5.3.3.2). We tested
the model’s false positive rate by fitting to datasets of 64 synthetic sequences generated
with the vLSD simulation, again with two genes in frames A and B, with 300 codons in
each and similar overlap proportion as in figure 5.6. We used each set of codon probabil-
ities used previously and multiple input site class distributions (i.e. {p0, p1, p2}; Methods
§5.6.3 and table 5.5) for gene 1, but all with p2 = 0, i.e. where there is no positive selection.
All density was on the negative selection site class for gene 2 (p0 = 1) and for both genes
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ω0 = 0.4. For each combination of input parameters, we simulated three independent
datasets.
5.4.2.1 Likelihood Ratio Test Shows High False Positive Rate
We fitted the null and alternative models to the datasets generated with the vLSD. Initial
tests showed model optimisation was sensitive to starting values (data not shown) and
we therefore repeated each model fitting using six different start values for the site class
distributions to guard against optimisation errors (listed in appendix H.1). The log-
likelihood values were mostly consistent across the different start conditions used (data
not shown), but where there were differences we selected the highest log-likelihood result,
summarised in table 5.4.
Despite there having been no positive selection in the generation of these 27 datasets,
the LRT indicates significantly superior fit of the alternative model for 14 them. There
were two false positives among the datasets generated with equal codon probabilities, both
generated with input p1 = 1. One dataset (generated with equal codon probabilities and
p0 = 1) saw a higher null log-likelihood than the best alternative model, indicating the
alternative model had failed to find the global optimum. There were no false positives for
any codon probabilities when input p0 = 1. However, for datasets generated with HIV-1
or human codon probabilities, there were false positives from all datasets generated with
input {p0, p1, p2} = {0, 1, 0} or {0.5, 0.5, 0}.
5.4.2.2 Parametric Bootstrapping Shows High False Positive Rate
In our simulation tests, the process generating the data (vLSD simulation) is not identical
to the models which we fit to it (the pentamer mixture models, null or alternative). Having
found a high false positive rate with the LRT, we considered whether the significantly
large differences between the null and alternative log-likelihoods could be exaggerated
by this model misspecification, in which case the null distribution used in the LRT (a
chi-squared, here with 2 degrees of freedom) is somewhat inappropriate. We therefore
investigated whether the outcome is consistent if using a precise null distribution, created
by parametric bootstrapping.
As demonstrative examples, we took the MLE parameters from null models fitted to
one dataset generated with equal, HIV-1 or human codon probabilities and input p1 = 1
(i.e. 3 datasets in total; table 5.4, repeat index 1 in each case), for which there had been
false positives observed originally. We used these to generate 100 datasets as before using
the vLSD simulation, giving 300 datasets in total (summarised in fig. 5.13). We fitted the
null and alternative models to each of these and computed each log-likelihood difference
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Codon Freq. {p0, p1, p2} Rep. Null lnL Alt. lnL D p Alt. ωˆ2
1/61 {0, 1, 0} 1 -15166.217 -15162.658 7.118 0.028 1.281
1/61 {0, 1, 0} 2 -15279.973 -15275.446 9.054 0.011 1.511
1/61 {0, 1, 0} 3 -14677.330 -14674.988 4.683 0.096 1.231
1/61 {0.5, 0.5, 0} 1 -14990.498 -14988.325 4.345 0.114 1.694
1/61 {0.5, 0.5, 0} 2 -15416.263 -15416.249 0.028 0.986 1.012
1/61 {0.5, 0.5, 0} 3 -15074.770 -15074.687 0.166 0.920 1.475
1/61 {1, 0, 0} 1 -14611.263 -14613.908 -5.290 n/a 1.000
1/61 {1, 0, 0} 2 -15022.424 -15022.424 0.000 1.000 1.000
1/61 {1, 0, 0} 3 -14963.210 -14963.210 0.000 1.000 1.000
H. sapiens {0, 1, 0} 1 -15254.079 -15239.219 29.720 0.000 2.275
H. sapiens {0, 1, 0} 2 -15666.062 -15651.901 28.323 0.000 1.726
H. sapiens {0, 1, 0} 3 -15543.447 -15532.750 21.393 0.000 1.365
H. sapiens {0.5, 0.5, 0} 1 -14967.938 -14962.193 11.488 0.003 1.405
H. sapiens {0.5, 0.5, 0} 2 -15214.590 -15210.196 8.789 0.012 2.149
H. sapiens {0.5, 0.5, 0} 3 -15327.023 -15320.347 13.353 0.001 2.171
H. sapiens {1, 0, 0} 1 -14934.784 -14934.784 0.000 1.000 1.000
H. sapiens {1, 0, 0} 2 -15066.507 -15066.507 0.000 1.000 1.000
H. sapiens {1, 0, 0} 3 -15307.179 -15307.179 0.000 1.000 1.000
HIV-1 {0, 1, 0} 1 -15840.412 -15804.508 71.807 0.000 2.309
HIV-1 {0, 1, 0} 2 -16494.878 -16463.533 62.688 0.000 2.145
HIV-1 {0, 1, 0} 3 -16460.042 -16419.475 81.134 0.000 2.051
HIV-1 {0.5, 0.5, 0} 1 -16080.608 -16048.353 64.511 0.000 2.342
HIV-1 {0.5, 0.5, 0} 2 -15563.937 -15538.949 49.976 0.000 2.299
HIV-1 {0.5, 0.5, 0} 3 -15817.324 -15796.941 40.766 0.000 2.035
HIV-1 {1, 0, 0} 1 -15948.315 -15946.565 3.499 0.174 2.401
HIV-1 {1, 0, 0} 2 -15998.759 -15996.573 4.373 0.112 1.383
HIV-1 {1, 0, 0} 3 -16122.190 -16121.468 1.445 0.485 2.148
Table 5.4: Log-likelihoods (natural logarithms) and likelihood ratio test statistics
from analyses of datasets generated with the variable local site dependence (vLSD)
simulation under a range of simulation conditions. Null and alternative models were
fitted with 6 sets of starting values (see table H.1) and the best-fitting result for each
dataset is shown. Columns: Codon freqs., codon probability set; {p0, p1, p2}, input
site class probability distribution in vLSD; Rep., arbitrary repeat dataset index (all
generated with identical simulation conditions); Null lnL, null model log-likelihood;
Alt. lnL, alternative model log-likelihood; D, test statistic for likelihood ratio test
(LRT); p, p value computed with LRT, 2 degrees of freedom; Alt. ωˆ2, maximum
likelihood estimate for ω2 parameter by alternative model. A negative D indicates
optimisation failure of the null model, meaning the LRT is not applicable (n/a).
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Figure 5.13: Summary of the parametric bootstrap procedure. Chosen input
parameters (θ = {ω0, ω2, p0, p1, etc.}) were used to generate the original sequence
datasets with the variable local site dependence (vLSD) simulation. The alterna-
tive (Alt.) and null pentamer mixture models were fitted to these datasets (table
5.4), and the difference in log-likelihoods (∆`) was noted. The maximum likelihood
estimate (MLE) parameter values from the null model were used to generate 100
bootstrap datasets, again with the vLSD. The alternative and null models were
fitted to each of these and the bootstrap ∆` was noted. The set of bootstrap ∆`
constitutes a null distribution. For example, if the original ∆` is greater than the
5th highest bootstrap ∆`, then p < 0.05.
(∆`; fig. 5.14). This was compared with the ∆` observed with the original datasets;
these were 3.559, 35.903 and 14.860 for equal, HIV-1 and human codon probabilities,
respectively.
The largest value in the distribution associated with equal codon probabilities (fig.
5.14a) was 3.651, slightly higher than the ∆` observed in the original analysis, which
would indicate the null hypothesis could not be rejected with p < 0.01. However, this high
value was itself an extreme outlier, and may result from an optimisation failure of the null
model. (Limited computing resources prevented us trying different starting values for each
bootstrap dataset.) The highest ∆` observed in the HIV-1 and human codon probability
distributions were approximately 1× 10−7 and 6× 10−7, respectively, considerably lower
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Figure 5.14: Frequency histograms of ∆`, found by fitting the null and alternative
models to 100 datasets generated with the variable local site dependence simulation
(vLSD) using the maximum likelihood estimate parameter values, themselves found
by fitting the same null model to data originally generated by the vLSD simulation
with: (A) equal codon probabilities,; (B) HIV-1 codon probabilities; or (C) human
codon probabilities; all where input p1 = 1. Note that different scales are used in
each panel.
than the ∆` observed with the original datasets (35.903 and 14.860, respectively).
Together, these results indicated that the null hypothesis could be comfortably rejected
with p < 0.05 in each instance. The original model fitting results found to be significant
with the LRT (table 5.4) therefore probably all constitute real false positives, despite the
possible distortion caused by model misspecification.
5.5 Discussion
Multiple attempts have been made to study selection of overlapping coding sequences (Hein
and Stovlbaek, 1995; Pedersen and Jensen, 2001; Sabath et al., 2008; Wei and Zhang, 2015),
but to date a precise, mathematically consistent and tractable approach to modelling their
evolution has not been developed. We have designed several substitution models intended
for routine selection analysis of single-strand overlapping coding sequences.
The novelty of our approach is to restore the assumption of site independence by mod-
elling selection at the level of nucleotides, taking into account uncertainty about the effect
of nucleotide substitutions on the amino acid sequence. Applying standard nucleotide
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substitution models to overlapping genes in the hepatitis B virus genome, Yang et al.
(1995) were able estimate which overlapping genes were experiencing more stringent puri-
fying selection, based on comparing the estimated nucleotide substitution rates associated
with each gene’s predominantly synonymous or nonsynonymous codon positions. How-
ever, from rate estimates alone it is difficult to infer the type of selection experienced
by individual overlapping genes: for example, if two genes have their respective codon
positions 1 and 2 at the same nucleotide sites, a somewhat elevated substitution rate is
consistent with both (i) positive selection in one gene and purifying selection in the other,
or (ii) relaxed purifying selection in both, etc. We have therefore invoked parameters (ω)
representing explicitly the propensity for amino acid diversification over conservation for
each gene. This offers the added advantage of being conceptually familiar to investigators
routinely using standard codon models for identifying positive selection in non-overlapping
coding sequences. Applying the mixture model approach with constrained ω parameters
allows us to identify specific codon sites under positive selection (eq. 5.23), as is done with
conventional codon models (e.g. Nielsen and Yang, 1998; Yang et al., 2005).
The simplistic genetic code weighting model (Theory §5.3.2.1), was found to be unable
to estimate ω values accurately (fig. 5.7, 5.10), and was associated with an unacceptably
high false positive rate (table 5.2). We note that the model formulation assumes both equal
codon frequencies (eq. 5.1-5.3) and unequal nucleotide frequencies (eq. 5.6) and that this
inconsistency may partly account for the poor parameter estimation. Similarly, the slightly
modified codon weighting model (Theory §5.3.2.2), was also unable to estimate ω values
accurately (fig. 5.7, 5.10) and relies on predefined codon frequencies (eq. 5.12), while also
estimating nucleotide frequency parameters. The more sophisticated frame independence
model (Theory §5.3.2.3) offered an improvement in accuracy but still over-estimated ω
values (fig. 5.11).
The pentamer model (Theory §5.3.2.4) was found to be suitably accurate in estimating
ω for all input values tested (fig. 5.12), to have acceptable false positive and false negative
rates and to be accurate over several of gene overlap proportions and sequence divergence
(appendix G.3, G.4). Based on the pentamer model substitution matrix, we implemented
a mixture model which would allow us to investigate selective constraints varying across
sites in overlapping coding sequences, without resorting to a overly parameter rich site-
specific model (Nielsen and Yang, 1998). Using an empirical Bayes procedure we would
then seek to identify codon sites under positive selection, while still modelling nucleotide
substitutions.
Based on a small number of samples, we found the mixture model test for positive
selection has an unacceptably high false positive rate both with the LRT (table 5.4)
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and parametric bootstrapping (fig. 5.14). This was apparently associated only with data
generated with all or half of the input probability density on the neutral selection class
(p1 ∈ {1, 0.5}). While the ω over-estimation and high false positive rate found with the
non-mixture models were dependent on the codon probabilities used, this problem with
the pentamer-based mixture model affected all codon probability sets tested.
It may be necessary to adjust the functional form used in the substitution model to
better represent the nucleotide substitution process in overlapping coding sequences, and
in particular it may be useful to better define codon probabilities. Here in the first instance,
we have assumed codon probabilities for all genes under study can be represented by their
frequencies in sequence databases for each organism; however, codon frequencies will be
expected to differ for individual genes in real data. Indeed, our assumption of identical
codon probabilities for overlapping coding sequences (eq. 5.17) may be inappropriately
simplistic, since certain combinations of overlapping codons are effectively impossible. For
example, methionine has a single codon (ATG) and a pentamer cannot contain more than
one instance; therefore a high probability of ATG in one frame necessarily reduces the
probability in other frames. Moreover, in this work we have fixed codon probabilities to
the same values used in the vLSD simulation (which we might expect to unduly enhance
accuracy) but this may prevent the model accounting for the stochastic variability in
codons actually present in different datasets; a higher nonsynonymous substitution rate
may therefore be favoured to account for the discrepancy between the codon probabilities
provided and the frequencies observed. This could be addressed by several means:
1. For each gene in each dataset, use the observed codon counts as the probability
distribution for that gene.
2. Estimate nucleotide equilibrium frequencies (probabilities) with a standard nu-
cleotide substitution model and assume codon probabilities are the product of the
probabilities of constituent nucleotides, as is done for codon models implemented in
codeml (Yang, 2007). For example, one could allow a set of nucleotide frequencies
for each site type in each zone; however, this would introduce 9Nz free parameters
for Nz zones.
3. Estimate codon fitnesses more precisely. The pentamer model assumes pentamer
probabilities are a function of codon fitnesses, which we assume underly the frequen-
cies of codons in sequence databases (explained in appendix F). But codon fitnesses
could be estimated from each dataset using codon substitution models which in-
corporate fixation probabilities (Halpern and Bruno, 1998; Yang and Nielsen, 2008;
Tamuri et al., 2012). Codon models necessarily ignore overlapping coding sequences,
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but this model misspecification may be acceptable if it provides a more accurate rep-
resentation of codon probabilities.
Separately, some technical improvements could be made to the implementation. As we
found there was sensitivity to parameter start values in the mixture model optimisations
(data not shown), different numerical algorithms may identify likelihood peaks more reli-
ably; e.g. the conjugate gradient method, which computes derivatives numerically. Instead
or in addition, more sophisticated strategies for avoiding local optima could be used, such
as multiple optimisations where output values from one optimisation course are manipu-
lated in a non-deterministic way and then used as starting values for a subsequent course.
We have conditioned on branch lengths estimated separately with the HKY85 substitu-
tion model for the sake of speed, but one would preferably estimate these alongside other
model parameters.
We have not tested our implementation of an empirical Bayes approach to computing
probabilities for codons belonging to particular site classes (Theory §5.3.3.3) and naturally
this would be one of the first things to consider if the false positive rate is addressed
successfully. It has been argued that this ‘naive’ empirical Bayes approach does not
account for inadequate sampling and that a method incorporating data at all sites is more
appropriate (Yang et al., 2005); similar extensions could be developed in this instance.
Our models’ performances have been tested using data generated with a single genetic
layout, namely two genes in frame A and B, respectively. It will be necessary to address
whether the models are suited to multiple genetic layouts, as the various possible pairings
(first codon position in A being the same as the third codon position in B, etc.; fig. 5.2)
could have different evolutionary dynamics.
In conclusion, modelling selection in overlapping coding sequences has been attempted
several times (Hein and Stovlbaek, 1995; Pedersen and Jensen, 2001; Sabath et al., 2008;
Wei and Zhang, 2015), but still no precise method suited to routine analysis has been
described. We have developed an approach which has initially shown encouraging results.
However, improvements to the form of the substitution model will be required in order
to extend it so variable selective constraints are accurately accounted for, and individual
sites under positive selection can be identified.
5.6. METHODS 149
5.6 Methods
5.6.1 Implementation
Each of the models described above have been implemented in a single program written
in Java, with the working title ‘YesWeCAN’. This uses several third-party class libraries:
Phylogenetic Analysis Library for phylogenetics specific data structures (Drummond and
Strimmer, 2001); Apache Commons Math for linear algebra and function optimisation
routines (Apache-Commons, 2015); classes from swMutSel for representing optimisable
model parameters (described by Tamuri et al., 2012); jCommander for command line
interface (Beust, 2015); and opencsv for reading comma-separated value files (Smith and
Conway, 2016).
We use tree branch lengths estimated by the HKY85 substitution model without rate
heterogeneity (as implemented in baseml in the PAML package, version 4.7b, Yang, 2007)
and the same topology as used in the simulations (see below).
5.6.2 Function Optimisation
5.6.2.1 Algorithms
The maximum likelihood optimisation of all non-mixture models used the Nelder-Mead
simplex algorithm (Nelder and Mead, 1965), implemented in Apache Commons Math
(Apache-Commons, 2015). This algorithm performed poorly in tests of the mixture
model (data not shown) and subsequently Michael J. D. Powell’s ‘Bound Optimization
BY Quadratic Approximation’ (BOBYQA; Powell, 2009) algorithm was used in the mix-
ture model, also implemented in Apache Commons Math.
5.6.2.2 Optimisation starting values
For the non-mixture models, starting parameter values were: κ = 1, ω = 1 for each gene
and, where relevant, c = 1. For the mixture model, we used repeated analyses using six
combinations of start values for the site class probability distributions for each dataset
analysed, detailed in appendix H.1. We used starting values of ω0 = 0.5, ω2 = 1.5, fixed
κ to the MLE found with HKY85 while optimising branch lengths.
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p0 p1 p2
a 0.0 1.0 0.0
b 0.5 0.5 0.0
c 1.0 0.0 0.0
Table 5.5: Site class probability distributions used for gene 1 in the variable local
site dependence (vLSD) simulation to generate datasets exhibiting heterogeneous
selection pressure. Three site classes (0, 1, and 2) were used, representing negative,
neutral and positive selection respectively. Each distribution is named by a letter
(first column) for reference.
5.6.3 Simulated Data for Testing Models
5.6.3.1 Testing Non-Mixture Models
For testing the non-mixture models, all synthetic datasets were generated with the LSD
simulation, involving two overlapping genes in frames A and B respectively (fig. 5.6). Ex-
cept when varying overlap proportion explicitly, there were 76 nucleotide sites containing
either gene alone and 749 nucleotide sites of overlap. The tree used in the simulation
was a symmetric 64 taxa bifurcating tree, with all branch lengths equal to 0.02; when
testing branch length explicitly, all branch lengths were set to 0.002, 0.02, 0.2 or 2.0.
Branch lengths were then estimated with HKY85 for use in the model fitting (see Meth-
ods §5.6.1). Input codon probabilities were equal (1/61 for sense codons), HIV-1 or human,
from the Codon Usage database (see above). The gene 2’s input ω was either 0.7 or 1.7
and input κ = 2.0. We tested 5 overlap proportions from 16 (149 nucleotide sites) to
6
6
(901 nucleotide sites), 4 branch lengths ({0.002, 0.02, 0.2, 2.0}) or 9 ω values for gene 1
({0.0, 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 2.5, 3.0}). We generated 5 repeat datasets for each com-
bination of parameter input values.
5.6.3.2 Testing Mixture Models
Synthetic datasets were generated with the vLSD simulation with varied ω applied across
sites. 64 sequences were evolved along a bifurcating tree with each branch length equal
to 0.02 substitutions per site, as for the non-mixture models. Two genes were present in
frames A and B respectively, each comprising 300 codons, with 824 nucleotide sequences
in the overlap region and equal lengths without overlap for each gene. Gene 2 (in frame
B) had all probability density on the negative selection class (p0 = 1), with ω0 = 0.4.
For gene 1, three site class distributions were used (table 5.5). Gene 1 ω0 = 0.4. We
also used each set of codon probabilities tested previously: equal (1/61), HIV-1 or human
probabilities. For each of these 3(3 + [4× 2]) = 33 conditions, we simulated five separate
datasets with the same parameters.
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5.6.4 Parametric Bootstrapping
Bootstrap datasets were generated with the vLSD simulation using an identical genetic
layout as the original simulation (two genes with the same amount of overlap), the branch
length and κ values estimated by HKY85 and the MLEs from the null model estimated
from the original datasets. The large number of datasets precluded using multiple different
start values when fitting models, so the start values used for each set of bootstrap datasets
was the start values yielding the highest log-likelihood when analysing the original data.
Appendices
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Appendix A
SAMHD1: List of Species and
Sequence Accession Numbers
Table A.1: Species represented in the SAMHD1 analyses described and Genbank
accession numbers for DNA sequences. The Tasmanian devil sequence was found
to be split between two records (see SAMHD1 methods). M., mammals; Cet.,
Cetartiodactyla; Pr., Primates.
Analysis group Common name Binomial name Sequence accession
M. Carnivora amur tiger Panthera tigris altaica XM 007077693.1
M. Carnivora cat Felis catus XM 003983547.2
M. Carnivora dog Canis lupus familiaris XM 542986.4
M. Carnivora ferret Mustela putorius furo XM 004746473.1
M. Carnivora giant panda Ailuropoda melanoleuca XM 002915170.2
M. Carnivora polar bear Ursus maritimus XM 008698122.1
M. Carnivora walrus Odobenus rosmarus divergens XM 004393158.1
M. Carnivora weddell seal Leptonychotes weddellii XM 006733646.1
M. Cet. alpaca Vicugna pacos XM 006202728.1
M. Cet. bactrian camel Camelus bactrianus XM 010960760.1
M. Cet. baiji Lipotes vexillifer XM 007447732.1
M. Cet. common bottlenose dolphin Tursiops truncatus XM 004326928.1
M. Cet. cow Bos taurus NM 001075861.1
M. Cet. dromedary camel Camelus dromedarius XM 010975213.1
M. Cet. goat Capra hircus XM 013968902.1
M. Cet. minke whale Balaenoptera acutorostrata scammoni XM 007193161.1
M. Cet. mouflon or sheep Ovis aries musimon XM 012114778.1
M. Cet. orca Orcinus orca XM 004272978.2
M. Cet. plains or american bison Bison bison bison XM 010829204.1
M. Cet. sheep Ovis aries XM 012189160.1
M. Cet. sperm whale Physeter catodon XM 007116777.1
M. Cet. tibetan antelope Pantholops hodgsonii XM 005968060.1
M. Cet. water buffalo Bubalus bubalis XM 006051717.1
M. Cet. wild bactrian camel Camelus ferus XM 006188650.1
M. Cet. wild boar Sus scrofa NM 001292105.1
M. Cet. yak Bos mutus XM 005896009.1
M. Chiroptera big brown bat Eptesicus fuscus XM 008149758.1
M. Chiroptera black flying fox Pteropus alecto XM 006921792.1
M. Chiroptera brandts bat Myotis brandtii XM 005868463.1
M. Chiroptera davids myotis bat Myotis davidii XM 006764508.1
M. Chiroptera large flying fox Pteropus vampyrus XM 011366586.1
M. Chiroptera little brown bat Myotis lucifugus XM 006089575.1
M. Glires brown rat Rattus norvegicus NM 001191743.1
M. Glires chinese hamster Cricetulus griseus XM 007625631.1
M. Glires damara mole rat Fukomys damarensis XM 010640022.1
M. Glires deer mouse Peromyscus maniculatus bairdii XM 006984164.1
M. Glires degu Octodon degus XM 004630995.1
M. Glires european rabbit Oryctolagus cuniculus XM 008256128.1
M. Glires golden hamster Mesocricetus auratus XM 005084653.1
M. Glires guinea pig Cavia porcellus XM 003467744.2
M. Glires house mouse Mus musculus NM 018851.3
M. Glires lesser egyptian jerboa Jaculus jaculus XM 004666629.1
M. Glires long tailed chinchilla Chinchilla lanigera XM 005384981.1
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M. Glires naked mole rat Heterocephalus glaber XM 004888567.1
M. Glires pika Ochotona princeps XM 004586040.1
M. Glires prairie vole Microtus ochrogaster XM 005363152.1
M. Glires thirteen lined ground squirrel Spermophilus tridecemlineatus XM 005329859.1
M. Glires upper galilee mountains mole rat Nannospalax galili XM 008836546.1
M. Pr. agile gibbon Hylobates agilis JQ231127.1
M. Pr. allens swamp monkey Allenopithecus nigroviridis JN936900.1
M. Pr. angola colobus Colobus angolensis palliatus JN936905.1
M. Pr. angolan talapoin Miopithecus talapoin JN936901.1
M. Pr. black capped squirrel monkey Saimiri boliviensis boliviensis XM 010342629.1
M. Pr. black white ruffed lemur Varecia variegata variegata JN936913.1
M. Pr. bonobo Pan paniscus NM 001279186.1
M. Pr. bornean orangutan Pongo pygmaeus JN936888.1
M. Pr. brown woolly monkey Lagothrix lagotricha JQ231150.1
M. Pr. chimp Pan troglodytes NM 001280510.1
M. Pr. collared mangabey Cercocebus torquatus JQ231133.1
M. Pr. colobus Colobus guereza JQ231145.1
M. Pr. common marmoset Callithrix jacchus JN936906.1
M. Pr. common squirrel monkey Saimiri sciureus JN936909.1
M. Pr. cotton tamarin Saguinus oedipus JN936908.1
M. Pr. crab eating macaque Macaca fascicularis NM 001287721.1
M. Pr. de brazzas monkey Cercopithecus neglectus JQ231141.1
M. Pr. diana monkey Cercopithecus diana JN936902.1
M. Pr. drill Mandrillus leucophaeus JQ231131.1
M. Pr. francois langur Trachypithecus francoisi JN936904.1
M. Pr. gelada Theropithecus gelada JN936896.1
M. Pr. geoffroys spider monkey Ateles geoffroyi JN936911.1
M. Pr. golden bellied mangabey Cercocebus chrysogaster JN936898.1
M. Pr. golden snub nosed monkey Rhinopithecus roxellana XM 010355318.1
M. Pr. gorilla Gorilla gorilla NM 001279619.1
M. Pr. gray mouse lemur Microcebus murinus JN936914.1
M. Pr. green monkey Chlorocebus sabaeus NM 001292080.1
M. Pr. grivet Chlorocebus aethiops KF741041.1
M. Pr. hamadryas baboon Papio hamadryas JN936890.1
M. Pr. human Homo sapiens NM 015474.3
M. Pr. lar gibbon Hylobates lar JN936889.1
M. Pr. mandrill Mandrillus sphinx JN936897.1
M. Pr. mantled howler Alouatta palliata JN936912.1
M. Pr. nancy mas night monkey Aotus nancymaae XM 012455058.1
M. Pr. northen greater galago Otolemur garnettii XM 003788255.1
M. Pr. olive baboon Papio anubis NM 001279525.1
M. Pr. patas monkey Erythrocebus patas JQ231138.1
M. Pr. philippine tarsier Tarsius syrichta XM 008049665.1
M. Pr. proboscis monkey Nasalis larvatus JQ231144.1
M. Pr. pygmy marmoset Callithrix pygmaea JQ231146.1
M. Pr. red bellied titi Callicebus moloch JQ231152.1
M. Pr. red shanked douc Pygathrix nemaeus nemaeus JN936903.1
M. Pr. rhesus macaque Macaca mulatta JQ231135.1
M. Pr. siamang Symphalangus syndactylus JQ231128.1
M. Pr. sooty mangabey Cercocebus atys JQ231132.1
M. Pr. southern pig tailed macaque Macaca nemestrina XM 011767026.1
M. Pr. sumatran orangutan Pongo abelii XM 002830274.3
M. Pr. tantalus monkey Chlorocebus tantalus JN936892.1
M. Pr. three striped night monkey Aotus trivirgatus JN936907.1
M. Pr. tufted capuchin Cebus apella JN936910.1
M. Pr. vervet monkey Chlorocebus pygerythrus JQ231137.1
M. Pr. white cheeked gibbon Nomascus leucogenys NM 001280119.1
M. Pr. white faced saki Pithecia pithecia JQ231151.1
M. Pr. white lipped tamarin Saguinus labiatus JQ231147.1
M. Pr. wolfs mona monkey Cercopithecus wolfi JQ231140.1
M. Remaining aardvark Orycteropus afer afer XM 007934742.1
M. Remaining african bush elephant Loxodonta africana XM 003411700.2
M. Remaining armadillo Dasypus novemcinctus XM 004466604.2
M. Remaining cape elephant shrew Elephantulus edwardii XM 006881709.1
M. Remaining cape golden mole Chrysochloris asiatica XM 006875733.1
M. Remaining common shrew Sorex araneus XM 004612642.1
M. Remaining european hedgehog Erinaceus europaeus XM 007518471.1
M. Remaining gray short tailed opposum Monodelphis domestica XM 001381548.3
M. Remaining horse Equus caballus XM 001499498.3
M. Remaining lesser hedgehog tenrec Echinops telfairi XM 004698253.1
M. Remaining przewalskis horse Equus przewalskii XM 008541885.1
M. Remaining star nosed mole Condylura cristata XM 004686953.1
M. Remaining sunda flying lemur Galeopterus variegatus XM 008575366.1
M. Remaining tasmanian devil (5’) Sarcophilus harrisii XM 003758997.2
” tasmanian devil (3’) ” XM 012553363.1
M. Remaining treeshrew Tupaia chinensis XM 006144103.1
M. Remaining west indian manatee Trichechus manatus latirostris XM 004370368.1
M. Remaining white rhinoceros Ceratotherium simum simum XM 004430428.1
Birds mallard Anas platyrhynchos XM 005018014.1
Birds chimney swift Chaetura pelagica XM 009999860.1
Birds rhinoceros hornbill Buceros rhinoceros silvestris XM 010146105.1
Birds chuck wills widow Caprimulgus carolinensis XM 010173576.1
Birds killdeer Charadrius vociferus XM 009886339.1
Birds yellow throated sandgrouse Pterocles gutturalis XM 010087934.1
Birds speckled mousebird Colius striatus XM 010208317.1
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Birds rock dove Columba livia XM 005512218.1
Birds cuckoo roller Leptosomus discolor XM 009957655.1
Birds northern carmine beeeater Merops nubicus XM 008938233.1
Birds common cuckoo Cuculus canorus XM 009565365.1
Birds golden eagle Aquila chrysaetos canadensis XM 011597780.1
Birds white tailed eagle Haliaeetus albicilla XM 009919832.1
Birds bald eagle Haliaeetus leucocephalus XM 010564547.1
Birds peregrine falcon Falco peregrinus XM 005229325.1
Birds chicken Gallus gallus NM 001030845.1
Birds wild turkey Meleagris gallopavo XM 010722256.1
Birds red throated diver Gavia stellata XM 009822020.1
Birds red legged seriema Cariama cristata XM 009702527.1
Birds sunbittern Eurypyga helias XM 010157504.1
Birds grey crowned crane Balearica regulorum gibbericeps XM 010310362.1
Birds brown mesite Mesitornis unicolor XM 010190900.1
Birds macqueens bustard Chlamydotis macqueenii XM 010128452.1
Birds red crested turaco Tauraco erythrolophus XM 009985674.1
Birds hoatzin Opisthocomus hoazin XM 009935818.1
Birds rifleman Acanthisitta chloris XM 009076070.1
Birds american crow Corvus brachyrhynchos XM 008643497.1
Birds hooded crow Corvus cornix cornix XM 010413192.1
Birds zebra finch Taeniopygia guttata XM 002195540.2
Birds atlantic canary Serinus canaria XM 009098810.1
Birds white throated sparrow Zonotrichia albicollis XM 005495259.1
Birds collared flycatcher Ficedula albicollis XM 005056959.1
Birds ground tit Pseudopodoces humilis XM 005532216.1
Birds golden collared manakin Manacus vitellinus XM 008934650.1
Birds medium ground finch Geospiza fortis XM 005428399.1
Birds little egret Egretta garzetta XM 009637821.1
Birds dalmatian pelican Pelecanus crispus XM 009486761.1
Birds white tailed tropicbird Phaethon lepturus XM 010296384.1
Birds great cormorant Phalacrocorax carbo XM 009514424.1
Birds crested ibis Nipponia nippon XM 009473373.1
Birds downy woodpecker Picoides pubescens XM 009903354.1
Birds northen fulmar Fulmarus glacialis XM 009575330.1
Birds kia Nestor notabilis XM 010010583.1
Birds budgerigar Melopsittacus undulatus XM 005146833.1
Birds emperor penguin Aptenodytes forsteri XM 009283269.1
Birds adelie penguin Pygoscelis adeliae XM 009329356.1
Birds barn owl Tyto alba XM 009970142.1
Birds ostrich Struthio camelus australis XM 009679283.1
Birds white throated tinamou Tinamus guttatus XM 010212581.1
Birds annas hummingbird Calypte anna XM 008506368.1
Birds bar tailed trogon Apaloderma vittatum XM 009878222.1
Reptiles american alligator Alligator mississippiensis XM 006278901.1
Reptiles chinese alligator Alligator sinensis XM 006034284.1
Reptiles carolina anole Anolis carolinensis XM 003220542.2
Reptiles burmese python Python bivittatus XM 007419878.1
Reptiles green sea turtle Chelonia mydas XM 007053931.1
Reptiles painted turtle Chrysemys picta bellii XM 005295427.2
Reptiles chinese softshell turtle Pelodiscus sinensis XM 006113201.1
Amphibians african clawed frog Xenopus laevis BC072238.1
Amphibians western clawed frog Xenopus tropicalis XM 002932885.2
Fish japanese rice fish Oryzias latipes XM 004070493.2
Fish mexican tetra Astyanax mexicanus XM 007239426.1
Fish astatotilapia burtoni cichlid Haplochromis burtoni XM 005940268.1
Fish zebra mbuna cichlid Maylandia zebra XM 004546443.1
Fish neolamprologus brichardi cichlid Neolamprologus brichardi XM 006804309.1
Fish haplochromis nyererei cichlid Pundamilia nyererei XM 005740532.1
Fish zebrafish Danio rerio NM 001159933.1
Fish amazon molly Poecilia formosa XM 007544174.1
Fish guppy Poecilia reticulata XM 008413867.1
Fish southern platyfish Xiphophorus maculatus XM 005811227.1
Fish northern pike Esox lucius XM 010868248.1
Fish bicolor damselfish Stegastes partitus XM 008293652.1
Fish large yellow croaker Larimichthys crocea XM 010741581.1
Fish tonguefish Cynoglossus semilaevis XM 008319362.1
Fish spotted gar Lepisosteus oculatus XM 006639574.1
Fish japanese pufferfish Takifugu rubripes XM 011621666.1
Fish australian ghostshark Callorhinchus milii XM 007908660.1
Fish lancelet Branchiostoma floridae XM 002604911.1
Fish west indian ocean coelacanth Latimeria chalumnae XM 006003809.1
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pr.bornean_orangutan.JN936888_1__site_566__K
pr.hamadryas_baboon.JN936890_1__site_566__K
wu.wild_bactrian_camel.XM_006188650_1__site_566__R
pr.wolfs_mona_monkey.JQ231140_1__site_566__K
wu.alpaca.XM_006202728_1__site_566__Q
wu.water_buffalo.XM_006051717_1__site_566__Q
pr.diana_monkey.JN936902_1__site_566__K
gl.pika.XM_004586040_1__site_566__H
pr.mandrill.JN936897_1__site_566__K
ma.african_bush_elephant.XM_003411700_2__site_566__Q
pr.siamang.JQ231128_1__site_566__K
pr.common_marmoset.JN936906_1__site_566__Q
cp.davids_myotis_bat.XM_006764508_1__site_566__Q
pr.de_brazzas_monkey.JQ231141_1__site_566__K
cp.big_brown_bat.XM_008149758_1__site_566__Q
gl.golden_hamster.XM_005084653_1__site_566__R
wu.bactrian_camel.XM_010960760_1__site_566__R
wu.plains_or_american_bison.XM_010829204_1__site_566__R
pr.golden_snub_nosed_monkey.XM_010355318_1__site_566__K
ma.sunda_flying_lemur.XM_008575366_1__site_566__Q
wu.orca.XM_004272978_2__site_566__Q
pr.vervet_monkey.JQ231137_1__site_566__K
pr.angola_colobus.JN936905_1__site_566__K
cn.polar_bear.XM_008698122_1__site_566__Q
gl.lesser_egyptian_jerboa.XM_004666629_1__site_566__-
pr.white_cheeked_gibbon.NM_001280119_1__site_566__K
gl.thirteen_lined_ground_squirrel.XM_005329859_1__site_566__R
ma.gray_short_tailed_opposum.XM_001381548_3__site_566__G
pr.angolan_talapoin.JN936901_1__site_566__K
ma.cape_golden_mole.XM_006875733_1__site_566__Q
pr.bonobo.NM_001279186_1__site_566__R
pr.rhesus_macaque.JQ231135_1__site_566__K
pr.golden_bellied_mangabey.JN936898_1__site_566__K
pr.colobus.JQ231145_1__site_566__K
pr.gray_mouse_lemur.JN936914_1__site_566__Q
ma.armadillo.XM_004466604_2__site_566__R
pr.grivet.KF741041_1__site_566__K
pr.patas_monkey.JQ231138_1__site_566__K
gl.european_rabbit.XM_008256128_1__site_566__R
wu.baiji.XM_007447732_1__site_566__Q
pr.cotton_tamarin.JN936908_1__site_566__Q
pr.philippine_tarsier.XM_008049665_1__site_566__Q
pr.proboscis_monkey.JQ231144_1__site_566__K
cp.large_flying_fox.XM_011366586_1__site_566__R
pr.tufted_capuchin.JN936910_1__site_566__Q
pr.sumatran_orangutan.XM_002830274_3__site_566__K
gl.brown_rat.NM_001191743_1__site_566__G
gl.upper_galilee_mountains_mole_rat.XM_008836546_1__site_566__-
pr.three_striped_night_monkey.JN936907_1__site_566__Q
ma.lesser_hedgehog_tenrec.XM_004698253_1__site_566__X
pr.tantalus_monkey.JN936892_1__site_566__K
pr.sooty_mangabey.JQ231132_1__site_566__K
pr.white_faced_saki.JQ231151_1__site_566__Q
ma.cape_elephant_shrew.XM_006881709_1__site_566__Q
ma.star_nosed_mole.XM_004686953_1__site_566__Q
gl.naked_mole_rat.XM_004888567_1__site_566__K
wu.tibetan_antelope.XM_005968060_1__site_566__R
cp.brandts_bat.XM_005868463_1__site_566__Q
cp.little_brown_bat.XM_006089575_1__site_566__Q
ma.horse.XM_001499498_3__site_566__R
gl.degu.XM_004630995_1__site_566__K
cn.cat.XM_003983547_2__site_566__H
pr.agile_gibbon.JQ231127_1__site_566__K
gl.chinese_hamster.XM_007625631_1__site_566__R
wu.cow.NM_001075861_1__site_566__R
gl.deer_mouse.XM_006984164_1__site_566__R
cn.amur_tiger.XM_007077693_1__site_566__H
gl.damara_mole_rat.XM_010640022_1__site_566__K
pr.southern_pig_tailed_macaque.XM_011767026_1__site_566__K
gl.guinea_pig.XM_003467744_2__site_566__K
cn.ferret.XM_004746473_1__site_566__H
gl.prairie_vole.XM_005363152_1__site_566__R
gl.long_tailed_chinchilla.XM_005384981_1__site_566__K
cn.dog.XM_542986_4__site_566__K
wu.common_bottlenose_dolphin.XM_004326928_1__site_566__-
pr.collared_mangabey.JQ231133_1__site_566__K
wu.mouflon_or_sheep.XM_012114778_1__site_566__R
pr.drill.JQ231131_1__site_566__K
gl.house_mouse.NM_018851_3__site_566__G
cn.weddell_seal.XM_006733646_1__site_566__Q
pr.mantled_howler.JN936912_1__site_566__Q
pr.gorilla.NM_001279619_1__site_566__R
cp.black_flying_fox.XM_006921792_1__site_566__R
ma.aardvark.XM_007934742_1__site_566__Q
pr.francois_langur.JN936904_1__site_566__R
wu.wild_boar.NM_001292105_1__site_566__R
pr.white_lipped_tamarin.JQ231147_1__site_566__Q
pr.black_capped_squirrel_monkey.XM_010342629_1__site_566__Q
pr.allens_swamp_monkey.JN936900_1__site_566__K
pr.green_monkey.NM_001292080_1__site_566__K
Figure C.1: Maximum likelihood tree for mammalian SAMDH1, coloured by residues in each
sequence at site 566. Topology and node support identical to figure 2.5. Sequence names contain:
analysis group prefix, species common name, sequence accession and letter code for residue. Group
prefixes: ‘pr’, Primates; ‘gl’, Glires; ‘wu’, Cetartiodactyla; ‘cn’, Carnivora; ‘cp’, Chiroptera; ‘ma’,
remaining mammals. Branch lengths are nucleotide substitutions per site.
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pr.white_cheeked_gibbon.NM_001280119_1__site_574__A
gl.naked_mole_rat.XM_004888567_1__site_574__A
wu.orca.XM_004272978_2__site_574__L
gl.pika.XM_004586040_1__site_574__V
cp.big_brown_bat.XM_008149758_1__site_574__Q
pr.colobus.JQ231145_1__site_574__A
gl.golden_hamster.XM_005084653_1__site_574__A
pr.sumatran_orangutan.XM_002830274_3__site_574__A
cn.weddell_seal.XM_006733646_1__site_574__L
cn.dog.XM_542986_4__site_574__L
ma.common_shrew.XM_004612642_1__site_574__L
pr.francois_langur.JN936904_1__site_574__A
wu.baiji.XM_007447732_1__site_574__L
gl.guinea_pig.XM_003467744_2__site_574__A
pr.three_striped_night_monkey.JN936907_1__site_574__S
wu.yak.XM_005896009_1__site_574__L
gl.damara_mole_rat.XM_010640022_1__site_574__A
gl.european_rabbit.XM_008256128_1__site_574__A
pr.black_capped_squirrel_monkey.XM_010342629_1__site_574__S
wu.bactrian_camel.XM_010960760_1__site_574__V
pr.geoffroys_spider_monkey.JN936911_1__site_574__S
ma.west_indian_manatee.XM_004370368_1__site_574__V
wu.water_buffalo.XM_006051717_1__site_574__L
ma.star_nosed_mole.XM_004686953_1__site_574__K
ma.armadillo.XM_004466604_2__site_574__L
gl.house_mouse.NM_018851_3__site_574__A
pr.mandrill.JN936897_1__site_574__A
wu.sperm_whale.XM_007116777_1__site_574__L
pr.chimp.NM_001280510_1__site_574__A
gl.lesser_egyptian_jerboa.XM_004666629_1__site_574__-
pr.common_marmoset.JN936906_1__site_574__S
pr.sooty_mangabey.JQ231132_1__site_574__A
pr.siamang.JQ231128_1__site_574__A
pr.vervet_monkey.JQ231137_1__site_574__A
gl.thirteen_lined_ground_squirrel.XM_005329859_1__site_574__L
cp.davids_myotis_bat.XM_006764508_1__site_574__A
pr.brown_woolly_monkey.JQ231150_1__site_574__S
pr.philippine_tarsier.XM_008049665_1__site_574__L
pr.diana_monkey.JN936902_1__site_574__A
pr.angolan_talapoin.JN936901_1__site_574__A
pr.red_shanked_douc.JN936903_1__site_574__A
ma.sunda_flying_lemur.XM_008575366_1__site_574__I
pr.bonobo.NM_001279186_1__site_574__A
ma.przewalskis_horse.XM_008541885_1__site_574__L
cp.brandts_bat.XM_005868463_1__site_574__A
ma.european_hedgehog.XM_007518471_1__site_574__L
wu.alpaca.XM_006202728_1__site_574__V
pr.cotton_tamarin.JN936908_1__site_574__S
pr.lar_gibbon.JN936889_1__site_574__A
pr.white_faced_saki.JQ231151_1__site_574__S
cn.cat.XM_003983547_2__site_574__L
pr.allens_swamp_monkey.JN936900_1__site_574__A
pr.tufted_capuchin.JN936910_1__site_574__S
ma.horse.XM_001499498_3__site_574__L
pr.wolfs_mona_monkey.JQ231140_1__site_574__A
cn.polar_bear.XM_008698122_1__site_574__L
wu.minke_whale.XM_007193161_1__site_574__L
pr.pygmy_marmoset.JQ231146_1__site_574__S
pr.gelada.JN936896_1__site_574__A
ma.treeshrew.XM_006144103_1__site_574__L
wu.mouflon_or_sheep.XM_012114778_1__site_574__L
pr.gorilla.NM_001279619_1__site_574__A
pr.mantled_howler.JN936912_1__site_574__S
gl.prairie_vole.XM_005363152_1__site_574__A
ma.gray_short_tailed_opposum.XM_001381548_3__site_574__M
wu.cow.NM_001075861_1__site_574__L
cn.amur_tiger.XM_007077693_1__site_574__L
wu.common_bottlenose_dolphin.XM_004326928_1__site_574__-
pr.white_lipped_tamarin.JQ231147_1__site_574__S
cp.black_flying_fox.XM_006921792_1__site_574__S
gl.upper_galilee_mountains_mole_rat.XM_008836546_1__site_574__-
pr.rhesus_macaque.JQ231135_1__site_574__A
pr.patas_monkey.JQ231138_1__site_574__A
gl.deer_mouse.XM_006984164_1__site_574__A
gl.long_tailed_chinchilla.XM_005384981_1__site_574__A
pr.olive_baboon.NM_001279525_1__site_574__A
pr.grivet.KF741041_1__site_574__A
gl.brown_rat.NM_001191743_1__site_574__A
cn.ferret.XM_004746473_1__site_574__L
pr.black_white_ruffed_lemur.JN936913_1__site_574__I
pr.green_monkey.NM_001292080_1__site_574__A
pr.hamadryas_baboon.JN936890_1__site_574__A
wu.dromedary_camel.XM_010975213_1__site_574__V
pr.tantalus_monkey.JN936892_1__site_574__A
ma.cape_golden_mole.XM_006875733_1__site_574__S
ma.aardvark.XM_007934742_1__site_574__F
pr.collared_mangabey.JQ231133_1__site_574__A
pr.drill.JQ231131_1__site_574__A
pr.nancy_mas_night_monkey.XM_012455058_1__site_574__S
pr.angola_colobus.JN936905_1__site_574__A
pr.agile_gibbon.JQ231127_1__site_574__A
wu.goat.XM_005688681_1__site_574__L
pr.human.NM_015474_3__site_574__A
wu.plains_or_american_bison.XM_010829204_1__site_574__L
ma.cape_elephant_shrew.XM_006881709_1__site_574__S
ma.lesser_hedgehog_tenrec.XM_004698253_1__site_574__L
pr.southern_pig_tailed_macaque.XM_011767026_1__site_574__A
pr.proboscis_monkey.JQ231144_1__site_574__A
wu.wild_boar.NM_001292105_1__site_574__L
pr.bornean_orangutan.JN936888_1__site_574__A
pr.de_brazzas_monkey.JQ231141_1__site_574__A
cn.giant_panda.XM_002915170_2__site_574__L
cn.walrus.XM_004393158_1__site_574__L
pr.red_bellied_titi.JQ231152_1__site_574__S
pr.northen_greater_galago.XM_003788255_1__site_574__I
pr.golden_bellied_mangabey.JN936898_1__site_574__A
wu.tibetan_antelope.XM_005968060_1__site_574__L
gl.degu.XM_004630995_1__site_574__A
wu.sheep.XM_012189160_1__site_574__L
gl.chinese_hamster.XM_007625631_1__site_574__A
pr.common_squirrel_monkey.JN936909_1__site_574__S
ma.tasmanian_devil.XM_003758997_2_XM_012553363_1__site_574__I
pr.golden_snub_nosed_monkey.XM_010355318_1__site_574__A
wu.wild_bactrian_camel.XM_006188650_1__site_574__V
cp.large_flying_fox.XM_011366586_1__site_574__S
cp.little_brown_bat.XM_006089575_1__site_574__T
pr.gray_mouse_lemur.JN936914_1__site_574__I
pr.crab_eating_macaque.NM_001287721_1__site_574__A
ma.african_bush_elephant.XM_003411700_2__site_574__S
ma.white_rhinoceros.XM_004430428_1__site_574__L
Figure C.2: The same tree as in C.1, showing residues for site 574.
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gl.european_rabbit.XM_008256128_1__site_594__R
gl.degu.XM_004630995_1__site_594__L
ma.african_bush_elephant.XM_003411700_2__site_594__R
pr.colobus.JQ231145_1__site_594__Q
gl.thirteen_lined_ground_squirrel.XM_005329859_1__site_594__R
pr.philippine_tarsier.XM_008049665_1__site_594__Q
pr.collared_mangabey.JQ231133_1__site_594__Q
ma.sunda_flying_lemur.XM_008575366_1__site_594__Q
ma.treeshrew.XM_006144103_1__site_594__R
pr.olive_baboon.NM_001279525_1__site_594__Q
pr.gorilla.NM_001279619_1__site_594__Q
pr.patas_monkey.JQ231138_1__site_594__Q
cn.dog.XM_542986_4__site_594__R
pr.pygmy_marmoset.JQ231146_1__site_594__Q
pr.black_white_ruffed_lemur.JN936913_1__site_594__R
wu.tibetan_antelope.XM_005968060_1__site_594__L
ma.lesser_hedgehog_tenrec.XM_004698253_1__site_594__Q
pr.brown_woolly_monkey.JQ231150_1__site_594__Q
ma.przewalskis_horse.XM_008541885_1__site_594__L
pr.cotton_tamarin.JN936908_1__site_594__Q
wu.sperm_whale.XM_007116777_1__site_594__R
cp.brandts_bat.XM_005868463_1__site_594__L
pr.allens_swamp_monkey.JN936900_1__site_594__Q
pr.nancy_mas_night_monkey.XM_012455058_1__site_594__Q
cn.weddell_seal.XM_006733646_1__site_594__R
ma.common_shrew.XM_004612642_1__site_594__R
wu.common_bottlenose_dolphin.XM_004326928_1__site_594__-
pr.crab_eating_macaque.NM_001287721_1__site_594__Q
wu.sheep.XM_012189160_1__site_594__R
wu.wild_boar.NM_001292105_1__site_594__R
pr.drill.JQ231131_1__site_594__Q
pr.sooty_mangabey.JQ231132_1__site_594__Q
pr.chimp.NM_001280510_1__site_594__Q
cn.amur_tiger.XM_007077693_1__site_594__R
ma.tasmanian_devil.XM_003758997_2_XM_012553363_1__site_594__M
gl.prairie_vole.XM_005363152_1__site_594__R
pr.golden_snub_nosed_monkey.XM_010355318_1__site_594__Q
ma.aardvark.XM_007934742_1__site_594__X
wu.water_buffalo.XM_006051717_1__site_594__R
pr.common_squirrel_monkey.JN936909_1__site_594__Q
wu.baiji.XM_007447732_1__site_594__R
gl.deer_mouse.XM_006984164_1__site_594__X
pr.francois_langur.JN936904_1__site_594__Q
cn.cat.XM_003983547_2__site_594__R
ma.horse.XM_001499498_3__site_594__L
pr.white_lipped_tamarin.JQ231147_1__site_594__Q
wu.alpaca.XM_006202728_1__site_594__L
cn.walrus.XM_004393158_1__site_594__R
pr.white_cheeked_gibbon.NM_001280119_1__site_594__Q
wu.goat.XM_005688681_1__site_594__R
wu.yak.XM_005896009_1__site_594__S
ma.cape_golden_mole.XM_006875733_1__site_594__-
pr.tantalus_monkey.JN936892_1__site_594__Q
pr.angolan_talapoin.JN936901_1__site_594__Q
wu.plains_or_american_bison.XM_010829204_1__site_594__R
wu.dromedary_camel.XM_010975213_1__site_594__L
pr.common_marmoset.JN936906_1__site_594__Q
pr.agile_gibbon.JQ231127_1__site_594__Q
ma.armadillo.XM_004466604_2__site_594__Q
ma.white_rhinoceros.XM_004430428_1__site_594__L
gl.chinese_hamster.XM_007625631_1__site_594__L
cp.davids_myotis_bat.XM_006764508_1__site_594__L
pr.siamang.JQ231128_1__site_594__Q
cn.giant_panda.XM_002915170_2__site_594__R
pr.proboscis_monkey.JQ231144_1__site_594__Q
ma.star_nosed_mole.XM_004686953_1__site_594__L
pr.mantled_howler.JN936912_1__site_594__Q
pr.bornean_orangutan.JN936888_1__site_594__Q
wu.mouflon_or_sheep.XM_012114778_1__site_594__R
gl.damara_mole_rat.XM_010640022_1__site_594__R
gl.pika.XM_004586040_1__site_594__Q
wu.minke_whale.XM_007193161_1__site_594__R
pr.grivet.KF741041_1__site_594__Q
ma.west_indian_manatee.XM_004370368_1__site_594__R
pr.golden_bellied_mangabey.JN936898_1__site_594__Q
pr.white_faced_saki.JQ231151_1__site_594__Q
pr.angola_colobus.JN936905_1__site_594__Q
pr.hamadryas_baboon.JN936890_1__site_594__Q
pr.red_shanked_douc.JN936903_1__site_594__Q
pr.vervet_monkey.JQ231137_1__site_594__Q
pr.lar_gibbon.JN936889_1__site_594__Q
ma.european_hedgehog.XM_007518471_1__site_594__Q
pr.rhesus_macaque.JQ231135_1__site_594__Q
gl.house_mouse.NM_018851_3__site_594__L
pr.green_monkey.NM_001292080_1__site_594__Q
pr.gray_mouse_lemur.JN936914_1__site_594__Q
cp.big_brown_bat.XM_008149758_1__site_594__L
pr.southern_pig_tailed_macaque.XM_011767026_1__site_594__Q
ma.gray_short_tailed_opposum.XM_001381548_3__site_594__R
wu.orca.XM_004272978_2__site_594__R
gl.upper_galilee_mountains_mole_rat.XM_008836546_1__site_594__-
pr.three_striped_night_monkey.JN936907_1__site_594__Q
gl.lesser_egyptian_jerboa.XM_004666629_1__site_594__M
gl.golden_hamster.XM_005084653_1__site_594__M
ma.cape_elephant_shrew.XM_006881709_1__site_594__-
pr.wolfs_mona_monkey.JQ231140_1__site_594__Q
pr.mandrill.JN936897_1__site_594__Q
pr.sumatran_orangutan.XM_002830274_3__site_594__Q
pr.black_capped_squirrel_monkey.XM_010342629_1__site_594__Q
cn.ferret.XM_004746473_1__site_594__R
pr.diana_monkey.JN936902_1__site_594__Q
pr.human.NM_015474_3__site_594__Q
cn.polar_bear.XM_008698122_1__site_594__R
wu.cow.NM_001075861_1__site_594__L
pr.tufted_capuchin.JN936910_1__site_594__Q
cp.large_flying_fox.XM_011366586_1__site_594__L
wu.bactrian_camel.XM_010960760_1__site_594__L
cp.little_brown_bat.XM_006089575_1__site_594__L
cp.black_flying_fox.XM_006921792_1__site_594__L
gl.long_tailed_chinchilla.XM_005384981_1__site_594__R
pr.geoffroys_spider_monkey.JN936911_1__site_594__Q
pr.bonobo.NM_001279186_1__site_594__Q
pr.de_brazzas_monkey.JQ231141_1__site_594__Q
pr.gelada.JN936896_1__site_594__Q
wu.wild_bactrian_camel.XM_006188650_1__site_594__L
gl.guinea_pig.XM_003467744_2__site_594__Q
gl.naked_mole_rat.XM_004888567_1__site_594__R
pr.red_bellied_titi.JQ231152_1__site_594__Q
pr.northen_greater_galago.XM_003788255_1__site_594__Q
gl.brown_rat.NM_001191743_1__site_594__L
Figure C.3: The same tree as in C.1, showing residues for site 594.
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wu.dromedary_camel.XM_010975213_1__site_596__M
pr.green_monkey.NM_001292080_1__site_596__K
pr.white_cheeked_gibbon.NM_001280119_1__site_596__K
wu.wild_boar.NM_001292105_1__site_596__L
ma.treeshrew.XM_006144103_1__site_596__-
pr.bornean_orangutan.JN936888_1__site_596__K
pr.three_striped_night_monkey.JN936907_1__site_596__D
gl.prairie_vole.XM_005363152_1__site_596__-
ma.gray_short_tailed_opposum.XM_001381548_3__site_596__P
pr.rhesus_macaque.JQ231135_1__site_596__K
pr.sooty_mangabey.JQ231132_1__site_596__K
pr.gelada.JN936896_1__site_596__K
ma.cape_golden_mole.XM_006875733_1__site_596__-
pr.philippine_tarsier.XM_008049665_1__site_596__S
pr.gray_mouse_lemur.JN936914_1__site_596__Q
wu.yak.XM_005896009_1__site_596__K
pr.tufted_capuchin.JN936910_1__site_596__D
ma.west_indian_manatee.XM_004370368_1__site_596__Q
wu.sheep.XM_012189160_1__site_596__L
pr.proboscis_monkey.JQ231144_1__site_596__K
ma.cape_elephant_shrew.XM_006881709_1__site_596__-
gl.damara_mole_rat.XM_010640022_1__site_596__P
pr.wolfs_mona_monkey.JQ231140_1__site_596__K
cp.big_brown_bat.XM_008149758_1__site_596__P
pr.gorilla.NM_001279619_1__site_596__K
ma.african_bush_elephant.XM_003411700_2__site_596__Q
pr.hamadryas_baboon.JN936890_1__site_596__K
pr.lar_gibbon.JN936889_1__site_596__K
cn.dog.XM_542986_4__site_596__A
cp.davids_myotis_bat.XM_006764508_1__site_596__K
gl.european_rabbit.XM_008256128_1__site_596__R
ma.horse.XM_001499498_3__site_596__K
ma.common_shrew.XM_004612642_1__site_596__R
pr.tantalus_monkey.JN936892_1__site_596__K
wu.wild_bactrian_camel.XM_006188650_1__site_596__M
ma.star_nosed_mole.XM_004686953_1__site_596__L
gl.pika.XM_004586040_1__site_596__K
cn.giant_panda.XM_002915170_2__site_596__V
ma.sunda_flying_lemur.XM_008575366_1__site_596__S
pr.white_faced_saki.JQ231151_1__site_596__D
cn.polar_bear.XM_008698122_1__site_596__V
gl.thirteen_lined_ground_squirrel.XM_005329859_1__site_596__P
gl.degu.XM_004630995_1__site_596__Q
pr.angola_colobus.JN936905_1__site_596__K
pr.black_white_ruffed_lemur.JN936913_1__site_596__R
wu.plains_or_american_bison.XM_010829204_1__site_596__S
pr.human.NM_015474_3__site_596__K
gl.brown_rat.NM_001191743_1__site_596__-
ma.white_rhinoceros.XM_004430428_1__site_596__R
cn.walrus.XM_004393158_1__site_596__M
cn.cat.XM_003983547_2__site_596__E
pr.de_brazzas_monkey.JQ231141_1__site_596__K
pr.diana_monkey.JN936902_1__site_596__K
wu.cow.NM_001075861_1__site_596__K
gl.chinese_hamster.XM_007625631_1__site_596__-
gl.guinea_pig.XM_003467744_2__site_596__P
pr.white_lipped_tamarin.JQ231147_1__site_596__D
cp.large_flying_fox.XM_011366586_1__site_596__L
pr.colobus.JQ231145_1__site_596__K
pr.vervet_monkey.JQ231137_1__site_596__K
wu.sperm_whale.XM_007116777_1__site_596__L
wu.orca.XM_004272978_2__site_596__S
gl.upper_galilee_mountains_mole_rat.XM_008836546_1__site_596__-
wu.common_bottlenose_dolphin.XM_004326928_1__site_596__-
gl.naked_mole_rat.XM_004888567_1__site_596__P
wu.minke_whale.XM_007193161_1__site_596__L
ma.armadillo.XM_004466604_2__site_596__M
cn.amur_tiger.XM_007077693_1__site_596__E
ma.aardvark.XM_007934742_1__site_596__X
ma.przewalskis_horse.XM_008541885_1__site_596__K
ma.lesser_hedgehog_tenrec.XM_004698253_1__site_596__V
pr.sumatran_orangutan.XM_002830274_3__site_596__K
cn.weddell_seal.XM_006733646_1__site_596__M
gl.lesser_egyptian_jerboa.XM_004666629_1__site_596__K
pr.brown_woolly_monkey.JQ231150_1__site_596__D
pr.mandrill.JN936897_1__site_596__K
ma.european_hedgehog.XM_007518471_1__site_596__K
wu.baiji.XM_007447732_1__site_596__L
pr.southern_pig_tailed_macaque.XM_011767026_1__site_596__K
cp.brandts_bat.XM_005868463_1__site_596__K
pr.crab_eating_macaque.NM_001287721_1__site_596__K
pr.drill.JQ231131_1__site_596__K
pr.common_marmoset.JN936906_1__site_596__D
pr.cotton_tamarin.JN936908_1__site_596__D
gl.deer_mouse.XM_006984164_1__site_596__X
pr.grivet.KF741041_1__site_596__K
pr.common_squirrel_monkey.JN936909_1__site_596__D
cp.little_brown_bat.XM_006089575_1__site_596__K
wu.tibetan_antelope.XM_005968060_1__site_596__K
pr.francois_langur.JN936904_1__site_596__K
pr.mantled_howler.JN936912_1__site_596__D
wu.water_buffalo.XM_006051717_1__site_596__L
pr.patas_monkey.JQ231138_1__site_596__K
pr.allens_swamp_monkey.JN936900_1__site_596__K
pr.pygmy_marmoset.JQ231146_1__site_596__D
wu.mouflon_or_sheep.XM_012114778_1__site_596__L
pr.agile_gibbon.JQ231127_1__site_596__K
pr.golden_bellied_mangabey.JN936898_1__site_596__K
pr.olive_baboon.NM_001279525_1__site_596__K
pr.chimp.NM_001280510_1__site_596__K
pr.siamang.JQ231128_1__site_596__K
gl.golden_hamster.XM_005084653_1__site_596__-
cn.ferret.XM_004746473_1__site_596__M
wu.alpaca.XM_006202728_1__site_596__T
cp.black_flying_fox.XM_006921792_1__site_596__L
pr.golden_snub_nosed_monkey.XM_010355318_1__site_596__K
pr.red_shanked_douc.JN936903_1__site_596__K
pr.collared_mangabey.JQ231133_1__site_596__K
wu.goat.XM_005688681_1__site_596__L
pr.red_bellied_titi.JQ231152_1__site_596__D
gl.long_tailed_chinchilla.XM_005384981_1__site_596__L
pr.geoffroys_spider_monkey.JN936911_1__site_596__D
ma.tasmanian_devil.XM_003758997_2_XM_012553363_1__site_596__A
wu.bactrian_camel.XM_010960760_1__site_596__M
pr.nancy_mas_night_monkey.XM_012455058_1__site_596__D
gl.house_mouse.NM_018851_3__site_596__-
pr.northen_greater_galago.XM_003788255_1__site_596__E
pr.bonobo.NM_001279186_1__site_596__K
pr.angolan_talapoin.JN936901_1__site_596__K
pr.black_capped_squirrel_monkey.XM_010342629_1__site_596__D
Figure C.4: The same tree as in C.1, showing residues for site 596.
Appendix D
Capsid: swMutsel and M8
Statistics
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CA Site Null lnL Alt. lnL D N p (LRT) p Adj. M8 BEB if > 0.5
5 -382.427 -369.912 25.029 5 < 10−3 0.001 -
13 -637.358 -626.377 21.963 7 0.001 0.014 -
14 -1703.045 -1679.461 47.168 9 < 10−3 < 10−3 1.0
15 -1556.981 -1535.878 42.207 9 < 10−3 < 10−3 -
31 -914.086 -900.244 27.682 7 < 10−3 0.002 -
41 -809.025 -797.965 22.119 6 < 10−3 0.007 -
47 -306.044 -297.577 16.934 6 0.005 0.045
50 -826.978 -824.376 5.204 11 0.877 0.999 1.0
58 -535.445 -520.496 29.897 7 < 10−3 0.001 -
68 -161.088 -147.145 27.885 4 < 10−3 < 10−3 -
83 -1668.036 -1652.526 31.019 10 < 10−3 0.004 1.0
86 -1352.182 -1334.430 35.504 10 < 10−3 0.001 -
87 -949.131 -926.638 44.988 6 < 10−3 < 10−3 -
91 -1766.896 -1746.538 40.715 14 < 10−3 0.002 1.0
94 -445.594 -436.168 18.852 5 < 10−3 0.010 -
98 -682.367 -673.707 17.319 5 0.002 0.018 -
110 -852.800 -843.726 18.149 6 0.003 0.028 -
116 -1379.594 -1359.572 40.043 13 < 10−3 0.001 1.0
120 n/a n/a n/a 10 n/a n/a 1.0
131 -294.859 -284.180 21.358 5 < 10−3 0.004 -
141 -111.847 -102.098 19.497 3 < 10−3 0.001 -
171 -960.372 -942.834 35.075 6 < 10−3 < 10−3 -
177 -638.185 -623.433 29.504 5 < 10−3 < 10−3 -
194 -1179.364 -1169.241 20.246 5 < 10−3 0.006 -
204 -420.406 -413.413 13.986 3 < 10−3 0.011 -
225 -1564.469 -1562.007 4.924 6 0.425 0.999 1.0
Table D.1: Test statistics from selection analyses of HIV-1 M and SIVcpz capsid
(CA) using maximum likelihood tree topology. Null and Alt. lnL, null and alterna-
tive swMutsel model log-likelihoods; D, test statistic for likelihood ratio test (LRT);
N , number of residues observed at the site; p (LRT), p value from LRT with N − 1
degrees of freedom; p Adj., p values adjusted for multiple hypothesis testing by
controlling false discovery rate to 5% (Benjamini and Hochberg, 1995); M8 BEB,
probabilities computed by the model M8 Bayes empirical Bayes procedure for be-
longing to a positive selection site class. Shown are all sites found to be significant
(p adj. < 0.05) with swMutsel or with BEB probability > 0.5 with M8.
Appendix E
Accessory Genes: swMutsel and
M8 Statistics
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Nef site Null lnL Alt. lnL N D p p Adj. M8 BEB
14 -1634.171 -1601.654 13 65.033 < 10−3 < 10−3 1.0
15 -2437.847 -2425.835 17 24.026 0.089 0.236 1.0
16 -1184.301 -1175.739 4 17.124 < 10−3 0.005 -
21 -1492.448 -1470.787 15 43.322 < 10−3 < 10−3 -
24 -1903.716 -1885.054 13 37.324 < 10−3 0.002 1.0
39 -1486.826 -1479.344 10 14.964 0.092 0.24 1.0
45 -1182.828 -1170.461 9 24.733 0.002 0.011 -
47 -534.094 -521.987 8 24.213 0.001 0.008 -
48 -794.783 -781.428 12 26.711 0.005 0.029 -
49 -1825.979 -1816.103 11 19.753 0.032 0.108 1.0
50 -2096.867 -2082.195 16 29.343 0.015 0.068 1.0
53 -1042.444 -1023.316 12 38.257 < 10−3 < 10−3 -
54 -1303.755 -1249.834 9 107.842 < 10−3 < 10−3 -
76 -865.779 -854.694 8 22.171 0.002 0.014 -
83 -1496.943 -1492.159 12 9.568 0.57 0.871 1.0
85 -2683.493 -2655.699 13 55.588 < 10−3 < 10−3 1.0
87 -795.247 -786.326 5 17.841 0.001 0.009 -
100 -853.279 -836.8 4 32.957 < 10−3 < 10−3 -
102 -1297.009 -1297.009 6 0 1 1 1.0
113 -14.069 -10.229 2 7.681 0.006 0.031 -
116 -910.114 -896.945 5 26.339 < 10−3 < 10−3 -
120 -1379.792 -1372.918 6 13.75 0.017 0.077 1.0
125 -767.065 -745.765 6 42.6 < 10−3 < 10−3 -
126 -734.069 -713.058 7 42.021 < 10−3 < 10−3 -
133 -1814.695 -1793.588 7 42.215 < 10−3 < 10−3 1.0
135 -1678.934 -1678.934 7 0 1 1 1.0
137 -598.33 -590.148 4 16.364 < 10−3 0.007 -
138 -492.009 -471.894 5 40.23 < 10−3 < 10−3 -
142 -404.903 -382.43 5 44.947 < 10−3 < 10−3 -
143 -752.225 -739.09 6 26.27 < 10−3 < 10−3 -
151 -1936.835 -1921.871 13 29.929 0.003 0.017 1.0
158 -1541.862 -1533.748 13 16.228 0.181 0.382 1.0
163 -1911.919 -1891.606 16 40.626 < 10−3 0.003 -
168 -1465.518 -1451.924 14 27.189 0.012 0.061 1.0
169 -972.743 -959.93 7 25.626 < 10−3 0.002 -
173 -1150.187 -1134.769 13 30.835 0.002 0.013 0.999
176 -2039.646 -2026.724 14 25.843 0.018 0.077 1.0
178 -1329.437 -1325.312 6 8.25 0.143 0.33 1.0
180 -882.347 -864.55 8 35.595 < 10−3 < 10−3 -
182 -2248.378 -2227.062 10 42.633 < 10−3 < 10−3 1.0
184 -1405.963 -1382.001 9 47.925 < 10−3 < 10−3 -
188 -1861.416 -1842.999 16 36.834 0.001 0.009 1.0
194 -2282.652 -2260.835 14 43.634 < 10−3 < 10−3 1.0
196 -1118.536 -1088.872 9 59.327 < 10−3 < 10−3 -
198 -2093.148 -2076.96 13 32.376 0.001 0.009 1.0
202 -1327.213 -1293.057 6 68.312 < 10−3 < 10−3 1.0
Table E.1: Test statistics from selection analyses of HIV-1 M and SIVcpz Nef using
maximum likelihood tree topology. Null and Alt. lnL, null and alternative swMutSel
model log-likelihoods; D, test statistic for likelihood ratio test (LRT); N , number of
residues observed at the site; p, p value from LRT with N − 1 degrees of freedom; p
Adj., p values adjusted for multiple hypothesis testing by controlling false discovery
rate to 5% (Benjamini and Hochberg, 1995); M8 BEB, probabilities computed by
the model M8 Bayes empirical Bayes procedure for belonging to a positive selection
site class. Shown are all sites found to be significant (p adj. < 0.05) with swMutSel
or with BEB probability > 0.95 with M8.
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Vpu Site Null lnL Alt. lnL D N p (LRT) p Adj.
6 -1983.587 -1970.257 26.660 12 0.005 0.025
10 -692.669 -679.756 25.826 9 0.001 0.011
14 -979.955 -965.636 28.638 11 0.001 0.012
15 -1724.487 -1712.124 24.727 11 0.006 0.025
23 -1480.134 -1469.130 22.007 9 0.005 0.025
25 -1021.676 -1012.731 17.890 7 0.007 0.025
27 -782.581 -766.084 32.994 10 < 10−3 0.007
29 -345.664 -331.376 28.574 12 0.003 0.018
34 -1026.178 -1013.073 26.210 12 0.006 0.025
37 -928.667 -913.237 30.860 11 < 10−3 0.010
42 -734.522 -719.880 29.283 9 < 10−3 0.007
43 -1386.587 -1373.312 26.550 11 0.003 0.019
46 -1241.981 -1226.374 31.215 12 0.001 0.011
Table E.2: Test statistics from selection analyses of HIV-1 M and SIVcpz Vpu
using maximum likelihood tree topology. Null and Alt. lnL, null and alternative
swMutsel model log-likelihoods; D, test statistic for likelihood ratio test (LRT); N ,
number of residues observed at the site; p, p value from LRT with N − 1 degrees of
freedom; p Adj., p values adjusted for multiple hypothesis testing by controlling false
discovery rate to 5% (Benjamini and Hochberg, 1995). Shown are all sites found to
be significant (p adj. < 0.05) with swMutsel.
Vpr Site Null lnL Alt. lnL D N p (LRT) p Adj.
61 -946.812 -931.096 31.433 8 < 10−3 0.002
63 -1743.501 -1721.757 43.489 11 < 10−3 < 10−3
Table E.3: Test statistics from selection analyses of HIV-1 M and SIVcpz Vpr
using maximum likelihood tree topology. Null and Alt. lnL, null and alternative
swMutsel model log-likelihoods; D, test statistic for likelihood ratio test (LRT); N ,
number of residues observed at the site; p, p value from LRT with N − 1 degrees of
freedom; p Adj., p values adjusted for multiple hypothesis testing by controlling false
discovery rate to 5% (Benjamini and Hochberg, 1995). Shown are all sites found to
be significant (p adj. < 0.05) with swMutsel.
Appendix F
Pentamer Probability
From Kimura (1962) and Iwasa (1988), we can describe the probability for a codon (nu-
cleotide triplet) xyz as
Pxzy =
(P 0xyz)(e
Fxyz)∑
a,b,c(P
0
abc)(e
Fabc)
(F.1)
where Fxyz is the fitness of xyz scaled by the effective chromosomal number and P
0
xyz is
its probability in the absence of selection. It follows that the probability of a nucleotide
pentamer is
Pghikl =
(P 0ghikl)(e
Fghikl)∑
a,b,c,d,e(P
0
abcde)(e
Fabcde)
. (F.2)
We assume the fitnesses of each constituent codon are independent of one another.
Therefore,
Pghikl =
(P 0ghikl)(e
Fghikl)∑
a,b,c,d,e(P
0
abcde)(e
Fabcde)
(F.3)
≈ (P
0
ghikl)(e
Fghi+Fhik+Fikl)∑
a,b,c,d,e(P
0
abcde)(e
Fabc+Fbcd+Fcde)
=
(P 0ghikl)(e
Fghi)(eFhik)(eFikl)∑
a,b,c,d,e(P
0
abcde)(e
Fabc)(eFbcd)(eFcde)
We also assume P 0xyz =
1
64 for all xyz, and therefore (P
0
ghi)(P
0
hik)(P
0
ikl) ∝ 1643 .
We then assume Pxyz is equivalent to the frequency G of xyz observed in large
databases of codon sequences; i.e.
Pxyz ∝ e
Fxyz∑
abc e
Fabc
≡ Gxyz. (F.4)
169
170 APPENDIX F. PENTAMER PROBABILITY
Therefore,
Pghikl ∝ PghiPhikPikl∑
a,b,c,d,e PabcPbcdPcde
≡ GghiGhikGikl∑
a,b,c,d,eGabcGbcdGcde
. (F.5)
Appendix G
Dependence of ω Estimation on
Divergence and Overlap
Proportion
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Homo sapiens codon frequencies C D
1/61 codon frequencies A B
HIV codon frequencies E F
Figure G.1: Genetic code weighting model and overlap proportion. Maximum
likelihood estimates of ω values estimated by the genetic code weighting model, as
a function of overlap proportion between two genes in simulated data. 64 sequences
were simulated, each 901 nucleotide sites long. Each point is the mean ω estimate
across separate model fitting to five independently simulated datasets and error bars
represent one standard deviation unit. The true ω values used in the simulation are
shown as solid lines; these were 0.7 or 1.7 for the gene of interest (purple) and 0.5 for
the background gene. The same procedure was done with equal codon probabilities
(A and B), human codon probabilities (C and D) and HIV codon probabilities (E
and F).
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Homo sapiens codon frequencies C D
1/61 codon frequencies A B
HIV codon frequencies E F
Figure G.2: Genetic code weighting model and branch length. Maximum like-
lihood estimates of ω values estimated by the genetic code weighting model as a
function of branch length used in simulated data, presented as in figure G.1. 64 se-
quences were simulated along a bifurcating tree where each branch length (in units
of 1 expected substitution per site) was specified by the value on the x-axis. The
black vertical lines at extreme branch lengths are large error bars which extend
beyond the scale of the plot.
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Homo sapiens codon frequencies C D
1/61 codon frequencies A B
HIV codon frequencies E F
Figure G.3: Maximum likelihood estimates of ω values estimated by the pentamer
model, as a function of overlap proportion between two genes in the same simulated
data analysed with the genetic code weighted model. Presented as in fig. G.1.
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Homo sapiens codon frequencies C D
1/61 codon frequencies A B
HIV codon frequencies E F
Figure G.4: Maximum likelihood estimates of ω values estimated by the pentamer
model as a function of branch length (nucleotide substitutions per site) used in
simulated data, presented as in figure G.2. The black vertical line in panels B and
F are large error bars which extend beyond the scale of the plot.
Appendix H
Mixture Model Optimisation
ID Gene 1 (Alt.) Gene 1 (Null) Gene 2 (All models)
p0 p1 p2 p0 p1 p2 p0 p1 p2
0 0.6 0.2 0.2 0.75 0.25 0 0.3˙ 0.3˙ 0.3˙
1 0.2 0.6 0.2 0.25 0.75 0 0.3˙ 0.3˙ 0.3˙
2 0.2 0.2 0.6 0.5 0.5 0 0.3˙ 0.3˙ 0.3˙
3 0.3˙ 0.3˙ 0.3˙ 0.5 0.5 0 0.6 0.2 0.2
4 0.3˙ 0.3˙ 0.3˙ 0.5 0.5 0 0.2 0.6 0.2
5 0.3˙ 0.3˙ 0.3˙ 0.5 0.5 0 0.2 0.2 0.6
Table H.1: Different combinations of starting values used for the site class probabil-
ity distribution in tests using data generated with the variable local site dependence
simulation (vLSD). Abbreviations: ID, identifier used in the text; Alt., alternative
mixture model; Null, null model; 0.3˙ ≈ 1
3
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